chabr
r
roy
nh
ho
ho
ho
hx
xh
xh
hx
x
x
x
nh
branch
aliphat
scaffold
n
nh
h
n
nh
h
n
n
h
nh
ab
system
ab
system
trival
core
tetraval
core
branch
aromat
scaffold
x
x
x
x
cocl
co
h
br
ch
oh
trival
core
x
x
x
oh
nh
br
cooh
ab
system
ho
cooh
oh
ho
ab
system
x
cocl
co
h
br
x
x
tetraval
core
cl
cl
cl
cl
cl
cl
hexaval
core
n
hn
n
nh
x
x
oh
ho
oh
ho
oh
hexaval
core
br
br
br
br
br
aco
aco
aco
oac
oac
aco
br
oac
nan
r
bn
r
bz
r
h
scheme
synthesi
tetramannosyl
pentaerythritol
extend
linker
scheme
extend
tetramannosyl
cluster
prepar
touaibia
et
al
x
aco
aco
x
oor
aco
aco
oac
aco
aco
aco
aco
oac
aco
aco
aco
oac
co
co
dioxan
sever
day
x
aco
x
oac
x
oac
x
aco
x
oac
x
aco
major
isom
major
isom
scheme
cobaltcatalyz
cyclotrimer
propargyl
glycosid
ro
bzo
bzo
bzo
obz
aco
aco
aco
oac
aco
aco
oac
aco
papaglc
poli
pnacryloylamidophenyl
aglucopyranosid
pb
phosphat
buffer
salin
pepo
pentaerythrityl
phosphodiest
oligom
pet
photoinduc
electron
transfer
pitc
phenylisothiocyan
pdt
photodynam
therapi
poss
polyhedr
oligosilsesquioxan
pmbc
peripher
blood
mononuclear
cell
ppi
polypropyleneimin
ps
photosensit
pvk
poli
methyl
vinyl
keton
pybop
hexafluorophosph
qsar
quantit
structureact
relationship
rca
ricinu
communi
agglutinin
rgp
radial
growth
polymer
scvcp
selfcondens
vinyl
copolymer
sem
scan
electron
microscopi
shc
sonogashiraheckcassar
cross
coupl
reaction
slt
shigalik
toxin
sltiie
shigalik
toxin
ii
edema
variant
spglac
schizophyllan
bear
lactosid
spr
surfac
plasmon
reson
sp
solidphas
synthesi
stec
shiga
toxigen
group
escherichia
coli
stx
shiga
toxin
swnt
singlewal
nanotub
tbaf
tetranbutylammonium
fluorid
tbah
tetranbutylammonium
hydroxid
tbtu
tetrafluorobor
tem
transmiss
electron
microscopi
tempo
tf
thomsenfriedenreich
antigen
tfa
trifluoroacet
acid
tga
thermogravimetr
analysi
thf
tetrahydrofuran
tri
tri
hydroxymethyl
aminomethan
vaa
viscum
album
agglutinin
vt
verotoxin
vvhrp
horseradish
peroxidaselabel
plant
lectin
v
villosa
vva
v
villosa
plant
lectin
wga
wheat
germ
agglutinin
yd
yolk
decasaccharid
introduct
gener
valenc
particl
name
small
molecul
oligosaccharid
protein
nucleic
acid
lipid
aggreg
molecul
viru
bacterium
cell
defin
number
separ
structur
unit
kind
interact
particl
ligandreceptor
interact
thu
one
consid
molecul
two
tether
ident
copi
bind
compon
classifi
dival
entiti
similarli
multival
polyval
interact
defin
specif
simultan
associ
multipl
ligand
epitop
present
molecular
construct
biolog
surfac
bind
cooper
way
multipl
receptor
express
complementari
entiti
ubiqu
multival
interact
differ
level
sever
biolog
mechan
testifi
essenti
role
fact
multival
natur
often
express
fractal
dendrit
architectur
repres
perhap
pervas
topolog
observ
veget
anim
kingdom
typic
exampl
pattern
may
found
differ
scale
dimension
length
meter
micron
typic
exampl
observ
abiot
system
snow
crystal
fractal
eros
manganes
dendrit
rock
biolog
world
reason
extens
mimicri
dendrit
topolog
virtual
scale
dimension
length
entir
clear
howev
one
might
specul
evolutionari
architectur
optim
past
sever
billion
year
provid
structur
manifest
maximum
interfac
optimum
energi
extractiondistribut
nutrient
extractiondistribut
inform
storageretriev
adhes
process
exampl
tree
use
fractal
dendrit
pattern
beneath
ground
order
enhanc
exposur
leav
sunlight
harvest
light
maxim
photosynthesi
process
root
collect
water
soil
notabl
natur
exampl
architectur
molecular
level
probabl
glycogen
amylopectin
hyperbranch
structur
natur
use
energi
storag
presum
mani
chain
end
decor
macromolecul
facilit
enzymat
access
glucos
highdemand
bioenergi
event
anoth
nanoscal
exampl
dendrit
architectur
biolog
system
found
proteoglycan
macromolecul
appear
provid
energyabsorb
cushion
properti
determin
viscoelast
properti
connect
tissu
addit
tremend
complex
dendrit
respiratori
network
compos
bronchiol
alveoli
give
maximum
surfac
effici
transfer
oxygen
bloodstream
arteri
central
nervou
system
network
togeth
kidney
lung
structur
also
consist
great
number
cell
grow
dendrit
structur
order
gain
largest
exchang
materi
inform
surround
tissu
recent
implic
dendrit
pattern
observ
feet
gecko
also
clarifi
explain
except
abil
anim
climb
rapidli
smooth
vertic
surfac
microscop
examin
shown
gecko
foot
nearli
five
hundr
thousand
keratin
hair
seta
compos
impress
dendrit
network
tini
foot
hair
spatula
measur
reveal
one
seta
time
effect
adhes
predict
maxim
estim
whole
anim
valu
adhes
forc
support
hypothesi
individu
seta
oper
weak
attract
quantum
chemic
forc
molecul
foothair
interact
van
der
waal
forc
molecul
surfac
final
strike
exampl
also
afford
natur
particularli
expos
wide
array
complex
dendrit
glycoconjug
mammalian
cell
surfac
carbohydr
structur
play
critic
role
multipl
key
cellular
event
cellular
adhes
recognit
regul
physiolog
function
pathogen
infect
sever
hypothesi
formul
concern
role
infect
process
specul
nlink
hyperbranch
high
mannos
oligosaccharid
man
glcnac
expos
exterior
envelop
glycoprotein
help
hidden
viru
escap
neutral
antibodi
inde
glycan
produc
host
cell
larg
unrecogn
immun
system
machineri
although
carbohydr
correspond
conjug
glycoform
long
regard
spacefil
matric
posttranscript
accessori
element
glycoprotein
serv
protect
prematur
degrad
becom
appar
glycoconjug
glycolipid
glycosaminoglycan
exhibit
broad
varieti
addit
biolog
function
inde
carbohydr
express
major
mammalian
cell
surfac
bound
protein
glycoprotein
glycolipid
conjug
cellular
constitu
proteoglycan
entangl
cell
membran
cluster
multiantennari
configur
term
oligosaccharid
constitut
signal
transductor
extraand
intracellular
media
henc
glycosyl
structur
respons
present
target
structur
microorgan
toxin
antibodi
control
halflif
protein
modul
protein
function
provis
ligand
specif
bind
event
addit
recent
emerg
antigen
determin
cellcel
recognit
signal
event
ligand
bacteri
viral
infect
constitut
first
line
contact
adhes
tissu
colon
sever
pathogen
express
carbohydratebind
protein
lectin
convers
sever
infecti
microorgan
use
escap
immun
defens
mechan
mask
import
receptor
antigen
determin
expos
selfcarbohydr
structur
mention
earlier
consequ
mask
event
bacteri
viral
pathogen
transport
target
tissu
self
cellular
system
despit
critic
import
carbohydrateprotein
interact
paradox
character
rather
weak
associ
constant
millimicromolar
limit
specif
select
persaccharid
basi
natur
usual
compens
situat
expos
numer
copi
carbohydr
ligand
extracellular
domain
cell
consequ
interact
transform
potent
attract
forc
dramat
natur
reinforc
multipl
ligand
copi
present
similarli
cluster
receptor
phenomenon
result
synerg
cooper
effect
known
glycoclust
dendrit
effect
initi
observ
asialoglycoprotein
receptor
found
hepatocyt
widespread
version
usual
assum
effect
sourc
enhanc
affin
given
multival
glycosid
toward
crd
carbohydraterecognit
domain
fulli
occupi
one
activ
site
timeth
phenomenon
wide
accept
basi
stabil
macroscop
crosslink
glycoclust
effect
thu
come
well
establish
multival
may
offer
numer
benefit
term
affin
receptor
select
versu
monoval
interact
induc
particular
cluster
organ
cell
surfac
notabl
provid
strategi
control
signal
transduct
pathway
within
cell
surprisingli
howev
mammal
util
nine
differ
monosaccharid
organ
massiv
amount
structur
divers
variat
anomer
configur
linkag
posit
saccharid
thu
respons
unravel
sever
distinct
glycocod
consequ
differ
architectur
topolog
express
result
origin
requir
high
affin
select
particular
tailor
recognit
event
interestingli
even
complex
multiantennari
glycan
man
glcnac
partli
involv
bind
process
often
unexpectedli
peripher
group
bound
receptor
activ
site
henc
multival
interact
understood
ubiquit
strategi
evolv
natur
wide
rang
function
provid
numer
benefit
uniqu
role
achiev
monoval
interact
consequ
simplist
point
view
multiantennari
glycan
may
regard
polyval
neoglycoconjug
welldefin
architectur
multival
design
mimic
complex
multiantennari
oligosaccharid
structur
emphas
recognit
sole
surfac
mention
multival
carbohydrateprotein
interact
mediat
mani
import
physiolog
pathophysiolog
process
howev
thorough
understand
suffer
natur
complex
carbohydr
result
incomplet
biosynthesi
subtl
attach
function
specif
posit
along
oligosaccharid
sequenc
numer
key
function
carbohydr
depend
observ
microheterogen
ad
welldefin
cluster
organ
order
studi
character
understand
manipul
critic
interact
strike
advanc
made
isol
purif
structur
analys
partial
select
degrad
process
altern
chemic
chemoenzymat
synthesi
multival
carbohydr
ligand
howev
like
remain
method
choic
afford
tailor
multival
architectur
develop
effector
inhibitor
biolog
mechan
accordingli
highli
desir
tackl
inher
problem
high
specif
increas
affin
simultan
optim
factor
involv
multival
intrins
fine
tune
ligand
toward
individu
target
carbohydratebind
protein
interact
achiev
goal
glycochemist
activ
pursu
approach
summar
fig
step
undertaken
may
express
follow
assess
bacterialvir
genom
proteom
analysi
search
carbohydratebind
protein
homolog
bioinformat
presenc
carbohydratebind
protein
confirm
bacteri
viral
lectin
isol
protein
label
fluorogen
probe
ligandbind
specif
fluoresc
lectin
determin
glycan
microarray
one
freeli
access
consortium
function
glycom
like
identifi
best
oligosaccharid
lead
recent
microarray
usual
constitut
approxim
natur
synthet
glycan
version
essenti
carbohydr
residu
epitop
respons
biolog
activ
interest
identifi
lead
candid
valid
use
rang
bind
assay
elisa
enzymelink
immunosorb
assay
ella
enzymelink
lectin
assay
itc
isotherm
titrat
calorimetri
spr
surfac
plasmon
reson
fret
fluoresc
reson
energi
transfer
xray
crystallographi
analog
techniqu
rel
bind
affin
confirm
oligosaccharid
ligand
next
evalu
panel
simpler
oligosaccharid
ideal
monosaccharid
simplest
target
eas
potenti
manufactur
purpos
lead
optim
obtain
classic
qsar
quantit
structureact
relationship
result
glycomimet
transform
multival
architectur
glycodendrim
also
undergo
iter
scaffold
optim
context
artifici
glycoform
play
crucial
role
understand
multival
interact
encompass
chelat
receptor
cluster
steric
stabil
subsit
bind
statist
rebind
phenomena
henc
research
synthet
multival
macromolecul
intensifi
give
rise
myriad
origin
glycoconjug
structur
constitut
highaffin
multival
ligand
target
surfac
receptor
name
enzym
lectin
toxin
pathogen
virus
bacteria
novel
nanometers
structur
thereupon
shown
great
potenti
potent
effector
inhibitor
surfacesurfac
interact
includ
cellcel
cellpathogen
interact
occur
biolog
system
follow
section
illustr
synthet
creativ
recent
devot
gener
plethora
multival
structur
use
biomed
field
therapeut
goal
particular
synthet
neoglycoconjug
carbohydr
residu
attach
carrier
thu
present
numer
advantag
term
character
structur
uniform
avail
henc
present
sugar
epitop
multipl
copi
appropri
scaffold
molecular
dendrit
polymer
creat
multival
display
effici
mimic
natur
mode
affin
enhanc
aris
multipl
interact
bind
protein
carbohydr
ligand
gener
carbohydr
ligand
usual
found
peripheri
macromolecul
effici
conjug
reaction
requir
complet
substitut
structur
integr
multival
glycoconjug
evalu
convent
techniqu
nmr
spectroscopi
mass
spectrometri
progress
encount
term
synthet
access
effici
allow
optim
modul
activ
factor
remain
necessari
investig
multival
structur
best
influenc
target
bind
activ
investig
critic
highlight
potenti
multival
carbohydr
inhibitor
highaffin
ligand
effector
capabl
cluster
cellsurfac
receptor
may
permit
gener
structur
tailor
biolog
activ
addit
use
polydispers
multival
glycomimet
promin
compon
surfac
mammalian
cell
neoglycoprotein
neoglycopeptid
neoglycolipid
glycoliposom
glycopolym
glyconoparticl
new
synthet
famili
welldefin
monodispers
glycosyl
macromolecul
recent
emerg
includ
glycoclust
glycosyl
nanomateri
glycofulleren
glyconanotub
glycosyl
architectur
supramolecular
assembl
process
final
glycodendrim
uniform
multival
neoglycoconjug
ensur
control
arrang
constitut
build
block
end
larg
panel
linkag
function
use
one
frequent
use
amid
thiourea
recent
obtain
via
dipolar
cycloaddit
alkyn
azid
precursor
process
term
click
chemistri
requir
function
instal
equal
success
either
sugar
scaffold
particular
applic
becom
wide
use
sinc
sugar
attach
effect
protect
free
sugar
protect
group
repeatedli
employ
sugar
ester
usual
difficult
remov
larg
number
ether
acetalprotect
sugar
exampl
benzyl
ether
moreov
lectinbind
effici
specif
multival
glycoconjug
found
depend
epitop
densiti
also
natur
core
geometr
characterist
multival
assembl
main
goal
chapter
consist
descript
recent
conceiv
multival
neoglycoconjug
emphas
synthet
strategi
requir
afford
welldefin
glycoclust
glycofulleren
glyconanotub
glycosyl
selfassembl
system
glycodendrim
togeth
discuss
concern
respect
relev
use
perspect
biomed
applic
glycoclust
cluster
glycosid
structur
consid
mimic
oligoantennari
oligosaccharid
natur
occur
glycoconjug
arbitrarili
chapter
consid
cluster
structur
multival
glycoconjug
regardless
number
peripher
saccharid
built
homemad
commerci
avail
scaffold
contain
repetit
unit
structur
characterist
allow
distinct
gener
rather
lowval
architectur
true
multigener
glycodendrim
present
later
section
straightforward
synthet
access
rather
small
structur
larg
varieti
glycoclust
base
multival
scaffold
illustr
fig
describ
past
year
henc
branch
aliphat
aromat
scaffold
calixaren
porphyrin
deriv
cyclic
peptid
carbohydr
cyclodextrin
exot
central
core
effici
use
core
molecul
afford
small
multival
glycoconjug
greatli
enhanc
avid
compar
correspond
monoval
carbohydr
particular
design
system
includ
valenc
introduct
suitabl
function
flexibl
linker
optim
length
tailor
thu
optim
rapidli
led
dramat
enhanc
neoglycoconjugateprotein
interact
use
determin
critic
paramet
optim
associ
geometri
includ
optim
distanc
saccharid
epitop
noteworthi
major
scaffold
also
use
construct
complex
multigener
glycodendrim
particular
orthogon
derivat
ab
x
system
tri
gallic
acid
deriv
continu
sinc
larg
panel
multival
scaffold
recent
review
roy
et
al
extens
detail
group
click
chemistri
section
dedic
describ
synthesi
optim
glycoclust
notabl
highlight
recent
synthet
advanc
led
multival
candid
strikingli
biolog
relev
order
synthes
target
complex
glycoclust
sever
commerci
avail
readili
derivat
aliphat
scaffold
constitut
small
multifunct
build
block
use
permit
rapid
access
multival
structur
fig
histor
one
first
branch
glycosid
cluster
base
readili
avail
ab
build
block
tri
hydroxymethyl
aminomethan
tri
use
lee
late
owe
synthet
advantag
term
symmetri
ensur
orthogon
rapid
function
build
block
constitut
ideal
candid
cluster
saccharid
henc
deriv
extens
use
sever
group
direct
glycosid
attach
hydroxyl
group
gener
trival
cluster
howev
although
chemistri
glycoclust
synthesi
establish
first
glycoconjug
gener
subject
unfavor
steric
factor
upon
bind
protein
context
et
al
use
extend
tri
deriv
prepar
highli
branch
glycomimet
fig
base
trival
build
block
peptidecoupl
methodolog
rapid
synthesi
tri
nonaval
mannosyl
cluster
vari
chemic
characterist
spacer
moieti
length
accomplish
trimannosyl
cluster
display
highest
bind
potenc
toward
fimbrial
lectin
escherichia
coli
fimh
test
inhibit
agglutin
elisa
show
ic
mm
unfortun
correspond
nonaval
dendron
present
poor
inhibitori
potenc
explain
priori
unexpect
result
postul
cluster
present
enough
hydroxyl
group
effici
interact
lectin
surfac
present
hydroxyl
function
group
appropri
orient
lectin
bind
altern
well
known
fimh
bind
mannosid
nonreduc
end
virtu
promis
preliminari
biolog
result
indic
triand
tetraval
glycoclust
constitut
potent
inhibitor
bacteri
bind
fit
particularli
well
crd
bacteri
lectin
especi
mannosespecif
adhes
straightforward
synthes
lowval
glycoclust
initi
context
prepar
glycosylamin
direct
condens
amin
reduc
sugar
could
appeal
strategi
direct
conjug
reduc
sugar
diethylenetriamin
previous
report
allow
effici
rapid
access
dival
carbohydr
deriv
excel
yield
year
later
hay
et
al
extend
strategi
describ
eleg
onepot
methodolog
allow
synthesi
higher
valent
deriv
reaction
morehighli
function
amin
cluster
unprotect
dmannos
dimannosid
scheme
sever
linker
differ
length
flexibl
valenc
includ
di
tri
tetraval
amin
readili
incorpor
gener
multival
target
good
yield
notabl
tri
amin
pentaerythrityl
tetraamin
prepar
tetrabromid
via
azid
substitut
follow
reduct
hydrogen
pdc
gave
correspond
triand
tetramannosid
cluster
respect
use
free
reduc
sugar
dmannos
c
symmetr
glycoclust
base
trival
central
core
exhibit
three
six
peripher
mannosid
similarli
prepar
dubber
lindhorst
examin
potenti
reduct
amin
introduc
aldehyd
group
dmannos
deriv
carbohydr
ligand
tri
amin
branch
core
end
glycoclust
synthes
ethan
obtain
ozonolysi
fig
earli
mannosid
cluster
use
ligand
e
coli
fimh
acetyl
allyl
admannopyranosid
follow
treatment
sodium
triacetoxyborohydrid
nabh
oac
scheme
howev
instabl
trival
conjug
aris
autocatalyt
deacetyl
led
author
use
excess
aldehyd
ensur
complet
doubl
nalkyl
morecomplex
carbohydratebas
multival
architectur
situat
may
afford
undesir
partial
structur
scheme
reduct
amin
lead
triand
tetraval
mannosyl
cluster
anoth
exampl
describ
li
et
al
propos
effici
converg
onepot
synthesi
trival
mannosid
cluster
use
ugi
fourcompon
reaction
involv
use
benzaldehyd
methyl
isocyanoacet
tri
amin
core
methanol
biolog
investig
ella
assay
indic
effici
inhibit
bind
yeast
mannan
phytohemagglutinin
concanavalin
con
synthes
ligand
notabl
ic
mm
trival
deriv
correspond
enhanc
valenc
correct
compar
methyl
admannopyranosid
standard
previous
mention
pentaerythritol
deriv
constitut
anoth
wide
use
famili
aliphat
core
allow
construct
multival
branch
structur
via
attach
four
similar
differ
group
two
pair
tilt
accordingli
tetraval
compound
receiv
consider
interest
orthogon
protect
handl
use
gener
combinatori
librari
build
block
fit
well
gener
structur
oligonucleotid
peptid
provid
addit
function
henc
year
pentaerythritolbas
multiantennari
glycoclust
exhibit
relev
carbohydr
bdgalactopyranosid
galili
antigen
lactosid
galabiosid
admannopyranosid
sialic
acid
effici
prepar
three
last
exampl
furnish
promis
antiadhesin
toward
pathogen
infect
describ
detail
follow
section
histor
one
first
exampl
glycoclust
base
pentaerythritol
furnish
late
hanessian
et
al
describ
synthesi
diand
trihapten
cluster
compos
tn
galnac
tf
bdgal
galnac
antigen
elong
serin
glycol
acid
spacer
attach
amid
bond
pentaerythritol
amino
deriv
fig
year
later
hansen
et
al
propos
first
biolog
evalu
galabiosid
cluster
built
around
thiolat
scaffold
differ
valenc
includ
pentaerythrityl
deriv
scheme
effici
inhibit
hemagglutin
hai
gramposit
bacterium
streptococcu
sui
nanomolar
concentr
achiev
construct
synthesi
potent
tetraval
solubl
inhibitor
start
galabiosid
treat
sodium
azid
follow
odeacetyl
condit
hydrogenolysi
afford
galabiosid
overal
yield
concern
central
core
commerci
avail
pentaerythritol
tetrabromid
treat
methyl
cesium
carbon
give
tetraest
upon
hydrolysi
led
correspond
tetraacid
excel
yield
carboxyl
acid
activ
via
format
pentafluorophenyl
ester
use
pentafluorophenol
diisopropylcarbodiimid
dic
subsequ
peptid
coupl
presenc
amin
allow
synthesi
yield
desir
deprotect
glycoclust
contain
four
galabiosid
residu
biolog
studi
indic
seri
multival
conjug
clear
connect
inhibitori
efficaci
number
galabios
unit
present
potenti
inhibitor
flexibl
structur
interestingli
tetraval
galabiosid
sever
hundr
time
effici
monomer
galabiosid
inhibit
agglutin
human
erythrocyt
sui
bacterium
result
complet
inhibit
concentr
low
nm
inhibit
bacteri
adhes
fimbriat
e
coli
pentaerythritolbas
cluster
bear
peripher
admannopyranosid
residu
also
often
address
albeit
without
systemat
structureact
relationship
context
lindhorst
et
al
propos
biolog
investig
pentaerythritolbas
mannosid
cluster
test
capac
block
bind
e
coli
yeast
mannan
vitro
propos
structur
accord
ration
approach
pentaerythritol
well
includ
c
spacer
use
structur
compon
substitut
inner
region
monosaccharid
moieti
scheme
tetraval
cluster
effici
synthes
accord
two
differ
synthet
pathway
first
rout
c
hydroxi
linker
introduc
within
aglycon
moieti
williamson
ether
synthesi
pentaerythritol
tetrabromid
led
mixtur
mono
di
tri
tetradent
conjug
even
eightfold
excess
correspond
alcohol
forc
reaction
condit
use
best
case
protect
tetraval
cluster
isol
yield
circumv
difficulti
altern
strategi
investig
involv
use
modifi
pentaerythritol
deriv
serv
longer
spacerequip
tetraol
subsequ
glycosyl
step
use
imid
end
pentaerythritol
initi
perallyl
extend
tetraol
obtain
hydroborationoxid
sequenc
doubl
bond
presenc
naoh
h
perbenzoyl
mannosyl
trichloroacetimid
use
glycosyl
donor
lewi
acidassist
mannosyl
reaction
deprotect
result
tetram
condit
afford
desir
cluster
excel
yield
evalu
antiadhes
properti
mannosyl
cluster
assess
use
elisa
inhibit
assay
comparison
monoval
refer
methyl
admannopyranosid
meaman
result
indic
tetraval
cluster
time
potent
thu
time
valencycorrect
basi
inhibit
mannosespecif
adhes
meaman
ic
mm
observ
inhibit
bacteri
adhes
probabl
explain
bind
cluster
glycosid
singl
crd
distribut
along
fimbria
rather
multival
bind
would
reflect
interact
sugar
cluster
one
crd
subsequ
touaibia
et
al
describ
effici
systemat
synthesi
famili
mannosid
cluster
built
pentaerythritol
dipentaerythritol
scaffold
use
regioselect
cu
catalyz
azidealkyn
dipolar
cycloaddit
cuaac
click
chemistri
synthet
strategi
first
involv
use
tetrazid
deriv
admannopyranosid
click
chemistri
condit
thu
provid
tetram
good
yield
odeacetyl
scheme
condit
cu
catalyst
gener
situ
copper
ii
sulfat
sodium
ascorb
reduc
agent
gener
provid
slightli
better
yield
use
cu
speci
cui
directli
second
cluster
obtain
treatment
tetraki
methan
prepar
via
nucleophil
substitut
correspond
pertosyl
pentaerythritol
propargyl
alkoxid
condit
alreadi
describ
excel
yield
extend
cluster
similarli
obtain
acetylgroup
deprotect
tetramannosid
analogu
bear
rigid
aromat
spacer
likewis
obtain
tyramin
mannosid
deriv
tetrapropargyl
core
interestingli
presenc
hydrophob
residu
mannosid
aglycon
triazol
consid
play
import
role
adequ
fit
e
coli
fimh
crd
activ
site
near
dendrit
growth
new
multiarm
cluster
flexibl
variou
geometri
also
consid
author
thu
hexatosyl
dipentaerythritol
convert
hexaazid
upon
treatment
propargyl
mannosid
standard
condit
click
chemistri
subsequ
odeacetyl
afford
hexaval
cluster
good
yield
two
step
scheme
elong
analogu
synthes
reaction
triazid
ditosyl
basic
condit
koh
scheme
result
hexakisazido
pentaerythritol
scaffold
n
independ
click
presenc
admannopyranosid
afford
hexaval
cluster
yield
deprotect
condit
furnish
correspond
conjug
respect
distanc
tripod
mannosid
moieti
preliminari
biolog
data
seri
mannosyl
cluster
indic
interest
potenc
inhibit
agglutin
e
coli
baker
yeast
approxim
hundr
time
improv
effici
obtain
monomer
dmannos
pioneer
observ
sharon
first
demonstr
bind
prefer
fimbriat
e
coli
mannopyrannosid
bear
aromat
aglycon
led
hypothesi
exist
subsiteassist
aglycon
bind
base
premis
group
roy
et
al
pursu
investig
enlarg
panel
mannopyranosid
cluster
via
singlestep
multipl
sonogashira
coupl
necessari
carbohydr
precursor
built
either
piodophenyl
propargyl
aglycon
wherea
central
core
consist
di
pentaerythritolbas
azid
propargyl
deriv
first
target
tetram
synthes
piodophenyl
admannopyranosid
previous
prepar
peracetyl
bdmannopyranos
glycosid
triflic
acid
promot
sonogashira
coupl
tetraki
methan
follow
subsequ
oacetyl
deprotect
provid
key
tetraval
cluster
good
yield
scheme
noteworthi
fact
transit
metalcatalyz
crosscoupl
optim
studi
recommend
use
mol
pd
pph
cl
presenc
mol
cu
catalyst
piperidin
base
tetrahydrofuran
thf
n
ndimethylformamid
dmf
slow
addit
tetraki
alkyn
prevent
homocoupl
degrad
altern
tetram
possess
revers
linkag
function
propargyl
group
instal
mannosid
residu
aryl
iodid
pentaerythritol
scaffold
also
similarli
prepar
investig
effect
aryl
pharmacophor
posit
bind
context
central
tetraki
methyl
methan
effici
elabor
nucleophil
substitut
pentaerythritol
tetrabromid
use
piodophenol
basic
condit
yield
treatment
admannopyranosid
optim
sonogashira
coupl
condit
describ
provid
tetram
upon
odeacetyl
gave
unprotect
tetram
yield
two
step
accord
strategi
use
et
n
dmf
c
instead
forego
sonogashira
crosscoupl
condit
correspond
hexaval
cluster
effici
obtain
use
dipentaerythritol
deriv
mannosid
convent
deprotect
three
differ
type
biolog
assay
put
place
evalu
rel
bind
properti
tetraand
hexaval
mannosyl
cluster
initi
crosslink
abil
molecul
investig
use
kinet
turbidimetr
assay
nephelometri
tetramer
phytohemagglutinin
con
canavalia
ensiformi
model
signific
activ
glycoclust
observ
use
ligand
interact
protein
receptor
rapid
format
crosslink
lattic
toward
con
especi
tetram
fact
last
exampl
best
candid
induc
almost
quantit
precipit
lectin
within
min
obvious
cluster
scheme
altern
strategi
toward
synthesi
hexaki
mannopyranosid
altern
triazol
heterocycl
extend
seri
sonogashira
coupl
less
effici
result
ration
author
basi
rel
stabil
result
insolubl
complex
molecular
model
tetram
show
mannopyranosid
residu
apex
tetrahedron
apart
distanc
could
easili
accommod
cluster
four
differ
tetramer
con
lectin
compound
evalu
rel
bind
affin
spr
measur
affin
lectin
domain
isol
fimh
e
coli
toward
cluster
obtain
competit
experi
immobil
antifimh
antibodi
free
mannosyl
cluster
accord
studi
tetram
design
best
ligand
known
k
nm
nmman
subnanomolar
rang
correspond
enhanc
refer
monom
methyl
admannopyranosid
strongest
monosaccharid
ligand
known
heptaman
respect
posit
phenyl
ring
appear
rather
import
regard
modul
activ
tetraval
conjug
k
nm
differ
invert
alkynephenyl
ring
sequenc
result
thu
demonstr
cluster
possess
aryl
moieti
vicin
anomer
oxygen
atom
show
best
overal
qualif
conjug
obtain
click
chemistri
alreadi
describ
also
studi
spatial
rearrang
hexam
triazol
ring
appear
determin
affin
nearli
five
time
better
analog
tetram
k
nm
respect
thu
illustr
influenc
multival
scaffold
distanc
anomer
oxygen
atom
triazol
ring
also
critic
factor
affin
hand
introduct
four
six
mannopyranosid
moieti
use
extend
precursor
sonogashira
coupl
minor
effect
rel
affin
final
cluster
test
inhibitor
hemagglutin
pig
rabbit
erythrocyt
piliat
clinic
isol
e
coli
inhibit
titer
lowest
concentr
inhibitor
agglutin
occur
show
tetram
best
inhibitor
hemagglutin
mm
factor
compar
affin
correspond
better
inhibit
induc
dmannos
overal
tetraval
cluster
best
noncoval
crosslink
con
best
ligand
known
e
coli
fimh
extend
biolog
investig
concern
structurefunct
studi
initi
evalu
abil
cluster
inhibit
con
ainduc
membran
metalloproteinas
mediat
activ
cell
death
antiprolif
properti
mesenchym
stromal
cell
msc
mobil
msc
recruit
experiment
vascular
tumor
involv
function
given
mannosespecif
lectin
con
induc
express
mimic
biolog
lectincarbohydr
interact
cluster
test
evalu
potenti
block
con
activ
msc
result
indic
specif
tetraand
hexaval
mannosid
cluster
especi
revers
con
amedi
chang
msc
morpholog
antagon
con
ainduc
activ
activ
also
inhibit
con
cytoskeletondisrupt
agent
cytochalasindinduc
cellsurfac
proteolyt
process
mechan
effect
cellcycl
phase
progress
antiprolif
proapoptot
impact
con
transport
signal
axi
also
revers
mannosid
conclus
famili
mannosyl
cluster
effect
inhibit
spectrum
cell
respons
could
potenti
transpos
target
tumorpromot
process
addit
noncytotox
allow
use
vivo
experiment
implant
tumor
recent
gouin
et
al
design
tetraval
cluster
base
potent
e
coli
fimh
ligand
heptyl
admannosid
preliminarili
recogn
strong
binder
fimh
k
nm
determin
spr
measur
fig
e
coli
bladder
cell
line
biofilm
format
vitro
also
decreas
bacteri
level
murin
cystiti
model
suitabl
function
flexibl
ethylen
glycol
linker
use
tether
moieti
order
ensur
water
solubl
effici
conjug
pentaerythritol
core
via
click
chemistri
afford
neoglycoconjug
bind
affin
new
flexibl
synthet
glycoclust
toward
e
coli
evalu
hai
bladderbind
assay
bba
result
indic
inhibit
bacteri
bladdercel
bind
nm
lower
mannos
respect
tetraval
compound
current
one
promis
antiadhes
drug
develop
treatment
urinari
tract
infect
pentaerythritolbas
glycoclust
also
investig
potenti
neuraminidas
inhibitor
context
linhardt
group
describ
straightforward
approach
gener
cluster
nonnatur
nglycosylamin
asial
acid
known
resist
neuraminidasecatalyz
hydrolysi
oppos
natur
oglycosid
influenza
virus
use
hemagglutinin
bind
sialic
acid
residu
locat
surfac
host
cell
gain
entri
cell
cell
infect
new
virion
use
neuraminidas
sialidas
escap
infect
cell
thu
neuraminidas
target
stop
viral
infect
block
viru
insid
infect
cell
end
small
librari
monoand
dival
sialic
acid
construct
via
click
chemistri
togeth
correspond
tetraval
cluster
gener
tetrapropargyl
core
asial
acid
azid
preliminari
neuraminidaseinhibit
assay
involv
fluoresc
measur
induc
releas
produc
hydrolysi
substrat
nacetylaneuramin
acid
enzym
neuraminidas
clostridium
perfringen
clostridium
welchii
address
result
indic
micromolar
ic
valu
notabl
tetram
ic
mm
compar
known
sialidas
inhibitor
mm
inasmuch
carbohydr
residu
contain
larg
oligosaccharid
involv
sever
bindingrecognit
process
trigger
inhibit
variou
biolog
phenomena
assum
role
remain
sugar
within
polym
limit
structur
matrix
act
simpli
spacer
maintain
epitop
proper
distanc
ensur
optim
interact
receptorbind
site
base
preliminari
assumpt
structur
analogu
elicitor
could
result
molecul
contain
aromat
core
support
pendant
sugar
epitop
substitut
structur
sugar
compon
benzenoid
group
rigid
polymer
matrix
would
preserv
minim
distort
threedimension
framework
first
closest
analog
aromat
core
harbor
cluster
glycosid
provid
yariv
et
al
first
describ
phloroglucinolbas
artifici
antigen
gener
formula
pglycosyloxyphenylazo
earli
multival
model
abil
form
brightli
color
crosslink
precipit
antibodi
direct
appropri
homolog
carbohydr
determin
fig
year
develop
transit
metalcatalyz
methodolog
notabl
involv
cyclotrimer
sonogashira
heck
cross
coupl
pave
way
rapid
effici
access
aryl
glycoclust
desir
control
valenc
glycoclust
intermolecular
cyclotrimerizationin
kaufman
sidhu
describ
onestep
synthesi
aromat
cluster
glycosid
via
metalcatalyz
cyclotrimer
appropri
acetylen
sugar
precursor
feasibl
type
benzannul
approach
glycochemistri
treatment
acetylen
precursor
convent
cyclotrimer
catalyst
dicobalt
octacarbonyl
co
co
gave
mixtur
correspond
regioisomer
trimer
glycosid
scheme
although
reaction
appear
quit
gener
yield
rang
tend
markedli
influenc
natur
start
materi
thio
analogu
afford
poor
yield
undoubtedli
due
poison
cobalt
catalyst
studi
author
also
proceed
construct
origin
octopuslik
hexaki
glycosid
readili
access
correspond
bi
glycosid
monom
scheme
thu
cyclotrimer
bi
bdglucopyranosid
octaacet
gave
benzenehexaylhexamethylen
hexaki
bdglucopyranosid
tetraeicoacet
excel
yield
correspond
thio
deriv
also
prepar
accord
similar
condit
lower
yield
hexaval
glycoclust
organ
around
hexaphenylbenzen
core
also
obtain
via
synthet
strategi
involv
diphenol
coupl
tetraoacetyladglucopyranosyl
bromid
use
stannat
methodolog
furnish
dival
glycoconjug
moder
yield
cyclotrimer
standard
cobaltcatalyz
condit
gave
desir
glucosyl
cluster
yield
howev
eleg
glycosyl
nanostructur
display
weak
biolog
activ
rel
nativ
glucan
elicitor
counterpart
nevertheless
glycoclust
provid
uniqu
environ
hostguest
chemistri
amphipath
molecul
owe
lipophil
core
surround
hydrophil
peripheri
subsequ
roy
et
al
improv
methodolog
provid
hexaval
mannopyranosid
via
cycloaddit
presenc
dicobalt
octacarbonyl
catalyst
reflux
h
compar
day
mannosid
cluster
obtain
previou
exampl
regioisomer
mixtur
cluster
obtain
yield
molar
ratio
interestingli
reaction
gener
could
equal
appli
sever
saccharid
prompt
success
dicobalt
octacarbonylcatalyz
cyclotrimer
group
attempt
similar
reaction
symmetr
mannosyl
disubstitut
alkyn
ident
condit
describ
correspond
hexam
obtain
yield
result
deprotect
cluster
obtain
quantit
odeacetyl
condit
water
solubl
show
excel
crosslink
abil
tetramer
plant
lectin
indic
spatial
orient
rigid
provid
extend
inner
aryl
core
offer
great
potenti
neoglycoconjug
year
later
group
extend
strategi
order
access
metabol
stabl
cglycosyl
cluster
contain
longarm
spacer
via
sequenc
transit
metalcatalyz
transform
scheme
scheme
molecularasterisk
bear
hydrolyt
stabl
cgalactosyl
group
synthes
roy
et
al
mannopyranosid
ratio
similar
observ
dicobalt
octacarbonylmedi
benzannul
decreas
reaction
time
much
improv
yield
therefor
glycosid
includ
acetyl
admannopyranosid
bdgalactopyranosid
lactosid
treat
grubb
catalyst
mol
dri
dichloromethan
room
temperatur
h
desir
trisubstitut
benzen
deriv
isol
typic
mixtur
yield
contrast
access
correspond
hexaval
analogu
via
cyclotrimer
disubstitut
symmetr
alkyn
success
perhap
steric
hindranc
b
glycoclust
crosscoupl
reactionsearli
work
mid
sever
research
group
highlight
format
crosslink
lattic
induc
multival
protein
receptor
admix
synthet
carbohydr
multim
includ
dimer
report
evid
support
notion
smallrigidifi
carbohydr
cluster
bear
hydrophob
residu
would
form
stabl
complex
result
synthet
effort
present
inevit
format
glycosid
cluster
wherein
sugar
moieti
link
side
arm
emerg
central
platform
cglycosid
linkag
base
observ
roy
et
al
propos
effici
synthesi
oligomer
carbohydr
cluster
name
sugarrod
use
sonogashiraheckcassar
shc
cross
coupl
reaction
context
dimer
conjug
constrain
conform
flexibl
incorpor
central
hydrophob
aryl
residu
obtain
standard
sonogashira
crosscoupl
condit
henc
heat
mixtur
protect
propynyl
glycosid
pdiiodobenzen
core
presenc
catalyt
tetraki
triphenylphosphin
palladium
mixtur
dmfet
n
quantit
afford
correspond
glycosyl
bisethynylen
deriv
worth
note
reaction
effect
absenc
cu
cocatalyst
thu
prevent
undesir
oxid
homodimer
propynyl
start
materi
glaser
reaction
gener
strategi
compat
variou
glycosid
usual
acet
protect
group
also
appli
toward
effici
synthesi
dival
rodlik
thioglycosid
repres
potenti
enzym
inhibitor
resist
enzymat
hydrolysi
sengupta
sadhukhan
adapt
onestep
pdcatalyz
methodolog
triand
tetraval
aromat
core
order
gener
multiantennari
glycoclust
scheme
threefold
sonogashira
crosscoupl
reaction
propargyl
bdglucosid
presenc
pd
dba
pph
mixtur
et
n
dmf
c
smoothli
gave
rise
central
planar
triantennari
glycoclust
isol
yield
author
also
present
exampl
wherein
multival
glycoclust
could
rapidli
assembl
via
multipl
heck
reaction
strategi
purpos
deriv
alcohol
use
central
tetrahedr
core
tetra
piodopenyl
methan
phasetransfercatalyz
condit
pd
oac
bu
nbr
nahco
dmf
c
result
tetrahedr
glycoclust
obtain
yield
year
later
dondoni
et
al
extend
pdcatalyz
crosscoupl
strategi
cglycosyl
compound
resist
enzymat
degrad
dens
cglycosyl
cluster
built
around
benzen
rigid
platform
therebi
synthes
via
multipl
shc
crosscoupl
reaction
use
variou
ethynyl
cglycosyl
deriv
polyiodin
benzen
limit
type
conjug
test
use
crowd
system
repres
vicin
polyiodobenzen
shortarm
sugar
acetylen
studi
elegantli
effici
afford
diand
trival
conjug
pdiiodobenzen
symtriiodobenzen
respect
involv
use
divers
protect
ethynyl
glycosid
acetyl
benzyl
addit
deprotect
via
hydrogenolysi
cluster
gener
conjug
benzyl
saccharid
afford
correspond
ethylenebridg
system
sinc
tripl
bond
also
reduc
oper
use
benzylprotect
ethynyl
cglycosyl
deriv
turn
ineffici
reaction
partner
shc
tetraiodobenzen
desir
tetraval
neoglycoconjug
biolog
investig
rigid
cluster
address
et
al
describ
prepar
lactosidebear
glycotop
bioisoster
strong
bind
affin
lectin
fig
accord
optim
sonogashira
condit
alreadi
describ
use
requir
diand
triiodin
benzen
core
peroacetyl
lactosid
obtain
dival
trival
glycosid
yield
respect
complet
odeacetyl
result
freeli
watersolubl
cluster
almost
quantit
yield
rel
affin
lactoclust
evalu
competit
solidphas
bind
assay
use
differ
label
sugar
receptor
probe
notabl
btrefoil
mistlto
lectin
viscum
album
agglutinin
vaa
three
mammalian
galectin
differ
mode
present
respect
crd
preliminari
result
indic
glycoclust
could
well
surpass
inhibitori
capac
lactos
note
fact
bind
two
homodimer
prototyp
effect
influenc
presenc
multival
compound
fig
diand
trival
rigidifi
lactosid
cluster
strong
affin
v
album
lectin
fact
manifest
inhibitori
capac
rang
free
lactos
demonstr
case
neg
correl
carrierdepend
present
lactos
inhibitori
effici
howev
trival
cluster
induc
strongest
cluster
effect
chimerictyp
ic
mm
mm
free
lactos
contrast
correspond
dival
lactosid
effici
independ
confirm
hemagglutin
vitro
cytofluorometr
tumorcel
bind
analysi
trival
compound
potent
inhibitor
block
bind
nativ
cell
surfac
final
data
underlin
feasibl
galectintyp
target
select
compound
design
despit
use
ident
headgroup
synthesi
c
persulfur
glycoclustersrec
two
research
group
independ
describ
synthesi
persulfur
glycoclust
organ
around
aromat
core
show
interest
lectinbind
activ
ongo
research
program
studi
mannosebind
protein
mbp
systemat
synthes
biolog
evalu
multival
glycomimet
inhibitor
bacteri
adhes
chabr
et
al
describ
synthesi
via
click
chemistri
dens
sulfur
glycoclust
contain
peripher
admannopyranosid
residu
scheme
synthet
strategi
employ
hexaval
sulfur
scaffold
initi
obtain
thioacetyl
commerci
hexabromomethyl
precursor
potassium
thioacet
function
tri
deriv
propargyloxi
methyl
aminomethan
trival
moieti
synthes
effici
threestep
sequenc
use
boc
nprotect
tri
follow
propargyl
basic
condit
quantit
remov
boc
protect
group
acid
condit
reaction
bromoacetyl
chlorid
led
precursor
treat
hexathioacet
basic
reduct
condit
afford
octadecapropargyl
dendrit
scaffold
excel
yield
treatment
tetraoacetyladmannopyranosid
use
click
chemistri
subsequ
deprotect
standard
condit
provid
dens
pack
cluster
contain
peripher
mannosid
residu
initi
evalu
bcla
lectin
burkholderia
cenocepacia
itc
reveal
promis
candid
ligand
strong
affin
chabr
et
al
unpublish
result
second
exampl
furnish
sleiman
et
al
propos
new
class
persulfur
semirigid
radial
lowval
glycosyl
molecularasterisk
possess
dual
function
ligand
probe
virtu
conjug
electron
system
moreov
glycoasterisk
could
exhibit
conform
prefer
altern
upanddown
pattern
around
central
core
expos
phenylthio
group
plane
benzen
ring
could
glycoclust
obtain
hexaamino
persulfur
benzen
precursor
readili
access
multigram
scale
coupl
sodium
commerci
hexachlorobenzen
dmi
subsequ
deprotect
concentr
hydrochlor
acid
variou
protect
carbohydr
contain
termin
carboxyl
acid
function
introduc
onto
multival
aminoscaffold
use
eedq
coupl
agent
yield
rang
odeacetyl
condit
occur
unev
provid
hexaval
cluster
order
assess
biolog
activ
author
investig
abil
inhibit
hemagglutin
rabbit
erythrocyt
con
result
indic
aglucos
asterisk
effici
inhibit
hemagglutin
mm
correspond
enhanc
per
sugar
rel
methyl
adglucopyranosid
signific
impact
record
admannosid
show
one
best
inhibitori
potenc
report
minimum
concentr
nm
henc
greater
increas
rel
activ
per
sugar
compar
methyl
admannopyranosid
control
experi
prove
nonspecif
interact
scaffold
respons
observ
inhibit
effect
probabl
induc
power
crosslink
phenomenon
addit
author
observ
amplif
select
mannos
glucos
cluster
rel
monoval
compound
meona
meoh
quant
con
mannosid
cluster
concentr
slightli
nanomolar
rang
accord
mannosedepend
partial
revers
process
final
result
suggest
rather
increas
avid
con
unusu
potenc
molecular
glycoasterisk
due
effici
kinet
control
macromolecular
assembl
strongli
amplifi
effect
lowval
ligand
glycoclust
calixaren
corecycl
polyaromat
calix
n
aren
owe
oligomer
natur
shape
tailor
size
macrocycl
ring
natur
substitu
lower
rim
attract
multival
scaffold
control
valenc
henc
constitut
valuabl
candid
onto
glycosid
expos
peripheri
particularli
analog
cd
calix
aren
block
cone
conform
extent
mimic
small
portion
multiantennari
cell
surfac
present
seri
glycosyl
residu
exterior
lipophil
caviti
moreov
caviti
spacer
upper
rim
calix
n
aren
sugar
unit
use
cooper
bind
molecul
hostguest
chemistri
process
way
inclus
complex
could
direct
toward
select
biolog
target
specif
recogn
carbohydr
unit
glycocalix
n
aren
act
novel
type
sitedirect
molecular
deliveri
system
thu
provid
versatil
platform
welldefin
shape
construct
moresophist
structur
includ
neoglycoconjug
may
name
calyx
sugar
furthermor
low
cytotox
calixaren
deriv
found
wide
applic
biomed
field
enzym
inhibitor
anticoagul
antithrombot
agent
antiangiogen
anticanc
antivir
antimicrobi
antifung
product
sinc
first
exampl
lower
upper
rim
glycocalixaren
obtain
marra
et
al
employ
mitsunobu
reaction
copper
ii
catalyz
glycosyl
develop
effici
synthet
methodolog
allow
emerg
sever
exampl
n
cglycosyl
calix
n
aren
recent
review
fig
sever
drawback
result
absenc
suitabl
spacer
arm
low
water
solubl
record
first
calix
n
areneglycoconjug
overcom
subsequ
year
use
adapt
chemic
ligat
suitabl
derivat
carbohydr
exampl
effici
conjug
calix
aren
scaffold
via
nucleophil
substitut
provid
extend
watersolubl
cluster
may
exhibit
dens
cluster
epitop
wittig
olefin
pdcatalyz
sonogashira
cross
coupl
click
chemistri
azidenitril
cycloaddit
act
hydrogenbond
group
describ
afford
elong
nanostructur
tailor
spacer
arm
shown
promis
applic
drug
deliveri
system
via
hostguest
supramolecular
chemistri
initi
exploratori
investig
address
dondoni
et
al
late
highlight
abil
calyx
sugar
recogn
neutral
charg
molecul
dglucosamin
hydrochlorid
tetrabutylammonium
dihydrogenphosph
show
interest
potenti
receptor
phosphat
phosphonatebear
molecul
biolog
relev
group
synthes
thiourealink
upper
rim
calix
aren
glycoconjug
expos
two
four
glucos
galactos
lactos
unit
investig
recognit
properti
glycocalixaren
togeth
interact
specif
lectin
solut
h
nmr
electrospray
ionizationmass
spectrometri
esim
experi
demonstr
anionrecognit
properti
enhanc
presenc
aromat
ring
guest
wherea
turbidimetr
analysi
indic
abil
glycoclust
bear
four
peripher
glucosid
galactosid
interact
con
peanut
lectin
respect
combin
featur
made
new
glycoclust
attract
possibl
sitespecif
molecular
deliveri
system
higher
valenc
analogu
glucosylthioureidocalix
calix
aren
investig
supramolecular
studi
suggest
format
selfassembl
small
discoidlik
particl
water
nm
size
equilibrium
monomer
macrocycl
ideal
could
exhibit
work
valenc
much
higher
compar
monomer
speci
turbidimetr
measur
atom
forc
microscopi
afm
assay
indic
strong
interact
con
especi
octamer
glycoconjug
caus
agglutin
format
larg
supramolecular
entiti
progress
evolv
toward
precipit
extens
lectin
crosslink
besid
preliminari
studi
demonstr
interest
potenti
calyx
sugar
recent
applic
afford
strike
concret
result
eleg
work
disclos
combin
effort
ungaro
bernardi
group
describ
synthesi
dival
cholera
toxin
ct
glycocalix
aren
ligand
higher
affin
natur
oligosaccharid
fig
bacteri
ct
produc
toxicogen
strain
gramneg
bacillu
vibrio
cholera
caus
agent
cholera
lifethreaten
acut
diarrhea
mainli
affect
thirdworld
popul
heterohexamer
ab
complex
compos
structur
independ
catalyt
activ
heterodimer
cta
enzymat
homopentamer
b
ctb
target
subunit
last
moieti
effect
recognit
anchor
cell
membran
sequenc
homolog
common
heatlabil
enterotoxin
secret
strain
e
coli
bacterium
lt
mode
action
remain
similar
toxin
exploit
intrins
complic
traffick
mechan
host
cell
gain
access
cytosol
exert
detriment
activ
prelud
infect
lumen
gastrointestin
tract
human
host
toxin
recogn
receptor
gangliosid
bgal
b
ic
nm
ct
surfac
epitheli
cell
b
subunit
arrang
pentamer
pattern
trigger
endocytosi
acut
structur
studi
biochem
data
concern
fundament
interact
ct
demonstr
critic
role
two
sugar
nonreduc
end
name
galactos
sialic
acid
take
specif
structur
properti
consider
ration
design
artifici
receptor
toxin
monoval
multival
ligand
envisag
prepar
gangliosid
repres
tediou
synthet
challeng
one
strategi
imped
interact
concern
design
synthesi
function
structur
context
dival
present
promis
candid
investig
author
use
fix
cone
conform
calix
aren
allow
introduct
molecul
onto
upper
rim
project
portion
space
thu
mimick
extent
small
portion
natur
cellsurfac
gangliosid
synthesi
dival
neoglycoconjug
base
initi
function
correspond
diacid
amin
spacer
introduct
squaric
acid
moieti
interact
deprotect
cluster
ct
studi
fluoresc
spectroscopi
indic
togeth
elisa
assay
ligand
display
higher
affin
ct
ic
nm
natur
oligosaccharid
condit
ic
nm
except
highaffin
enhanc
rel
monoval
ligand
therebi
obtain
roughli
name
per
sugar
mimic
although
complementari
detail
thermodynam
analysi
need
determin
precis
role
multival
particular
system
result
constitut
anoth
strike
exampl
highlight
advantag
util
calixaren
scaffold
togeth
use
glycomimet
subsequ
et
al
propos
seri
calixaren
substitut
glcnac
directli
link
thiourea
spacer
test
bind
activ
heterogen
express
activ
ctype
lectinlik
receptor
rat
natur
killer
nk
cell
receptor
human
nk
cell
macrophag
nk
cell
import
compon
innat
immun
respons
tumor
earli
protect
virus
intracellular
pathogen
interestingli
highaffin
carbohydr
ligand
major
activ
receptor
found
particularli
glcnac
recogn
highaffin
receptor
studi
furthermor
multival
multiantennari
branch
glcnaccontain
structur
found
crucial
highli
specif
recognit
bind
event
receptor
vitro
henc
studi
initi
determin
differ
bind
capabl
calix
arenebas
glycoconjug
recombin
receptor
well
effect
prolifer
cytotox
celleffector
function
result
indic
case
bind
affin
bdglcnacsubstitut
calixaren
carri
two
four
sugar
unit
compar
observ
known
linear
chitooligom
influenc
glcnac
substitut
calixaren
skeleton
bind
affin
receptor
profound
correspond
tetraval
cluster
contain
thiourea
function
display
potent
inhibitori
activ
logic
high
make
one
best
ligand
receptor
use
glycoconjug
lower
valenc
led
dramat
decreas
bind
activ
addit
immunostimul
activ
tetraval
glycoconjug
indic
prolifer
stimul
natur
cytotox
human
peripher
blood
mononuclear
cell
pbmc
concentr
observ
lipopolysaccharid
moreov
concentr
induc
increas
spontan
death
tumor
target
gener
calyx
sugar
deriv
superior
correspond
dendrit
pamamglcnac
analogu
see
next
synthesi
novel
anticanc
vaccin
candid
built
nonpeptid
scaffold
cluster
four
slink
tn
antigen
glycomimet
stn
conjug
immunoadjuv
moieti
trihexadecanoylsglycerylcysteinylserin
p
cs
calix
aren
scaffold
describ
glycomimet
stn
antigen
chosen
antigen
determin
higher
metabol
stabil
capabl
determin
maxim
immunostimul
activ
construct
lower
dose
respect
natur
otn
analogu
prepar
calix
aren
platform
start
disymmetr
aren
react
ethyl
bromoacet
presenc
nah
furnish
ester
quantit
scheme
direct
replac
tertbutyl
group
via
aromat
nitrat
afford
nitrocalixaren
deriv
upon
subsequ
reduct
h
atmospher
pressur
use
pdc
catalyst
afford
amino
analogu
afterward
four
bocglycin
spacer
effici
introduc
upper
rim
macrocycl
via
standard
amid
coupl
presenc
pybop
dipea
saponif
aq
koh
thf
ester
group
led
intermedi
contain
singl
carboxyl
acid
function
macrocycl
lower
rim
amid
p
cs
immunoadjuv
unit
lead
remov
boc
group
tfa
coupl
stn
acid
deriv
hoatedc
dri
dmf
allow
format
target
conjug
thu
design
construct
four
stn
antigen
unit
link
coval
glycin
spacer
calix
aren
three
propyloxi
group
one
pendant
p
cs
unit
narrow
rim
block
synthet
core
rigid
coneshap
conform
ensur
preorient
antigen
unit
side
respect
median
plane
macrocycl
allsyn
orient
tn
antigen
crucial
better
mimick
cancer
cell
surfac
presenc
glycin
spacer
avoid
steric
hindranc
ensur
flexibl
advantag
antigenimmun
system
interact
author
evalu
immunogen
tetratn
construct
mice
use
monoval
glycoconjug
refer
compound
aim
investig
role
cluster
effect
amplifi
antibodi
product
respect
singl
present
tn
antigen
unit
serumdilut
rang
consid
mice
immun
tetram
show
substanti
signific
product
antibodi
even
concentr
monoval
compound
increas
fourfold
respect
parent
monoval
deriv
reactiv
elicit
cluster
construct
significantli
higher
data
clearli
show
cluster
effect
provok
higher
immunostimul
activ
tetraval
cluster
compar
monoval
analogu
author
thu
present
still
convinc
evid
vaccin
candid
built
nonpeptid
platform
induc
moreeffect
immun
respons
due
cluster
effect
present
optim
arrang
tn
antigen
rigid
calix
aren
scaffold
claim
properli
mimic
mucin
surfac
encount
vivo
later
investig
set
calix
n
aren
n
thiourealink
galactos
lactos
moieti
prepar
analyz
reactiv
toward
refer
plant
lectin
vaa
rel
three
human
galectin
despit
high
degre
flexibl
calix
aren
gener
prove
especi
effect
plant
abtoxin
solidphas
model
system
involv
vaa
lectin
use
absorb
glycoprotein
asialofetuin
asf
inhibitori
potenc
hexaand
octaval
galactosid
cluster
mm
respect
correspond
roughli
enhanc
compar
free
galactos
demonstr
solidphas
cellbind
assay
cluster
macrocycl
also
particularli
effect
toward
fact
among
human
lectin
differ
respons
pattern
regist
tandemrepeattyp
react
sensit
presenc
test
compound
ic
valu
lactosid
cluster
lower
factor
rel
free
sugar
calcul
sugar
concentr
assay
bioassay
underlin
clear
intergalectin
differ
depend
inhibit
conform
properti
calix
n
aren
scaffold
well
shape
valenc
glycoclust
e
glycoclust
porphyrin
coresth
attach
saccharid
compon
porphyrin
macrocycl
give
rise
variou
deriv
term
glycoporphyrin
might
becom
great
import
medicin
applic
catalysi
molecular
recognit
sinc
pioneer
synthesi
type
glycoconjug
first
describ
maillard
et
al
late
via
condens
tetraoacetylbdglucopyranosid
pyrrol
improv
synthet
methodolog
gener
highli
promis
watersolubl
glycoconjug
show
potenti
photosensit
pss
photodynam
therapi
pdt
antibiot
antivir
agent
drug
sensor
interestingli
despit
fact
carbohydr
porphyrin
deriv
constitut
two
group
natur
occur
compound
great
signific
exist
organ
exampl
natur
glycoporphyrin
known
tolyporphin
isol
bluegreen
alga
tolypothrix
nodosa
whose
total
synthesi
report
chlorophyl
c
monogalactosyldiacylglycerid
deriv
isol
emiliana
huxleyi
two
exampl
natur
glycoporphyrinlik
deriv
fig
biolog
signific
glycoporphyrin
limit
natur
occurr
widespread
applic
made
avail
compound
scientif
challeng
sever
research
group
synthet
approach
consist
direct
glycosyl
prefunction
porphyrin
chemic
synthesi
suitabl
glycoconjug
precursor
two
gener
approach
thu
use
access
glycoporphyrin
first
base
lindsey
method
involv
coupl
pyrrol
dipyrromethan
glycoaldehyd
speci
acidcatalyz
condens
follow
oxid
reaction
mixtur
instanc
ddq
fig
strategi
c
slink
glycosyl
compound
obtain
examin
detail
interestingli
higher
valenc
glycoporphyrin
obtain
follow
pyrrolealdehyd
condens
strategi
gener
oglycosyl
porphyrin
dimer
possess
ether
linkag
second
methodolog
involv
direct
introduct
glycosyl
moieti
onto
suitabl
function
mesoarylporphyrin
scaffold
access
natur
sourc
protoporphyrinix
total
synthesi
sever
nglycoporphyrin
thu
prepar
fig
moreov
order
explor
influenc
cluster
peripher
saccharid
around
porphyrin
scaffold
evalu
photophys
properti
synthesi
dodecaval
porphyrin
bear
four
trival
glycodendron
via
amid
ligat
achiev
pdt
certainli
promis
applic
kind
neoglycoclust
concept
base
concentr
ps
target
cell
upon
subsequ
irradi
visibl
light
presenc
oxygen
lead
specif
destruct
target
cell
tissu
gener
agreement
princip
mechan
wherebi
cell
destruct
occur
involv
disrupt
cellular
mitochondri
nuclear
membran
singlet
oxygen
gener
action
ps
photofrin
first
pdt
formul
introduc
approv
sever
countri
includ
usa
canada
netherland
franc
germani
japan
treatment
bladder
esophag
gastric
cervic
lung
cancer
sever
diseas
although
photofrin
effect
number
malign
ideal
ps
lack
welldefin
structur
weak
absorb
red
region
visibl
spectrum
longlast
skin
photosensit
induc
mainli
drawback
sever
deriv
synthes
requir
peripher
substitu
carbohydr
residu
control
water
solubl
biodistribut
pharmacokinet
affinityselect
cancer
cell
five
novel
diethylen
glycol
deg
link
oand
sgalacto
mannoconjug
mtetraphenyl
porphyrin
prepar
biolog
photobiolog
properti
investig
vitro
human
retinoblastoma
cell
line
preliminari
studi
establish
human
retinoblastoma
cell
express
sugar
receptor
exhibit
preferenti
affin
galactos
mannos
residu
precursor
pphenol
use
synthesi
glycoconjug
studi
scheme
trival
oglycosyl
deg
porphyrin
bgal
agal
aman
obtain
treat
requisit
bromosubstitut
glycosid
follow
deprotect
condit
yield
rang
two
step
correspond
thioglycosyl
porphyrin
analogu
bgal
aman
obtain
accord
slightli
modifi
strategi
involv
preliminari
synthesi
bromosubstitut
porphyrin
glycol
via
standard
williamson
etherif
final
introduct
peracetyl
basic
condit
improv
overal
yield
amount
ps
taken
retinoblastoma
cell
first
determin
fluoresc
intens
measur
reflect
intern
drug
concentr
scheme
galactoand
mannosubstitut
tetraphenyl
porphyrin
use
pdt
human
retinoblastoma
use
flow
cytometri
result
indic
effici
intern
glycoconjug
preferenti
membran
cytoplasm
organel
extent
uptak
depend
upon
natur
sugar
compon
anomer
configur
linker
use
increas
spacer
length
link
tetrapyrrol
ring
sugar
moieti
result
higher
cellular
uptak
case
obgal
sbgal
oaman
consider
decreas
drug
intern
observ
oagal
henc
result
highlight
import
amphiphiliclipophil
charact
cluster
indic
high
lipophil
led
low
cellular
uptak
bind
affin
toward
sugarspecif
receptor
cell
also
investig
examin
possibl
competit
effect
glycoporphyrin
correspond
glycosyl
albumin
indic
inhibit
uptak
valu
possibl
due
cellsugarreceptor
satur
addit
phototox
dark
evalu
measur
cell
surviv
fraction
found
neglig
case
high
photoact
observ
two
agalactomanno
porphyrin
ld
mm
respect
nm
low
fluenc
jcm
addit
glycoporphyrin
also
exhibit
possibl
cellmembran
interact
affect
instanc
plasma
lifetim
particular
drug
promis
result
obtain
compound
sinc
one
show
high
vitro
photobiolog
activ
human
retinoblastoma
cell
low
dose
drug
associ
low
light
intens
suffici
observ
mark
effect
moreov
compound
undergo
limit
cellular
metabol
degrad
group
investig
vitro
phototox
order
determin
influenc
differ
structur
paramet
despit
lower
photodynam
activ
observ
hydroxyl
pss
particular
common
foscan
temoporphyn
glycoconjug
display
phototox
cell
signific
intrins
cytotox
result
confirm
photoact
could
strongli
modul
presenc
deg
spacer
chromophor
glycosid
anomer
configur
sugar
trival
aogalactosyl
porphyrin
determin
better
candid
foscan
clinic
applic
pdt
conserv
therapi
retinoblastoma
second
exampl
address
synthesi
potenti
applic
seri
neutral
oglycosyl
porphyrin
dimer
two
origin
oglycosyl
cation
dimer
examin
pdt
order
understand
influenc
number
glycosyl
moieti
spatial
geometri
ionic
charact
photodynam
activ
evalu
vitro
result
concern
photocytox
human
chronic
leukemia
cell
compar
favor
common
ps
photoprin
ii
two
strategi
prepar
neutral
monocation
porphyrin
model
use
presenc
spacer
arm
directli
attach
meso
phenyl
posit
porphyrin
gave
access
seri
dimer
differ
substitu
meso
posit
differ
geometri
neutral
bisporphyrin
synthes
accord
lindsey
methodolog
name
coupl
pyrrol
pformylphenyl
oor
phydroxybenzaldehyd
control
stoichiometri
presenc
bf
et
catalyst
scheme
subsequ
oxid
porphyrinogen
intermedi
pchloranil
gave
porphyrin
yield
respect
treatment
excess
k
co
dmf
reflux
afford
deriv
yield
respect
dimer
form
reaction
monohydroxyl
precursor
via
nucleophil
substitut
follow
odeacetyl
modifi
condit
analog
triglycosyl
bisporphyrin
similarli
obtain
tristolylporphyrin
eleg
synthesi
monomer
porphyrin
intermedi
bear
one
pyridyl
three
glycosyl
unit
precursor
cation
dimer
also
describ
scheme
author
first
determin
partit
coeffici
deprotect
bisporphyrin
conjug
order
evalu
lipophil
charact
triglycosyl
conjug
found
lipophil
b
next
studi
concern
photosensit
properti
consist
trap
reaction
ergosterol
acet
indic
product
high
yield
compar
refer
hematoporphyrin
hp
vitro
photocytotox
evalu
leukemia
cell
line
amphiphil
charact
found
essenti
factor
effici
pdt
sinc
amphiphil
triglycosyl
dimer
particularli
neutral
found
activ
quasisimilar
activ
photofrin
min
irradi
induc
cellular
death
probabl
apoptosi
addit
shown
presenc
glucosyl
residu
side
dimer
conjug
crucial
optim
activ
final
illustr
biolog
potenti
glycoporphyrin
provid
ballut
scheme
synthesi
glucosyl
porphyrin
bear
cation
headgroup
dmpc
liposom
membran
measur
interact
result
conjug
con
lectin
context
author
design
new
famili
glycoconjug
pss
bear
one
glycodendron
moieti
variabl
length
spacer
link
carbohydr
porphyrin
scaffold
para
posit
one
mesophenyl
group
fig
briefli
cbzglycin
spacer
introduc
via
peptid
coupl
onto
amino
function
trival
precursor
follow
deprotect
three
termin
carboxyl
acid
function
scaffold
subsequ
introduct
aminoethyl
admannopyrannosid
deriv
amid
ligat
suitabl
function
aminodendron
cbzhydrogenolysi
coupl
porphyrin
amid
linkag
standard
odeacetyl
afford
trival
glycoporphyrin
good
overal
yield
order
evalu
condit
incorpor
compound
liposom
membran
two
deriv
mix
dmpc
ratio
mixtur
spread
airwat
interfac
interestingli
incorpor
elong
conjug
dmpc
induc
format
larger
vesicl
phospholipid
one
diamet
vs
nm
compound
mix
poorli
lead
smaller
less
stabl
vesicl
probabl
repuls
interact
sugar
moieti
vicin
phospholipid
headgroup
moreov
h
contact
mix
liposom
contain
con
led
dramat
increas
vesicl
diamet
nm
polydispers
observ
strike
result
postul
origin
long
spacer
would
increas
mobil
mannosid
moieti
thu
facilit
interact
lectin
addit
exist
con
dimer
tetram
ph
studi
allow
lectin
interact
one
porphyrin
molecul
possibl
born
differ
liposom
multipl
interact
would
lead
format
network
vesicl
bridg
con
molecul
result
dramat
increas
f
aromat
glycoclustersclearli
access
type
cluster
also
address
instanc
use
convent
glycosyl
strategi
context
synthesi
trival
bdgalactosid
use
stereoselect
lewi
acidcatalyz
trisglycosyl
galact
deriv
describ
fig
second
exampl
concern
synthesi
trival
cluster
contain
disaccharid
lactosid
ligand
morecomplex
alfucp
bdglcnac
inhibit
bind
paiil
lectin
pseudomona
aeruginosa
gener
click
chemistri
aromat
tripropargyl
core
deriv
trimesyl
chlorid
correspond
glycosid
azid
inhibitori
properti
mm
observ
conjug
hai
assay
compris
enhanc
compar
free
lactos
persaccharid
correct
basi
addit
moreunusu
macrocycl
scaffold
phthalocyanin
recent
emerg
afford
dens
glycoclust
biolog
relev
remain
determin
structur
carbohydr
deriv
interest
polyfunct
platform
synthesi
oligosaccharid
mimet
glycoclust
possibl
select
function
variou
hydroxyl
group
wellestablish
methodolog
control
rel
orient
branch
configur
conform
bia
make
fullcarbohydr
glycoclust
ideal
suit
map
geometr
requir
effici
lectin
bind
context
sever
synthet
strategi
effici
derivat
variou
carbohydr
scaffold
describ
notabl
includ
perallyl
nonreduc
monoor
disaccharid
subsequ
ligat
sglycosid
thioether
linkag
photochem
promot
radic
addit
control
introduct
desir
function
hydroxyl
amino
termin
allyl
function
also
permit
construct
glycoclust
ether
thiourea
linkag
fig
systemat
studi
aim
evalu
biolog
properti
uropathogen
e
coli
initi
address
measur
rel
affin
con
toward
dglucosecent
mannosyl
cluster
correspond
analogu
competit
ella
assay
henc
known
allyl
bdglucopyranosid
chosen
core
buildingblock
prepar
pseudosymmetr
pentabranch
deriv
versatil
reactiv
termin
alken
exploit
differ
way
produc
glycoclust
exhibit
varieti
link
function
group
thioether
ether
thiourea
strategi
higherval
dglucosecent
glycoclust
also
obtain
ic
valu
pentaval
cluster
mm
respect
indic
strong
con
affin
rel
refer
methyl
admannopyranosid
correspond
enhanc
per
mannosid
basi
tetraval
analogu
contain
aglycon
oxygen
atom
present
ident
avid
indic
multival
present
four
branch
suffici
elicit
cluster
effect
sharp
contrast
replac
wedg
admannopyranosylthioureido
unit
virtual
abolish
multival
statist
effect
along
dramat
decreas
bind
affin
altern
ligand
possess
classic
oglycosid
linkag
effici
inhibitor
con
ayeast
mannan
associ
ic
mm
howev
valencycorrect
rel
potenc
onehalf
pentaval
deriv
result
illustr
potenti
carbohydr
multival
scaffold
glycoclust
synthesi
underlin
import
care
design
overal
architectur
optim
glycoclust
recognit
specif
lectin
mention
introduct
tri
scaffold
optim
simultan
bind
without
util
elong
spacer
allow
sever
lectin
bind
maximum
access
sugar
ligand
contemporari
studi
sever
other
multimannosid
glycoconjug
base
carbohydr
scaffold
similarli
construct
use
click
chemistri
construct
multival
glycoclust
involv
first
introduct
propargyl
azid
function
monoor
oligosaccharid
maltosid
maltotriosid
central
core
subsequ
reaction
glycosyl
ligand
contain
complementari
function
fig
remark
exampl
biolog
relev
dglucosecent
glycoclust
achiev
kitov
et
al
design
oligoval
watersolubl
carbohydr
ligand
name
starfish
subnanomolar
inhibitori
activ
toward
shigalik
toxin
slti
shiga
toxin
stx
shigalik
toxin
slt
vt
verotoxin
ribosomeinactiv
protein
act
nglycosylas
cleav
sever
nucleobas
rna
therebi
halt
eukaryot
protein
biosynthesi
infect
bacteria
produc
slt
result
seriou
gastrointestin
urinari
tract
disord
known
caus
potenti
lethal
diseas
hemolyt
urem
syndrom
hu
may
result
kidney
failur
stx
produc
shigella
dysenteria
wherea
slt
produc
shiga
toxigen
group
e
coli
stec
includ
serotyp
enterohemorrhag
e
coli
ehec
e
coli
toxin
divid
slti
sltii
conserv
structur
bind
site
sltii
edema
variant
sltiie
like
ct
slt
belong
famili
bacteri
enterotoxin
harbor
hexamer
ab
structur
denot
cytotox
enzym
locat
center
one
face
b
subunit
repres
symmetr
homopentamer
lectinlik
carbohydraterecogn
complex
doughnut
shape
facilit
deliveri
entri
compon
cell
host
slti
virtual
ident
structur
mechan
action
toxin
express
dysenteria
similar
bsubunit
differ
one
residu
vs
asubunit
vivo
receptor
stx
slt
trisaccharid
portion
p
k
neutral
glycolipid
globotriosylceramid
gbose
gb
agal
bgal
bglc
ceramid
present
greater
amount
surfac
kidney
glomerular
endotheli
cell
renal
toxic
stx
may
attribut
fig
crystallograph
structur
protein
carbohydratelig
protein
known
possibl
model
multival
oligosaccharid
inhibitor
mention
slt
possess
five
noncoval
bsubunit
per
molecul
subunit
present
three
carbohydratebind
domain
therefor
oligoval
tailor
structur
bsubunit
pentam
offer
best
opportun
design
higher
affin
inhibitor
bind
site
symmetr
arrang
across
toxin
surfac
engag
cell
membran
thu
highli
select
potent
bind
slt
gb
mainli
attribut
multipl
interact
bsubunit
pentam
trisaccharid
moieti
gb
basi
fact
sever
slt
antagonist
trisaccharid
moieti
combin
use
variou
dendrit
core
structur
report
among
forego
studi
synthesi
multival
neoglycoconjug
particular
afford
spectacular
result
effect
neutral
slt
infect
henc
use
crystal
structur
b
subunit
e
coli
sltib
conjunct
analogu
carbohydr
receptor
allow
design
tailor
multival
glycoclust
bear
peripher
function
p
k
residu
structur
decaval
cluster
name
starfish
compris
radial
symmetr
starshap
carbohydr
backbon
dglucos
pair
gb
trisaccharid
tip
arm
ideal
space
orient
simultan
engag
bsubunit
thu
permit
pentaval
interact
slt
achiev
display
tether
ligand
glucos
molecul
chosen
central
core
adequ
pentaval
present
via
derivat
pentaallyl
ether
freerad
reaction
thioglycol
acid
subsequ
chain
elong
radial
arm
design
span
central
core
toxin
tether
adapt
bridg
bind
site
bsubunit
elisa
solidphas
inhibit
assay
indic
highest
molar
activ
inhibitor
report
subnanomolar
inhibitori
activ
stli
ii
ic
nm
respect
thu
higher
monoval
ligand
furthermor
abil
inhibitor
protect
host
cell
lethal
dose
slti
cultur
could
determin
use
vero
cell
cytotox
assay
indic
starfish
inhibitor
provid
effect
protect
vero
cell
cultur
presenc
slti
ic
mm
sltii
ic
mm
even
coincub
period
interestingli
crystal
structur
show
one
starfish
molecul
bound
one
two
bsubunit
pentam
instead
bind
site
tether
p
k
trisaccharid
starfish
bound
two
bsubunit
monom
separ
toxin
molecul
experi
concentr
starfish
suffici
form
complex
suggest
format
sandwich
must
thermodynam
favor
ct
extend
investig
made
group
order
circumv
differenti
slti
sltii
biolog
studi
fact
starfish
protect
mice
inject
subcutan
admixtur
lethal
dose
slti
sltii
also
reduc
distribut
istli
istlii
murin
kidney
brain
modif
natur
length
linkag
oligosaccharid
compon
backbon
therebi
increas
flexibl
tether
necessari
protect
moretox
sltii
despit
consider
decreas
inhibitori
activ
solidphas
inhibit
assay
ic
nm
correspond
increas
compar
equival
decreas
perform
socal
daisi
challeng
slti
sltii
verocytotoxicityneutr
assay
appar
fig
subcutan
inject
protect
mice
oral
challeng
slti
also
stliiproduc
stec
interestingli
interfer
abil
murin
immun
system
produc
sltsspecif
protect
antibodi
class
welldefin
biocompat
cd
also
provid
interest
altern
construct
carbohydratecent
cluster
nonimmunogen
scaffold
combin
uniqu
structur
featur
high
symmetri
truncat
coneshap
hydrophob
caviti
exploit
effici
radial
epitop
present
togeth
complex
hydrophob
drug
caviti
target
drug
deliveri
particularli
perglycosyl
cd
show
much
improv
abil
form
stabl
complex
antitumor
fig
variant
starfish
p
k
antigen
link
central
glucos
core
anomer
posit
reagent
compar
cd
provid
one
potent
candid
among
specif
carrier
toward
drugdeliveri
system
order
introduc
peripher
carbohydr
macrocycl
scaffold
varieti
select
function
deriv
describ
often
gener
without
need
hydroxylgroup
protect
sinc
first
synthesi
perthioglucosyl
deriv
bcd
sever
group
describ
altern
synthet
pathway
multifunction
cd
either
primari
face
face
simultan
methodolog
involv
welldocu
photoaddit
thioglycosid
polyallyl
bcd
ether
antimarkovnikov
fashion
follow
select
introduct
reactiv
function
primari
posit
iodin
amin
chloroacetamid
gave
rise
panel
neoglycoconjug
name
glycocd
exhibit
simpl
bdglucosid
nacetyldglucosamin
ether
thiourea
amid
linkag
moresophist
carbohydr
appendag
elong
sialic
acid
sialyl
lewi
x
via
thioether
function
fig
concern
gener
biolog
relev
glycocd
demonstr
system
often
show
amplifi
inhibitori
effect
compar
monoval
analogu
instanc
roy
group
synthes
small
librari
compris
bdglucosyl
bdgalactosyl
admannosyl
nacetylbdglucosamin
cd
evalu
rel
bind
properti
toward
differ
natur
carbohydratebind
plant
lectin
use
microtit
plate
competitiveinhibit
experi
doublesandwich
assay
use
horseradish
peroxidas
hrpo
label
lectin
turbidimetr
assay
gener
persubstitut
bcd
show
good
excel
inhibitori
properti
togeth
abil
crosslink
analog
plant
lectin
capac
anchor
microtit
plateco
lectin
correspond
peroxidaselabel
deriv
confirm
use
multival
neoglycoconjug
bioanalyt
assay
anoth
exampl
provid
furuik
et
al
propos
effici
practic
synthesi
cdscaffold
glycoclust
via
standard
nucleophil
substitut
iodid
heptaki
precursor
variou
unprotect
sodium
thiolat
deriv
propyl
glycosid
fig
henc
novel
glycocd
dgalactos
nacetyldglucosamin
lactos
nacetyllactosamin
residu
obtain
high
yield
rang
order
evalu
effect
cluster
biolog
potenc
four
glycoclust
hemagglutin
inhibitori
activ
examin
mean
wheat
germ
agglutinin
wga
triticum
vulgari
erythrina
corallodendron
lectin
ecorl
known
nacetyldglucosamineand
nacetyllactosaminespecif
lectin
anticip
heptaval
glcnaccd
show
drastic
enhanc
affin
wga
comparison
monoval
analogu
correspond
enhanc
inhibitori
effect
similarli
three
glycoconjug
effici
inhibit
hemagglutin
induc
ecorl
notabl
compound
bear
nacetyllactosamin
residu
show
lowest
inhibitori
concentr
mic
mm
final
anoth
remark
exampl
design
varieti
glycocd
bear
cluster
mannosyl
ligand
prepar
investig
bind
toward
tetramer
plant
lectin
con
context
key
templat
deoxybcyclodextrin
modifi
branch
compon
isothiocyanatofunction
admannopyranosyl
cluster
prepar
tri
coupl
isothiocyan
deriv
aminefunction
trimannosid
branch
compon
gave
thioureabridg
glycodendrimercd
conjug
monosubstitut
hexaval
bcd
mannoclust
show
strong
cluster
effect
inhibit
con
bind
yeast
mannan
ic
mm
constitut
increas
molar
basi
compar
monoval
deriv
addit
cd
deriv
exhibit
extrem
high
water
solubl
higher
compar
parent
cd
mm
furthermor
potenti
util
system
activ
sugardirect
drug
deliveri
specif
saccharid
receptor
biolog
surfac
investig
thu
caviti
bcd
use
carri
anticanc
drug
taxoter
water
solubl
greatli
improv
construct
gl
taxoter
solubil
mm
aqueou
solut
trival
mannocyclodextrin
deriv
c
correspond
solubl
enhanc
compar
water
solubl
isol
drug
gl
class
peptidebas
glycoclust
constitut
valuabl
addit
arsen
glycoconjug
serv
import
tool
glycobiolog
structur
properti
allow
act
mimet
glycocalyx
constitu
permit
present
glycan
particular
optim
orient
ideal
unnatur
peptid
scaffold
cyclic
might
provid
much
greater
design
flexibl
one
afford
natur
sequenc
gener
manipul
length
natur
amino
acid
sequenc
cyclic
peptid
provid
opportun
design
multival
ligand
suitabl
differ
geometr
requir
moreov
variat
number
glycan
attach
well
distanc
glycan
togeth
subsequ
introduct
suitabl
chemic
handl
conjug
carrier
protein
constitut
paramet
could
readili
tailor
scaffold
synthesi
although
standard
chemic
process
use
access
linear
bioactiv
glycopeptid
solidphas
synthesi
sp
constitut
one
appeal
synthet
methodolog
led
larg
varieti
welldefin
glycoclust
graft
onto
synthet
peptid
platform
numer
success
encount
sp
variou
peptidebas
conjug
coupl
eas
prepar
purif
complex
deriv
motiv
chemist
appli
methodolog
synthesi
peptid
glycoclust
henc
linear
peptid
contain
glycoclust
head
group
multival
cyclic
neoglycopeptid
includ
instanc
three
nacetylglucosamin
residu
multitop
biotinyl
glycoclust
build
topolog
cyclodecapeptid
templat
repres
remark
illustr
power
straightforward
methodolog
fig
concern
biolog
investig
zhang
et
al
describ
sp
pentaval
ligand
cyclic
decapeptid
scaffold
builtin
linker
order
creat
effici
inhibitor
ct
b
pentam
vari
natur
flexibl
amino
acid
lack
side
chain
lysin
gaminobutano
acid
eaminohexano
acid
allow
author
achiev
desir
ringsiz
variat
increas
likelihood
peptid
might
adopt
expand
conform
solut
fig
synthet
peptidecor
bear
five
galactosylamin
residu
assay
abil
block
ct
b
pentam
bind
gangliosideco
plate
interestingli
ligand
longer
shorter
linker
optim
exhibit
loss
inhibitori
power
demonstr
ligand
effect
dimens
match
target
decreas
ligand
affin
submicromolar
ic
valu
obtain
best
deriv
ligand
depend
core
size
rang
result
glycoclust
present
fold
increas
monoval
galactos
ic
mm
receptorbind
inhibitori
assay
sever
glycopeptid
particularli
mannosid
complex
oligomannosid
endgroup
potenti
becom
entir
synthet
vaccin
notabl
follow
exampl
direct
rais
protect
immun
respons
infect
noteworthi
fact
sever
infecti
microorgan
use
escap
immun
defens
mechan
mask
import
receptor
antigen
determin
expos
selfcarbohydr
structur
consequ
mask
event
bacteri
viral
pathogen
transport
target
tissu
self
cellular
system
emerg
exampl
irregular
situat
recognit
bind
transport
hyperbranch
highmannos
oligosaccharid
man
glcnac
present
hiv
dendrit
cell
ensu
transport
hidden
viru
particl
lymph
node
danishefski
group
use
cyclic
peptid
bear
bturn
provid
two
dprolpro
sequenc
append
extrem
scaffold
elegantli
construct
potent
carbohydr
antigen
strongli
recogn
human
swap
protect
igg
antibodi
fig
cyclic
peptid
contain
two
three
handl
glycan
attach
togeth
singl
cystein
residu
carrier
protein
biolog
marker
conjug
built
prolin
trityl
resin
use
solidphas
peptid
chemistri
synthet
oligosaccharid
man
glcnac
nh
prepar
amin
reduc
sugar
attach
aspart
acid
residu
properli
posit
onto
cyclic
peptid
use
lansburi
aspartyl
procedur
thu
provid
dimer
trimer
respect
studi
spr
indic
control
peptid
lack
saccharid
portion
well
monoval
glycopeptid
show
measur
respons
thu
confirm
import
multival
bind
event
critic
recognit
process
correspond
dival
trival
glycopeptid
prove
strong
ligand
bound
surfac
indic
topograph
homolog
natur
structur
confirm
antigen
glycopeptid
author
use
sulfhydryl
anchor
dival
antigen
attach
highli
immunogen
maleimidoderiv
outer
membran
protein
complex
ompc
carrier
neisseria
meningitidi
conjug
addit
perform
nearneutr
ph
afford
vaccin
candid
bear
copi
carbohydr
antigen
also
recogn
antibodi
elisa
assay
use
x
asp
r
ch
co
h
x
ala
r
either
glycoconjug
coat
antigen
hors
radish
peroxidaseconjug
antihuman
igg
hrpigg
evidenc
detect
bind
event
result
indic
antigen
could
bind
antibodi
natur
bound
effici
immunolog
properti
semisynthet
vaccin
present
investig
analog
exampl
provid
construct
tetramer
glycan
epitop
use
determin
shortest
version
deriv
arm
man
glcnac
prepar
extend
azidebear
aglycon
fig
cyclic
peptid
scaffold
built
lysin
glycin
prolin
residu
four
lysin
eamino
group
acyl
propyno
acid
glycan
attach
click
chemistri
remain
two
eamin
coupl
univers
cell
epitop
deriv
tetanu
toxoid
peptid
tt
afford
fulli
synthet
vaccin
candid
bind
vaccin
candid
human
antibodi
analyz
spr
technolog
synthet
monomer
oligosaccharid
well
natur
highmannos
type
nglycan
man
glcnac
asn
four
unit
arm
tetrasaccharid
demonstr
affin
antibodi
furthermor
result
suggest
appropri
spatial
orient
sugar
chain
cluster
crucial
highaffin
bind
antibodi
introduct
thelper
epitop
onto
cyclic
decapeptid
templat
affect
structur
integr
oligosaccharid
cluster
form
face
templat
therefor
compound
constitut
valuabl
immunogen
might
also
abl
rais
carbohydratespecif
neutral
antibodi
better
understand
critic
role
oligosaccharidereceptor
interact
molecular
mechan
clustereffect
thu
access
optim
synthet
ligand
sever
research
group
shown
creativ
propos
origin
multival
platform
could
allow
tailor
valenc
dimens
epitop
orient
instanc
burk
et
al
investig
templat
ligand
array
base
conform
defin
macrocycl
scaffold
three
mannosid
residu
append
solubil
linker
display
fig
c
symmetr
hydropyran
cyclooligolid
core
previous
obtain
accord
iter
multistep
synthet
sequenc
notabl
involv
keystep
macrolacton
kecksteglich
high
dilut
condit
particular
templat
rigid
confer
specif
orient
saccharid
residu
eman
singl
face
addit
molecularmodel
studi
predict
maximum
separ
mannos
residu
approxim
given
bind
site
within
con
tetram
separ
trival
ligand
could
simultan
occupi
two
mannosebind
site
within
tetramer
lectin
therefor
could
use
explor
mechan
multival
ligand
bind
absenc
chelat
effect
spr
competitionbind
assay
con
indic
absenc
nonspecif
interact
induc
templat
highlight
fact
promot
rather
inhibit
bind
con
mannosesubstitut
lipid
surfac
data
suggest
glycoclust
abl
bind
two
three
con
tetram
simultan
form
solubl
cluster
high
avid
immobil
ligand
assay
fret
show
revers
phenomenon
corrobor
fact
cluster
con
depend
subsequ
precipit
cluster
bind
surfac
addit
synergist
interact
favor
format
con
cluster
rather
format
onetoon
complex
con
trival
ligand
anoth
strike
exampl
provid
exploit
cucurbit
n
uril
cb
n
n
famili
macrocycl
cavitand
compris
n
glycoluril
unit
multival
scaffold
carbohydr
possess
hydrophob
caviti
access
two
ident
carbonylfring
portal
form
stabl
hostguest
complex
wide
rang
guest
molecul
henc
cb
base
cluster
present
averag
carbohydr
moieti
attach
peripheri
bglucos
bgalactos
amannos
respect
prepar
via
photoreact
allyloxi
cb
correspond
acetylthioglycosid
follow
standard
odeacetyl
fig
particular
mannosid
cluster
present
strong
avid
con
excess
meaman
necessari
disrupt
crosslink
interact
lectin
itc
confirm
affin
indic
behav
predominantli
trival
ligand
lectin
bind
constant
k
time
higher
meaman
author
exploit
caviti
provid
conjug
incorpor
hostguest
interact
fluorescein
isothiocyan
fitc
spermin
conjug
order
estim
potenti
drugdeliveri
vehicl
target
deliveri
experi
vitro
thu
carri
fitc
spermin
deriv
fluoresc
probe
well
drug
model
hepatocellular
carcinoma
cell
overexpress
galactos
receptor
target
cell
intracellular
transloc
estim
confoc
microscopi
result
confirm
intern
cb
galactos
fitc
spermin
complex
via
galactosemedi
endocytosi
studi
demonstr
potenti
glycocucurbituryl
deriv
target
drugdeliveri
system
pave
way
interest
therapeut
applic
touaibia
roy
use
biodegrad
biocompat
cyclophosphazen
deriv
multival
platform
afford
dens
function
admannosid
cluster
fig
use
short
effici
strategi
base
singlestep
sonogashira
click
chemistri
afford
varieti
glycoclust
around
cyclotriphosphazen
differ
valenc
spacer
epitop
spatial
arrang
hexaval
deriv
obtain
commerci
hexachlorocyclotriphosphazen
p
n
cl
onto
variou
phenol
deriv
conjug
via
nucleophil
substitut
direct
ligat
admannosid
contain
adequ
complementari
function
via
optim
pdcatalyz
crosscoupl
click
chemistri
subsequ
deprotect
condit
afford
hexaval
conjug
excel
yield
higher
valenc
glycoclust
also
obtain
reaction
hexabromomethyl
p
n
scaffold
deriv
dior
triazid
build
block
contain
hydroxi
anchor
function
fig
correspond
deprotect
dodecaand
octadecamannosid
cluster
therebi
isol
follow
click
chemistri
odeacetyl
similarli
decamannosid
obtain
dimer
bear
n
p
cl
fragment
prepar
doubl
monosubstitut
hexachlorocyclotriphosphazen
bisphenol
use
nbuli
base
appropri
stoichiometri
subsequ
replac
remain
chlorid
iodoaryl
group
allow
prepar
sonogashira
adduct
evalu
influenc
structur
paramet
govern
cyclophosphazen
core
concern
valenc
spatial
orient
epitop
well
natur
linker
directli
relat
ligat
techniqu
use
mannosid
incorpor
author
perform
preliminari
kinet
turbidimetr
assay
con
insolubl
crosslink
complex
form
rapidli
compound
without
mark
differ
hexaval
analogu
hand
incorpor
addit
mannosyl
unit
led
mere
statist
bindingaffin
enhanc
notabl
lessdens
decam
present
favor
extend
intersugar
distanc
class
azamacrocycl
also
constitut
interest
platform
control
multival
present
epitop
fig
although
exampl
quit
scarc
use
gener
biolog
relev
glycoclust
instanc
tetraval
amannosyl
cluster
scaffold
cyclam
describ
show
interest
inhibitori
properti
adhes
fimbriat
e
coli
guinea
pig
erythrocyt
bind
properti
toward
con
fig
modular
design
multival
antagonist
antiadhesin
target
member
ab
bacterialtoxin
famili
achiev
includ
ct
e
coli
heatlabil
enterotoxin
lt
strategi
exploit
fivefold
symmetri
bind
site
toxin
b
pentam
synthet
plan
base
difficulti
distinguish
ligandmedi
aggreg
protein
actual
gain
effect
affin
highli
multimer
ligand
studi
context
author
expect
substanti
enhanc
affin
use
multival
system
allow
geometr
restrain
present
expos
ligand
match
specif
arrang
target
protein
bind
site
mind
synthesi
variou
pentaval
deriv
contain
three
distinct
modul
achiev
semirigid
core
finger
project
outward
direct
receptor
bind
site
fit
perfectli
activ
site
assembl
studi
describ
synthes
bdgalactosyl
pentaval
ligand
built
around
pentacyclen
core
adopt
fivefold
symmetri
systemat
effect
flexibl
linker
publish
fig
preliminari
result
detail
affin
lt
best
pentaval
ligand
r
r
n
show
ic
fold
higher
galactos
year
later
group
optim
structur
incorpor
five
copi
potent
mnitrophenyl
adgalactosid
mnpg
deriv
rather
five
copi
bdgalactos
higher
singlesit
affin
enhanc
mnpg
bind
site
toxin
rel
galactos
found
yield
proportion
increas
affin
ic
measur
respect
pentaval
construct
inde
elisa
experi
involv
ctb
pentam
reveal
ic
mm
r
r
correspond
affin
enhanc
r
r
result
demonstr
improv
affin
singlesit
ligand
confer
parallel
improv
affin
pentaval
construct
present
five
copi
ligand
furthermor
dl
studi
crystallograph
data
result
complex
major
mode
associ
solut
ligand
toxin
lead
structur
affin
incorpor
guanidinebridg
poli
ethylen
glycol
variou
length
order
enhanc
water
solubl
thu
compound
r
r
optim
effect
fig
best
ligand
e
coli
heatlabil
enterotoxin
dimens
strong
affin
display
ic
nm
lower
natur
receptor
repres
first
multival
ligand
base
simpl
galactosid
nanomolar
affin
ctb
parallel
investig
spectacular
improv
observ
construct
famili
complex
ligand
five
flexibl
arm
end
bival
ligand
r
r
elisa
test
reveal
improv
decaval
deriv
significantli
potent
show
affin
ctb
order
magnitud
better
correspond
nonbranch
ligand
precis
fold
enhanc
inhibitori
power
monoval
ligand
achiev
best
decaval
candid
n
ic
nm
valu
lie
rang
ic
natur
receptor
nm
dynam
lightscatt
studi
demonstr
format
concentrationdepend
uniqu
ligandtoxin
discret
complex
solut
sign
format
larg
aggreg
crystallograph
studi
confirm
decaval
inhibitor
result
sandwich
arrang
two
b
pentam
face
bridg
ligand
improv
ic
display
decaval
ligand
might
attribut
substanti
differ
affin
galactos
fragment
within
pentaval
ligand
rather
short
nonspan
bival
galactos
moieti
present
decaval
ligand
final
two
exot
scaffold
describ
ad
larg
panel
glycoclust
describ
far
first
consist
linear
pentaerythrityl
phosphodiest
oligom
pepo
onto
galactosyl
cluster
attach
via
combinatori
autom
synthesi
solid
support
fig
propargyl
scaffold
synthes
standard
dna
solidphas
support
phosphoramidit
chemistri
azidogalactosid
residu
conjug
click
chemistri
microwaveassist
acceler
reaction
time
afford
correspond
multival
cluster
b
control
length
valenc
elong
fucosyl
analogu
also
describ
author
show
increas
affin
ella
competit
assay
p
aeruginosa
lectin
paiil
ic
valu
time
higher
monoval
lfucos
correspond
modest
twofold
increas
per
saccharid
basi
second
one
concern
polyhedr
oligosilsesquioxan
poss
function
carbohydr
moieti
via
standard
amid
bond
effici
via
photolyt
thiol
addit
perallyl
precursor
biolog
evalu
octaval
possglycoclust
exhibit
elong
lactosid
residu
investig
measur
inhibitori
effect
bind
asialooligosaccharid
human
glycoprotein
agp
bgalactos
specif
lectin
use
capillaryaffin
electrophoresi
first
result
indic
strong
inhibit
time
higher
induc
free
lactos
thu
attribut
cluster
effect
past
year
wit
discoveri
develop
case
largescal
product
manufactur
novel
materi
lie
within
nanomet
size
scale
particularli
incorpor
nanotechnolog
earlystag
develop
new
drug
diagnost
therapeut
constitut
power
addit
arsen
classic
macromolecular
structur
consequ
strategi
open
new
avenu
origin
effici
design
adapt
nanomedicin
context
owe
threedimension
architectur
fulleren
nanotub
carbonbas
nanomateri
constitut
promis
candid
novel
nanometr
construct
biolog
properti
offer
challeng
scaffold
toward
multival
present
saccharid
unit
fulleren
third
allotrop
form
carbon
along
graphit
diamond
novel
class
spheroid
shape
molecul
made
exclus
carbon
atom
gener
much
enthusiasm
numer
research
effort
past
year
henc
chemic
physic
featur
c
also
name
buckminsterfulleren
repres
exampl
among
fulleren
extens
explor
intrins
properti
size
hydrophob
threedimension
electron
properti
made
extrem
promis
nanostructur
offer
interest
featur
interfac
variou
scientif
disciplin
rang
materi
scienc
biolog
medicin
chemistri
order
demonstr
illustr
attract
potenti
forego
applic
array
studi
record
includ
cytotox
investig
unmodifi
function
fulleren
initi
result
indic
novel
fascin
architectur
carcinogen
appli
skin
affect
prolifer
viabil
cell
intern
henc
despit
observ
dosedepend
toxic
phenomenon
report
certain
relat
deriv
earli
observ
indic
great
promis
applic
dna
cleavag
pdt
enzymat
inhibit
antivir
antibacteri
antiapoptot
activ
howev
total
lack
solubl
aqueou
physiolog
media
sever
drawback
quick
effici
develop
suitabl
carrier
order
circumv
natur
repuls
fulleren
water
sever
methodolog
adopt
includ
entrap
tailor
microcapsul
suspens
help
cosolv
chemic
derivat
notabl
introduct
onto
peripher
solubil
appendag
furthermor
shown
multival
present
polar
group
around
fulleren
sphere
prevent
cluster
phenomena
reason
dilut
solut
consequ
increas
hydrosolubl
result
conjug
context
varieti
chemic
function
util
increas
hydrophil
group
oh
co
h
nh
quaternari
ammonium
cd
prepar
novel
compound
possess
biolog
pharmacolog
activ
among
panel
known
fulleren
deriv
fulleroglycoconjug
also
term
glycofulleren
exhibit
combin
interest
properti
relat
water
solubl
biolog
relev
spheric
topolog
fulleren
furnish
suitabl
scaffold
multival
present
peripher
carbohydr
residu
chemistri
adapt
effici
control
conjug
first
exampl
glycofulleren
monoval
conjug
subsequ
tailor
optim
gener
multival
glyconanostructur
base
c
biolog
properti
enhanc
take
advantag
glycosid
cluster
effect
monoval
structuresin
earli
vasella
et
al
report
first
synthesi
monoglycosyl
fulleren
introduc
one
carbohydr
residu
c
via
nucleophil
glycosyliden
carben
precursor
gener
enantiomer
pure
spiro
clink
glycosylc
deriv
scheme
anoth
approach
permit
synthesi
fulleren
glycoconjug
via
thermal
cycloaddit
peroacetyl
glycosyl
azid
boil
chlorobenzen
although
methodolog
gener
mixtur
two
insepar
stereoisom
nbglycopyranosyl
azafulleroid
rel
poor
yield
gener
reaction
demonstr
seri
mono
dglucopyranos
dgalactopyranos
di
lactos
maltos
trisaccharid
conjug
c
soon
afterward
dondoni
et
al
develop
threecompon
approach
involv
c
carbohydr
aldehyd
nmethylglycin
sarcosin
lead
format
glycofulleropyrrolidin
monocycloadduct
poor
yield
via
cycloaddit
reaction
intermedi
azomethin
ylide
c
feasibl
nevertheless
demonstr
use
seri
deriv
galactopyranos
glucopyranos
mannofuranos
moreov
methodolog
advantag
adapt
synthesi
c
deriv
contain
bdglycopyranosylamino
unit
altern
strategi
util
initi
introduct
suitabl
chemic
function
onto
fulleren
adopt
sever
research
group
allow
conjug
saccharid
complementari
function
final
synthet
step
approach
led
improv
flexibl
chemic
function
carbohydr
moieti
especi
anchor
one
better
control
number
attach
saccharid
residu
anoth
exampl
provid
ito
et
al
describ
use
methanofulleren
deriv
power
stabl
precursor
glycofulleren
studi
base
use
fullerenoacetyl
chlorid
obtain
tertbutyl
fullerenoacet
deriv
prepar
yield
treatment
correspond
stabil
sulfonium
ylide
c
subsequ
transform
ptsoh
toluen
gave
fullerenoacet
acid
directli
convert
correspond
acyl
chlorid
use
thionyl
chlorid
standard
ester
format
methyl
addit
studi
investig
dnaand
proteindegrad
properti
novel
glycofulleren
deriv
synthesi
base
dielsald
reaction
c
follow
reduct
cyclohexanon
deriv
dibalh
toluen
afford
correspond
racem
cyclohexanol
excel
yield
glycosyl
glycosyl
bromid
presenc
agclo
caco
caso
toluen
subsequ
deprotect
condit
gave
desir
glycofulleren
shown
effect
select
degrad
hivproteas
photoirradi
synthet
aspect
access
monoval
fullerenecarbohydr
hybrid
highlight
biolog
applic
mention
contrast
multival
present
saccharid
multipl
anchorag
structur
present
antennari
glycodendron
gener
promis
result
b
multival
structuresdival
hybrid
glyconanostructur
prepar
via
cycloaddit
reaction
glycopyranosid
deriv
c
first
exampl
describ
strategi
synthesi
fullerenol
carri
monoand
bisadmannopyranosid
scheme
methodolog
base
initi
thermal
coupl
mannopyranosid
equimolar
amount
c
chlorobenzen
give
mixtur
two
isomer
monoadduct
admannosyl
azafulleroid
admannosyl
aziridinofulleren
bismannosyl
adduct
subsequ
simultan
deacetyl
polyhydroxyl
conduct
presenc
tetranbutylammonium
hydroxid
tbah
aqueou
naoh
afford
deprotect
mono
bisfullerenol
averag
heterogen
distribut
oh
group
per
c
biolog
evalu
notabl
involv
lectininduc
hai
assay
admannosidespecif
lectin
con
reveal
monoand
bismannosyl
fullerenol
exhibit
diminish
activ
bind
con
aggreg
erythrocyt
compar
activ
mannosyl
neoglycopolym
year
later
similar
graft
methodolog
use
gener
seri
monoand
bissugarpend
fulleren
deriv
prepar
varieti
carbohydratelink
azid
phototox
correspond
deprotect
glycoconjug
evalu
potenti
applic
pdt
substanti
product
singlet
oxygen
laser
irradi
nm
observ
adduct
notabl
monosugar
deriv
shown
better
photosensit
abil
addit
vitro
studi
involv
hela
cell
confirm
photocytotox
indic
carbohydratedepend
effici
line
previou
work
anoth
applic
propos
describ
format
stabl
selfassembl
structur
aqueou
solvent
deprotect
bi
admannopyranosyl
fulleren
conjug
diamet
result
larg
aggreg
nm
resembl
bilay
vesicl
unadulter
liposom
determin
dl
afm
supramolecular
structur
abl
encapsul
ba
ion
organ
molecul
acridin
red
constitut
instanc
promis
candid
slow
drug
deliveri
abil
mannofulleren
bind
mannosiderecogn
lectin
con
also
investig
colloid
suspens
stabl
selfassembl
structur
present
higher
block
activ
two
monoadduct
interest
submicromolar
mic
minimum
inhibitori
concentr
valu
lectininduc
hemagglutin
assay
strong
proteinbind
activ
ration
author
fact
fulleren
scaffold
allow
spatial
arrang
bi
mannopyranosid
moieti
could
mimic
adtrimannosid
natur
ligand
con
unfortun
methodolog
often
gener
mixtur
divers
substitut
adduct
difficult
separ
rather
low
yield
present
limit
solubl
water
altern
synthet
approach
first
develop
bingel
allow
effici
nucleophil
cyclopropan
fulleren
via
reaction
bromomalon
deriv
presenc
base
approach
reliabl
method
synthesi
function
methanofulleren
combin
advantag
mild
reaction
condit
good
yield
exclus
format
bridg
adduct
furthermor
degre
function
could
control
stoichiometri
malon
deriv
access
higher
adduct
one
step
bi
hexaki
methodolog
suffer
howev
complex
prepar
bromomalon
often
gener
mixtur
monoand
dibromo
deriv
similar
chromatograph
properti
optim
methodolog
propos
camp
hirsch
avoid
use
bromomalon
direct
treatment
fulleren
malon
presenc
cbr
dbu
exploit
collabor
work
describ
synthesi
amphiphil
glycofullerodendrim
incorpor
langmuir
langmuirblodgett
film
scheme
synthesi
first
c
dendrim
conjug
contain
one
glycodendron
headgroup
start
treatment
c
diethyl
malon
presenc
cbr
dbu
furnish
monoadduct
yield
scheme
clean
format
diester
accomplish
toluen
molar
excess
nah
c
result
bismalon
deriv
engag
doublebingel
macrocycl
c
afford
c
symmetr
bisadduct
yield
subsequ
select
cleavag
tertbutyl
ester
acid
condit
provid
desir
diacid
core
final
treat
glycodendron
forego
condit
yield
glycofullerodendrim
exhibit
six
peripher
protect
glucopyranosid
residu
work
author
highlight
preponder
role
bulki
glycodendron
headgroup
c
form
compact
insul
layer
around
carbon
sphere
avoid
gener
propens
amphipil
fulleren
deriv
aggreg
irrevers
henc
amphiphil
fulleren
abl
form
stabl
order
monomolecular
langmuir
layer
airwat
interfac
show
revers
behavior
success
compressionexpans
cycl
addit
monolay
transfer
success
xtype
langmuirblodgett
film
onto
quartz
slide
anticip
applic
biosensor
group
hirsch
report
synthesi
sugar
ball
accord
two
distinct
methodolog
alreadi
mention
involv
direct
graft
glycosyl
dendron
onto
c
scheme
also
describ
supramolecular
assembl
aqueou
solut
context
bi
admannopyranosyl
fulleren
synthes
sequenc
involv
bi
admannopyranosyl
malon
result
peptidecoupl
reaction
correspond
quantit
obtain
correrspond
azid
deriv
stauding
reduct
malon
acid
yield
subsequ
nucleophil
cyclopropan
c
typic
bingelhirsch
condit
follow
odeacetyl
condit
afford
fulli
deprotect
monoadduct
overal
isol
yield
noteworthi
protect
architectur
present
robust
amid
linkag
around
malon
anchor
point
toler
basic
cleavag
acetyl
protect
group
without
side
reaction
decomposit
fullereno
sugar
scheme
synthesi
bismannosidec
adduct
use
bingelhirsch
procedur
unfortun
rel
low
solubl
aqueou
media
compel
author
enhanc
number
peripher
saccharid
unit
toward
goal
develop
fulleren
glycoconjug
two
dendrit
branch
termin
six
deprotect
admannopyranosyl
build
block
connect
two
adjac
imino
bridg
allcarbon
framework
scheme
moreov
type
c
adduct
constitut
ahomo
h
fulleren
deriv
entir
system
fulleren
core
retain
prepar
ab
glycosyl
dendrit
build
block
first
synthes
preliminari
protect
newkom
dendron
benzyl
chloroform
cbzcl
treatment
formic
acid
orthogon
quantit
cleavag
tertbutyl
ester
give
triacid
upon
peptid
coupl
provid
trimannosid
yield
select
remov
cbz
protect
group
hydrogenolysi
gave
correspond
amin
quantit
yield
engag
without
purif
suitabl
linker
bear
termin
azid
group
name
ethoxi
acetyl
fluorid
presenc
dmap
ch
cl
provid
azido
oligo
ethylen
glycol
termin
glycodendron
yield
subsequ
thermal
coupl
c
toluen
afford
mixtur
monoand
bisglycodendron
adduct
separ
purif
column
chromatographi
gave
regioselect
twofold
clusteropen
diazabishomofulleren
adduct
scheme
direct
anchor
azidebear
mannosyl
dendron
onto
c
yield
final
quantit
deprotect
standard
condit
provid
c
glycoconjug
six
peripher
mannosid
residu
watersolubl
fullereno
sugar
mgml
known
amphiphil
natur
coneshap
structur
trigger
format
small
supramolecular
aggreg
aqueou
solut
observ
dosi
nmr
corrobor
tem
investig
uniform
spheric
micel
extrem
narrow
size
distribut
micellar
sugar
ball
diamet
nm
furnish
origin
arrang
saccharid
open
gate
new
biomed
applic
anoth
fruit
methodolog
initi
develop
nakamura
group
allow
introduct
five
carbohydr
moieti
onto
c
scaffold
use
effici
synthesi
c
symmetr
fulleren
deriv
scheme
thiolatealkyl
halid
coupl
reaction
aqueou
basic
media
provid
onestep
synthesi
good
yield
take
advantag
high
nucleophil
thiolat
anion
gener
synthesi
key
fulleropentathiol
intermedi
involv
fivefold
addit
reaction
copper
deriv
prepar
situ
correspond
grignard
reagent
cubr
sme
desir
fulleren
cyclopentadien
bear
tetrahydropyranylprotect
thiophenol
moieti
yield
subsequ
instal
five
saccharid
moieti
via
nucleophil
substitut
reaction
aqueou
thf
equival
sodium
hydroxid
glycopyranosid
afford
fulleren
glycoconjug
admannosid
bdglucosid
bdgalactosid
yield
respect
despit
gener
methodolog
simpl
carbohydr
deriv
applic
introduct
larger
oligosaccharid
via
direct
nucleophil
substitut
produc
side
product
led
lower
yield
circumv
situat
author
describ
optim
adapt
methodolog
quantit
synthesi
fulleren
bear
five
saccharid
glucos
maltotrios
globotriaosylceramid
k
trisaccharid
deriv
scheme
henc
moresophist
nanometerscal
pentaval
molecular
architectur
could
readili
prepar
use
key
pentaalkynylfulleren
intermedi
obtain
directli
derivat
fulleropentathiol
yield
forego
condit
click
chemistri
allow
effici
conjug
function
saccharid
moieti
termin
complementari
azid
function
pentaalkynyl
core
mild
condit
henc
typic
presenc
cubrsm
dipea
deprotect
fulleroderiv
obtain
nearli
quantit
yield
optim
condit
involv
control
heat
microwav
irradi
similarli
starfish
design
alreadi
describ
fig
peripher
radial
present
five
p
k
trisaccharid
residu
present
tailor
spacer
could
scheme
alkyl
fulleropentathiol
alkyn
spacer
follow
click
chemistri
variou
azido
sugar
includ
p
k
trisaccharid
furnish
adapt
structur
effici
specif
interact
slt
line
promis
result
obtain
function
fulleren
sever
research
group
recent
describ
derivat
carbon
nanotub
cnt
biolog
relev
carbohydr
cnt
member
fulleren
structur
famili
consist
exclus
carbon
atom
arrang
seri
condens
benzen
ring
organ
graphit
sheet
roll
tubular
structur
cnt
made
singl
graphen
layer
wrap
cylindr
structur
constitut
singlewal
cnt
swnt
wherea
multiwal
cnt
mwnt
gener
central
tubul
nanometr
diamet
surround
sever
graphit
layer
space
distanc
nm
commonli
diamet
rang
cnt
vari
nm
swnt
nm
mwnt
length
rang
micromet
nm
moreov
cnt
typic
form
bundl
entangl
togeth
solid
state
give
rise
highli
complex
spaghetti
network
intrins
cnt
possess
interest
uniqu
physicochem
properti
high
surfac
area
order
structur
high
aspect
ratio
ultralight
weight
excel
chemic
stabil
high
electr
conduct
high
thermal
conduct
metal
semiconduct
behavior
accord
arrang
hexagon
ring
along
tubular
surfac
reason
nanoobject
rais
great
enthusiasm
expect
mani
differ
applic
includ
materi
biolog
medic
scienc
particularli
intrigu
structur
properti
led
emerg
function
cnt
new
biolog
relev
altern
therapeut
diagnost
applic
includ
use
vector
deliveri
therapeut
molecul
plasmid
gene
deliveri
peptidesprotein
antibiot
inde
prior
becom
viabl
effect
nanomedicin
toxicolog
pharmacolog
profil
cnt
determin
sever
research
group
review
lacerda
et
al
biolog
studi
fulleren
function
cnt
offer
potenti
nanomedicin
wherea
nonfunction
cnt
usual
contain
amorph
carbon
carbon
nanoparticl
residu
metal
catalyst
regardless
procedur
product
inde
inher
hydrophob
properti
associ
innat
propens
form
bundl
via
aggreg
van
der
waal
forc
constitut
major
technic
barrier
util
medicin
applic
overcom
drawback
modif
surfac
typic
achiev
adsorpt
electrostat
interact
coval
bond
differ
molecul
chemic
procedur
render
solubl
biolog
media
modif
gener
improv
water
solubl
cnt
decreas
aggreg
phenomenon
transform
biocompat
biodistribut
profil
shown
experiment
bioactiv
protein
nucleic
acid
gene
particularli
carbohydr
success
conjug
cnt
particular
versatil
mode
chemic
modif
solubil
onedimension
nanostructur
swnt
high
surfac
areatoweight
ratio
structur
flexibl
exploit
platform
multival
carbohydr
array
physiolog
condit
result
dens
attach
sugar
pendant
group
cnt
hybrid
serv
multival
carbohydr
ligand
show
potenti
biolog
activ
well
behav
glycoconjug
polym
multival
present
saccharid
residu
realiz
via
noncoval
stabil
process
favor
hydrophob
pp
stack
electrostat
interact
via
sidewallor
defecttarget
coval
function
sever
group
report
multival
carbohydratecnt
conjug
schizophyllan
polysaccharid
lipidtermin
glycopolym
carbohydr
ligand
toward
bacteri
toxin
viral
protein
glyconanotub
noncoval
interactionsth
initi
challeng
obtain
swnt
solubl
organ
aqueou
media
supramolecular
approach
motiv
necess
retain
intrins
physic
properti
without
affect
allcarbon
scaffold
first
success
exampl
realiz
noncoval
function
wrap
synthet
biocompat
watersolubl
polym
around
swnt
format
supramolecular
complex
solut
swnt
preform
helic
structur
starch
polym
compos
linear
amylos
branch
amylopectin
investig
enhanc
water
solubl
supramolecular
complex
signific
investig
suggest
presenc
preform
helic
structur
amylos
may
requir
studi
examplifi
complex
swnt
cd
also
yield
interest
result
natur
extens
preliminari
studi
promis
applic
area
glyconanotechnolog
direct
toward
artifici
glycoconjug
carri
bioactiv
carbohydr
dens
distribut
onto
cnt
platform
mimic
cellsurfac
oligosaccharid
strike
exampl
describ
biomimet
surfac
modif
cnt
use
glycosyl
polym
design
mimic
cellsurfac
mucin
scheme
high
molecular
weight
glycoprotein
involv
specif
molecular
cellcel
recognit
process
addit
dens
cluster
olink
glycan
confer
rigid
provid
strong
hydrat
passiv
biofoul
cell
adhes
thu
ensur
protect
structur
function
nonspecif
biomolecular
interact
demonstr
nativ
mucin
cluster
nacetyladgalactosamin
agalnac
residu
proxim
peptid
major
contributor
rigidif
peptid
backbon
base
observ
author
prepar
synthet
tractabl
mucin
mimic
mm
agalnac
residu
link
oxim
bond
poli
methyl
vinyl
keton
pvk
lipidtemin
backbon
prepar
start
initi
introduct
c
scheme
noncoval
function
swnt
use
amphiphil
glycopolym
end
lipid
tail
mucin
mimicri
fulli
solubil
suggest
format
hydrophil
surfac
coat
selfassembl
termin
lipid
chain
nanotub
via
hydrophob
interact
afford
glycoconjug
c
ammswnt
evid
mucin
mimet
coat
provid
three
differ
imag
techniqu
name
afm
scan
electron
microscopi
sem
transmiss
electron
microscopi
tem
anticip
substanti
enhanc
water
solubl
observ
previous
entangl
swnt
bundl
dissoci
form
much
finer
bundl
stabl
aqueou
solut
sever
month
despit
inher
difficulti
imag
techniqu
condit
format
individu
nanotub
fairli
uniform
diamet
nm
observ
recognit
resist
properti
nanotubemucin
mimet
investig
use
helix
pomatia
agglutinin
hpa
incub
solut
hpa
conjug
fluorescein
isothiocyan
hpafitc
appropri
subsequ
treatment
led
signific
fluoresc
attribut
depend
receptorligand
interact
moreov
studi
similar
condit
involv
glycoconjug
bear
b
anom
galnac
manifest
signific
fluoresc
label
henc
lectin
interact
coat
nanotub
absenc
favor
ligand
result
clearli
demonstr
swnt
coat
mm
could
engag
specif
molecular
recognit
protein
receptor
resist
nonspecif
protein
bind
year
later
group
extend
studi
function
cntscell
interact
order
exploit
abil
interact
cell
advantag
hexaval
hpa
capabl
crosslink
cell
glycoprotein
explor
two
parallel
experi
conduct
one
hand
involv
preform
complex
hpafitc
c
ammcoat
cnt
incub
chines
hamster
ovari
cho
cell
preincub
cho
cell
unmodifi
hpa
subsequ
treatment
modifi
c
ammcoat
cnt
contain
fluoresc
dye
texa
red
instanc
analysi
fluoresc
microscopi
flow
cytometri
suggest
format
tricompon
agalnachpacntcel
surfac
complex
doseand
precomplexationdepend
label
second
studi
control
cnt
modifi
c
bmmcnt
indic
signific
fluoresc
label
low
concentr
conclus
demonstr
lipidtermin
poli
mvk
base
glycopolym
could
coat
cnt
surfac
promot
bind
cell
receptorligand
interact
demonstr
modifi
cnt
nontox
cultur
cell
cho
jurkat
cell
irregular
surfac
nonuniform
thick
cnt
coat
might
explain
high
polydispers
polym
employ
surfac
heterogen
gener
could
constitut
drawback
systemat
use
reproduc
way
glycopolymerco
cnt
sensor
protein
bind
immobil
rca
lectin
ricinu
communi
agglutinin
blacspecif
gold
surfac
result
indic
highli
specif
affin
toward
lectin
specif
also
confirm
confoc
laserscan
microscop
cslm
observ
use
fitclabel
rca
promis
applic
swntsbase
sensori
system
demonstr
author
succeed
construct
layerbylay
structur
compos
spglacswnt
composit
rca
methodolog
individu
dispers
watersolubl
swnt
randomli
wrap
helic
glycoconjug
polym
poli
pnacryloylamidophenyl
adglucopyranosid
papaglc
obtain
characterist
sharp
photoluminesc
signal
observ
nearinfrar
fluoresc
spectroscopi
associ
multival
present
peripher
carbohydr
made
system
promis
new
sens
approach
detect
carbohydraterecognit
protein
prepar
biocompat
swnt
noncoval
function
bioactiv
glycodendrim
report
scheme
bifunct
dendrit
scaffold
built
use
hydroxymethyl
propano
acid
build
block
link
azidopyren
tail
scheme
synthes
glycodendron
hydrophob
fluoresc
pyren
headgroup
pp
stack
swnt
swnt
pp
interact
orthogon
synthet
approach
base
sequenti
condens
dendritit
polyol
hydroxymethyl
propano
anhydrid
desir
gener
azidefunction
pyren
chemoselect
ligat
propargyl
hydroxyl
dendrit
scaffold
cuaac
methodolog
panel
deprotect
monoor
disaccharid
amannosid
bgalactosid
blactosid
effici
graft
onto
multival
dendrim
click
chemistri
uniforn
puriti
result
amphiphil
glycodendrim
confirm
nmr
spectroscopi
malditof
mass
spectrometri
glycodendrim
adsorb
onto
swnt
ultrason
aqueou
solut
analysi
group
suitabl
anchor
site
constitut
favor
coval
methodolog
instal
suitabl
function
group
render
cnt
solubl
appropri
solvent
typic
carboxyl
acid
function
gener
cnt
oxid
surfac
defect
suspend
cnt
hno
treatment
aqueou
hcl
scheme
alreadi
present
chapter
addit
biolog
relev
conjug
unprotect
carbohydr
onto
allcarbon
scaffold
solv
problem
intrins
low
solubl
one
first
exampl
watersolubl
swnt
glycoconjug
obtain
coval
graft
glucosamin
via
amid
bond
carboxyl
acid
function
first
convert
correspond
acyl
chlorid
suspend
function
swnt
solut
thionyl
chlorid
socl
dmf
result
solid
mix
anhydr
solut
glucosamin
thf
reflux
afford
glucosamin
graftedswnt
new
glycoconjug
character
uvvi
afm
analysi
solubl
water
rang
mgml
depend
temperatur
synthesi
first
bdgalactosidemodifi
swnt
galswnt
high
water
solubl
describ
along
interact
galactosespecif
lectin
form
supramolecular
junction
surfac
glycoco
swnt
fig
use
similar
strategi
analog
manswnt
conjug
effect
captur
pathogen
e
coli
physiolog
solut
also
synthes
synthesi
base
use
bdgalactopyranosid
graft
onto
swntbound
carboxyl
acid
sonic
condit
carbodiimideactiv
amid
carbodiimid
edac
aqueou
kh
po
buffer
complet
instrument
character
includ
solutionphas
nmr
sem
tem
raman
nearir
spectroscopi
optic
absorpt
thermogravimetri
spectrophotometri
result
galactosylatedswnt
exfoli
well
dispers
present
total
sugar
content
high
sugar
ratio
larg
surfac
area
coval
galactosyl
swnt
permit
display
abund
sugar
array
implic
strong
bind
interact
receptor
pathogen
e
coli
cell
signific
cell
agglutin
observ
sem
multipl
nanotub
bind
one
cell
nanotub
bridg
adjac
cell
research
group
went
detail
concern
antimicrobi
properti
monosaccharideco
swnt
advantag
exploit
applic
effici
specif
recognit
nonvirul
strain
bacillu
anthraci
context
similar
nanostructur
contain
larg
number
monosaccharid
mannos
galactos
synthes
conjug
correspond
glycopyranosid
b
onto
amid
result
watersolubl
conjug
strongli
bound
b
anthraci
spore
lead
signific
aggreg
mediat
ca
dival
cation
bind
phenomenon
uniqu
nanotubedisplay
monosaccharid
molecul
avail
display
platform
polymer
nanoparticl
polystyren
nanobead
instanc
indic
specif
arrang
carbohydr
ligand
nanotub
scaffold
furthermor
associ
substanti
reduct
colonyform
unit
cfu
could
potenti
find
valuabl
applic
effort
detect
decontamin
anoth
seri
hydrophil
glycodendronfunction
swnt
also
synthes
lectinbind
interact
studi
assum
limit
defect
site
origin
nanotub
surfac
could
gener
limit
number
carboxyl
acid
function
desir
dens
popul
multival
ligand
could
therefor
reach
coval
graft
sugar
dendron
contain
suitabl
anchor
function
toward
goal
bdgalactopyranosid
dendron
gal
nh
gal
nh
analog
admannopyranosid
dendron
man
nh
man
nh
effici
prepar
systemat
synthet
sequenc
base
use
trisubstitut
benzen
core
scheme
dival
b
tetraval
glycodendron
b
obtain
bromin
deriv
b
b
respect
synthesi
requir
dendrit
build
block
initi
trisubstitut
benzen
core
tbutyl
ester
remov
tfa
afford
bromin
precursor
tetraval
bromineend
analogu
synthes
select
etherif
alcohol
order
doubl
surfac
function
follow
introduct
bromin
function
pph
nb
tandem
acetyl
amineteth
monosaccharid
b
conjug
carbodiimideactiv
amid
yield
protect
glycodendron
b
b
yield
respect
final
amineend
glycodendron
prepar
common
synthet
protocol
involv
treatment
nan
odeacetyl
condit
subsequ
hydrogenolysi
h
pdc
aminederivat
glyco
wedg
final
use
function
swnt
acid
peptid
coupl
afford
fig
result
larger
number
display
ligand
per
swnt
respons
signific
increas
water
solubl
increas
function
enhanc
biocompat
addit
enabl
quantit
character
permit
better
understand
structur
detail
swnt
exhibit
multival
carbohydr
ligand
solut
gelphas
nmr
studi
sem
raman
optic
absorpt
studi
spectrophotometri
thermogravimetr
analysi
tga
employ
order
determin
morpholog
arrang
glycodendron
around
swnt
scaffold
sugar
content
meaning
differ
sampl
composit
gal
man
gal
man
gal
man
glyconanotub
function
moieti
observ
sugar
residu
display
amount
swnt
dival
conjug
monoval
one
furthermor
interestingli
electron
properti
cnt
larg
preserv
function
carbohydratefunction
swnt
evalu
bind
assay
pathogen
e
coli
bacillu
subtili
nonvirul
form
b
anthraci
anthrax
compar
bind
properti
galswnt
e
coli
induc
decreas
cfu
evok
earlier
consider
improv
record
dival
gal
swnt
presenc
e
coli
strain
amount
recov
cellular
aggreg
clearli
larger
signific
reduct
cfu
favor
bind
process
ii
naomemeoh
quant
iii
pdc
h
meoh
quant
nai
aceton
quant
gal
swnt
seem
suggest
pair
bdgalactosid
effect
specif
interact
moreov
man
swnt
man
swnt
capabl
bind
aggreg
b
subtili
spore
presenc
calcium
cation
despit
preliminari
encourag
observ
quantit
evalu
forego
bind
assay
complex
lack
major
tendenc
inconsist
result
seri
render
interpret
difficult
inaccur
final
subsequ
studi
furnish
clear
demonstr
cnt
could
provid
suitabl
support
rapid
effici
polymer
growth
synthesi
novel
biocompat
linear
hyperbranch
glycopolym
graft
strategi
good
high
reproduc
fig
success
control
linear
glucopyranosidepolym
graft
onto
mwnt
achiev
atomtransf
radic
polymer
atrp
hyperbranch
glycopolym
introduc
selfcondens
vinyl
copolymer
scvcp
correspond
function
inim
ethyl
methacryl
via
atrp
mwntco
h
precursor
gener
oxid
crude
mwnt
hno
modifi
ethylen
glycol
gener
mwntoh
cntbase
macroiniti
mwntbr
atrp
form
treat
mwntoh
bromid
morpholog
nanostructur
result
multihydroxyl
conjug
observ
sem
tem
sfm
indic
format
nanotubesupport
polym
brush
linear
polym
polym
layer
coreshel
structur
hyperbranch
structur
impli
uniform
growth
surfac
mwnt
origin
watersolubl
glycopolymergraft
cnt
offer
promis
field
tissu
engin
bionanomateri
conclus
threedimension
carbonbas
nanostructur
fulleren
nanotub
constitut
scaffold
whose
effici
function
derivat
develop
recent
year
accur
control
introduct
biolog
relev
moieti
achiev
give
rise
origin
nanostructur
intrigu
promis
properti
particular
monoval
carbohydr
complex
oligosaccharid
glycodendron
success
anchor
surfac
coval
noncoval
methodolog
although
practic
applic
remain
yet
limit
preliminari
result
suggest
nanomateri
offer
uniqu
favor
arrang
multival
carbohydr
array
readili
avail
display
platform
enhanc
number
saccharid
unit
exhibit
construct
multival
scaffold
supramolecular
chemistri
provid
interest
altern
rapid
synthesi
glycodendrim
dynam
revers
selfassembl
process
consist
coordin
metalassist
associ
ligand
one
strike
exampl
supramolecular
organ
year
optic
electrochem
properti
variou
complex
wide
studi
exploit
differ
domain
materi
biolog
applic
target
specif
biolog
event
cell
tissu
introduct
relev
recognit
molecul
carbohydr
investig
recent
year
context
metalloglycoclustersiniti
selfassembl
ligand
contain
simpl
saccharid
dens
glycodendron
around
coordin
metal
contribut
valuabl
addit
origin
promis
structur
rang
avail
multival
glycoconjug
rather
surpris
exampl
describ
metalassist
associ
carbohydr
compon
offer
straightforward
access
carbohydr
cluster
number
rel
orient
carbohydr
residu
modul
almost
chang
structur
ligand
natur
metal
addit
intrins
photophys
properti
metal
complex
advantag
exploit
instanc
creat
effici
biosensor
furthermor
second
exampl
multival
present
carbohydr
selforgan
process
result
lipophil
core
furnish
aggreg
glycodendrim
aqueou
solut
allow
homogen
control
format
hyperval
structur
distinct
recognit
properti
compar
individu
precursor
histor
first
multival
glycoconjug
obtain
metalassist
selfassembl
describ
sakai
sasaki
fig
methodolog
base
trimer
unsymmetr
bipygalnac
induc
presenc
fe
ii
salt
give
trident
fe
ii
bipygalnac
cluster
mixtur
four
diastereomer
isom
lfac
dfac
lmer
dmer
compar
studi
involv
bipygalnac
fe
ii
bipygalnac
dendrim
asialoglycophorin
use
galnacspecif
plant
lectin
vicia
villosa
b
assess
author
determin
compar
rel
bind
potenti
better
bind
affin
observ
trival
complex
monoval
precursor
indic
role
play
cluster
format
galnac
residu
around
metal
templat
interestingli
similar
strong
bind
affin
observ
asialoglycophorin
natur
glycoprotein
contain
sever
repeat
unit
galnac
link
ser
thr
residu
fe
ii
bipygalnac
attribut
adapt
organ
galnac
residu
complex
adequ
intercarbohydr
distanc
year
later
group
propos
investig
explain
strong
bind
affin
earlier
observ
selfassembl
complex
describ
dynam
molecular
recognit
synthet
ligand
lectin
studi
involv
v
villosa
b
lectin
complex
highlight
fact
ratio
four
diastereoisom
gradual
chang
bind
experi
h
room
temperatur
author
record
enrich
lmer
isom
end
compris
total
isom
vs
nativ
mixtur
experiment
observ
suggest
dynam
equilibrium
seen
room
temperatur
allow
spatial
arrang
three
galnac
residu
selfadjust
order
provid
better
complementar
multival
carbohydratebind
site
lectin
tendenc
confirm
studi
involv
galnacspecif
lectin
glycin
max
specif
termin
adgalnac
residu
attach
oh
group
galactos
select
enrich
diastereoisom
observ
indic
adapt
process
lectin
present
differ
shape
functionn
carbohydratebind
pocket
intramolecular
lectin
bind
site
distant
one
anoth
reach
close
galnac
residu
strongli
suggest
dynam
crosslink
process
kobayashi
et
al
employ
hexaval
metal
complex
base
selfassembl
three
symmetr
bipyridin
ligand
tether
two
function
glycopyranosid
around
ruthenium
iii
iron
ii
core
compon
fig
undertook
complet
compar
studi
involv
glycosyl
trisbypyridin
iron
ruthenium
complex
order
develop
robust
biosensor
monitor
saccharidebind
phenomena
synthesi
ligand
base
use
dicarboxyl
acid
core
onto
amino
glycopyranosid
deriv
conjug
via
amid
function
henc
selfassembl
glycoclust
fig
selfassembl
glycodendrim
use
chelat
metal
cation
dival
bipyridin
scaffold
consist
direct
nlink
glycosylamin
appendag
complex
olink
pbutanamidophenyl
spacer
produc
three
equival
result
conjug
treat
rucl
fecl
minimum
amount
boil
wateralcohol
mixtur
afford
correspond
trisbipyridineruthenium
iron
complex
mixtur
separ
diastereoisom
determin
import
structur
paramet
first
studi
involv
ferrou
n
glycoclust
context
influenc
spacer
lectin
affin
investig
rel
bind
properti
specif
lectin
evalu
hai
assay
spr
use
aglucosideand
amannosidespecif
cona
bgalactosidespecif
rca
lectin
lectin
affin
observ
nlinkedglycoclust
low
high
affin
ic
micromolar
rang
record
elong
conjug
thu
highlight
import
flexibl
densiti
carbohydr
scaffold
flexibl
seem
essenti
reach
high
specif
lectinrecognit
probabl
induc
optim
conform
organ
epitop
fit
bind
site
lectin
hand
strong
bind
avid
lectin
observ
labil
iron
complex
readili
dissoci
dilut
aqueou
solut
reason
author
investig
stabl
elong
ruthenium
olink
glycoclust
show
avid
correspond
lectin
enhanc
reach
ic
nanomolar
rang
compar
known
potent
glycopolym
result
indic
dens
saccharid
cluster
play
essanti
role
specif
strong
bind
compar
monoval
precursor
furthermor
complex
exhibit
intens
emiss
spectra
excit
metaltoligand
charg
transfer
mlct
band
water
compar
nonglycosyl
ruthenium
complex
strong
luminesc
attribut
peripher
carbohydr
shell
caus
close
pack
saccharid
cluster
could
possibl
isol
luminesc
core
lost
outer
aqueou
environ
structur
consid
author
resembl
natur
protein
redox
luminesc
core
embed
polypeptid
shell
interestingli
bind
lectin
glycoconjug
decreas
luminesc
disrupt
outer
carbohydr
shell
structur
combin
effort
two
research
group
mention
develop
onepot
transglycosyl
strategi
construct
complextyp
disialooligosaccharid
start
adglucopyranosid
residu
selfassembl
onto
trisbipyridineruthenium
complex
ru
cl
scheme
succeed
commend
chemoenzymat
onepot
transform
use
endobdglcnacas
mucor
hiemali
endo
effect
catalyz
transfer
eggyolk
decasaccharid
yd
asparaginebond
complextyp
disialooligosaccharid
ydsasn
onto
posit
adglucosid
unit
therefor
mixtur
two
separ
product
consist
mono
yd
dru
bisadduct
obtain
yield
respect
bind
properti
presenc
influenza
typea
virus
evalu
use
inhibit
test
virusinfect
mdck
cell
result
reveal
despit
small
molecular
weight
ydsadduct
especi
exhibit
strong
inhibitori
potenc
ic
mm
valu
two
order
magnitud
higher
parent
ydsasn
origin
excel
viru
affin
unknown
specul
concern
favor
electrostat
hydrophob
interact
cation
aromaticrich
complex
center
certain
amino
acid
residu
hemagglutinin
formul
addit
exhibit
strong
luminesc
nm
intens
increas
number
yd
residu
evok
earlier
work
enhanc
attribut
bulki
oligosaccharid
span
around
luminesc
core
interestingli
addit
influenza
typea
virus
pb
result
luminesc
quench
probabl
caus
disrupt
saccharid
shell
result
exposur
luminesc
core
aqueou
environ
although
exact
mechan
clear
strategi
could
allow
construct
robust
effici
sensit
biosensor
variou
toxin
virus
bacteria
scheme
enzymat
transglycosyl
preform
bisglucobipyridin
core
selfassembl
hexaval
cluster
around
ruthenium
cation
strategi
constitut
extens
work
constabl
et
al
initi
describ
selfassembl
peripher
saccharid
coval
link
terpyridin
moieti
dival
iron
ii
ruthenium
ii
complex
bear
function
bdglucopyranosid
bdgalactopyranosid
effici
prepar
approach
scheme
peracetyl
glucosyl
terpyridin
ligand
obtain
phasetransf
condit
involv
reaction
nucleophil
terpyridin
tetraoacetyladglucopyranosyl
bromid
elong
analogu
synthes
simpl
nucleophil
substitut
use
k
co
ki
tetraoacetylbdglucopyranosid
similarli
treat
use
sodium
hydrid
thf
afford
dival
complex
typic
form
treat
terpyridin
intermedi
nh
fe
acetonitril
ethanol
precipit
ammonium
hexafluorophosph
subsequ
deprotect
saccharid
portion
aqueou
methanol
k
co
trifluoroacet
acid
water
respect
afford
glycoadduct
author
conduct
preliminari
biolog
investig
complex
studi
stabil
toward
enzymat
hydrolysi
interestingli
glucosid
residu
releas
complex
action
almond
bglucosidas
scheme
selfassembl
glycoclust
use
monosubstitut
terpyridin
ligand
free
ligand
hydrolyz
similar
condit
precis
molecular
origin
effect
howev
determin
later
group
attempt
improv
effici
coupl
carbohydr
onto
terpyridin
scaffold
introduc
reactiv
pentaflurophenyl
group
onto
posit
use
simpl
alcohol
saccharid
scheme
somewhat
surprisingli
appear
nucleophil
n
aryl
substitut
could
deliv
expect
conjug
reli
altern
strategi
use
tetrafluorophenoxi
spacer
allow
synthesi
intermedi
via
attack
electrophil
sugar
complex
format
ferrou
chlorid
furnish
dival
iron
complex
good
yield
lengthi
synthet
sequenc
togeth
modest
yield
obtain
start
materi
render
strategi
unsuit
develop
order
prove
gener
concept
enhanc
stabil
result
complex
sever
research
group
investig
use
variou
ligand
coordin
metal
concept
mind
versatil
synthet
methodolog
lead
selfassembl
galactoseoligopyridin
conjug
around
variou
metal
core
disclos
simpl
success
strategi
allow
structur
variat
compon
linker
gener
multival
adduct
differ
size
shape
valenc
conform
mobil
synthesi
necessari
galactosyl
precursor
start
tetraoacetylbd
complex
bipyridin
ligand
cuotf
terpyridin
ligand
zn
otf
afford
correspond
complex
respect
singl
speci
fig
depend
metal
ligand
spectroscop
evid
indic
format
tetrahedr
structur
cu
complex
regardless
length
natur
spacer
trigonalbipyramid
geometri
observ
selfassembl
glycoconjug
result
scheme
synthesi
bdgalactopyranosid
precursor
bear
amin
alcohol
iodid
anchor
function
metalbas
selfassembl
zn
metal
addit
unprotect
bipyridinecu
complex
obtain
via
odeacetyl
condit
contrast
terpyridinezn
ii
adduct
complex
decompos
later
investig
describ
attach
differ
bipyridin
obtain
biolog
stabl
ligand
radiolabel
metal
complex
tc
scheme
novel
ligand
obtain
coupl
bipyridin
basic
condit
ensu
thioglycosid
link
bipyridin
deriv
odeacetyl
standard
condit
afford
watersolubl
ligand
luminesc
rhenium
complex
form
reflux
methanol
suspens
correspond
ligand
rhenium
pentacarbonyl
chlorid
co
cl
new
glycoconjug
complex
gener
formula
l
co
cl
consid
luminesc
probe
character
mass
spectrometri
element
analysi
h
c
nmr
ir
uvvi
fluoresc
spectroscopi
one
structur
unequivoc
character
xray
crystallographi
indic
surpris
nonsymmetr
metallocomplex
architectur
addit
rather
stabl
radiolabel
tc
order
increas
complex
peripher
epitop
result
selfassembl
process
glycodendron
success
graft
onto
variou
ligand
allow
format
dens
glycocomplex
inde
exampl
branch
dendrim
produc
microenviron
scheme
prepar
luminesc
tc
glycoclust
obtain
selfassembl
encapsul
coordin
metal
core
drastic
modifi
photochem
electrochem
properti
modul
suitabl
applic
first
exampl
propos
roy
kim
describ
synthesi
rel
lectinbind
properti
squar
planar
complex
organ
around
cu
ii
coordin
core
glycodendron
contain
four
eight
peripher
tnantigen
unit
agalnac
known
cancer
marker
coval
link
bipyridin
core
scheme
analogu
contain
elong
linker
obtain
peptid
coupl
nbocprotect
acid
follow
acid
deprotect
tfa
ch
cl
use
anchor
compound
coupl
dicarboxyl
acid
chlorid
provid
dival
tn
antigen
respect
deprotect
order
provid
access
selfassembl
structur
increas
carbohydr
valenc
author
describ
converg
strategi
dimer
galnac
build
block
shortand
longspac
arm
thu
amin
deriv
preform
dendron
cluster
around
copper
ii
cuso
aqueou
media
provid
effici
symmetr
hydroxyl
glycoclust
glycodendrim
fig
respect
exhibit
four
eight
galnac
residu
metal
adgalnacbear
glycodendrim
fulli
character
standard
spectrometr
analys
h
c
nmr
malditof
mass
spectrometri
uvvi
spectroscopi
potenti
selfassembl
complex
crosslink
precipit
horseradish
peroxidaselabel
plant
lectin
v
villosa
vvahrp
confirm
solidphas
competit
inhibit
assay
ella
use
asialoglycophorin
coat
materi
neoglycoconjug
includ
simpl
dival
tetraval
ligand
inhibit
bind
asiaglycophorin
vvahrp
greater
efficaci
monomer
standard
inhibitor
allyl
adgalnac
ic
mm
anticip
elong
dimer
analogu
potent
ic
mm
tetraval
ligand
show
less
potenc
ic
mm
probabl
shorter
intrasugar
distanc
branch
compar
nonmet
complex
metal
cluster
clearli
exhibit
enhanc
inhibitori
potenc
follow
expect
cluster
effect
inde
cu
ii
bipygalnac
tetram
respect
potent
monoval
control
octam
exhibit
enhanc
avid
interestingli
best
bind
affin
record
tetram
cu
ii
nucleat
deriv
scheme
elong
tnantigen
adgalnac
cluster
selfassembl
longest
intersugar
distanc
result
clearli
demonstr
structur
arrang
flexibl
molecul
play
crucial
role
rel
bind
affin
work
confirm
aglycon
spacer
valenc
enhanc
sugar
residu
neoglycoconjug
respons
increas
bind
affin
carbohydrateprotein
interact
supramolecular
assembl
process
also
direct
toward
synthesi
metal
fluoresc
glycodendrit
architectur
thu
homogen
fluoresc
sugarfunction
metal
dendrim
contain
variou
number
type
monosaccharid
prepar
chelat
transit
lanthanid
metal
ensur
presenc
scheme
metal
glycodendrim
contain
peripher
mannosid
residu
prepar
start
n
tri
methyl
methylamin
treat
concentr
hcl
ethanol
yield
triester
success
peptid
coupl
bocbalanin
acid
yield
function
tripod
hydrolysi
coupl
pentafluorophenol
afford
activ
triester
yield
tetraacetyl
mannos
contain
anomer
linker
coupl
gener
trival
neoglycoconjug
odeacetyl
hydrogenolysi
afford
correspond
complex
precursor
yield
two
step
secondgener
mannosyl
dendron
synthes
process
employ
start
introduct
bocbalanin
triester
provid
yield
saponif
coupl
pentafluorophenol
standard
condit
afford
triester
mannosid
coupl
give
situ
remov
nbocprotect
group
tfa
treatment
afford
deprotect
nonaval
glycodendron
fig
adgalnac
bipyridin
oligom
selfassembl
around
copper
ii
salt
yield
four
step
final
treatment
forego
precursor
appropri
stoichiometri
zn
oac
al
oac
gdcl
lower
gener
hot
methanol
afford
selfassembl
complex
yield
contain
either
peripher
mannopyranosyl
residu
fig
assess
interest
optic
properti
complex
specif
protein
interact
cona
model
lectin
investig
preliminari
scheme
mannosyl
dendron
ligand
focal
point
selfassembl
turbidimetri
assay
initi
result
indic
metal
secondgener
glycodendrim
induc
strong
bind
larg
dens
glycoclust
surfac
highli
effici
lectin
sensor
approach
lanthanideglycodendrim
instanc
gd
iii
might
thu
provid
tunabl
fluoresc
mri
reagent
imag
research
group
extend
studi
propos
systemat
investig
core
activ
differ
carbohydr
densiti
biosens
process
three
new
mannosyl
dendrim
ru
bipi
core
unit
synthes
influenc
number
size
dendrit
branch
rate
electron
energi
transfer
well
lectinbiosens
abil
scheme
investig
mannosecap
dendrim
prepar
use
glycosyl
bipyridin
precursor
treatment
rucl
cisru
bipi
cl
firstgener
dendron
prepar
modest
yield
via
previou
strategi
remov
nboc
protect
group
subsequ
peptid
coupl
dicarboxyl
acyl
chlorid
secondgener
dendron
contain
nine
saccharid
unit
shown
synthes
yield
introduct
amin
deriv
coupl
follow
nboc
deprotect
tfa
subsequ
peptid
coupl
bipyridin
deriv
gave
yield
two
step
boil
firstand
secondgener
glycodendron
ethanol
presenc
cisru
bipi
cl
rucl
follow
odeacetyl
condit
yield
dendrit
complex
scheme
contain
peripher
mannopyranosid
respect
scheme
mannosyl
glycodendrim
bipyridin
core
ruthenium
complex
rate
electron
transfer
within
complex
investig
photoinduc
electron
transfer
pet
photoexcit
ru
ii
templat
suitabl
quencher
n
n
bi
acid
bipyridinium
dibromid
bbv
high
affin
sugar
expect
compound
exhibit
differ
extent
quench
depend
degre
peripher
carbohydr
densiti
effici
insul
core
properti
rate
energi
transfer
induc
photoexcit
complex
also
evalu
quantif
molecular
oxygen
singlet
state
trap
quencher
tempo
rate
appear
gener
stabl
speci
tempo
decreas
thu
support
notion
dens
carbohydr
insul
ru
ii
templat
present
shield
stop
effect
energi
transfer
dissolv
oxygen
addit
select
sensit
process
studi
use
complex
lectin
biosensor
cona
galanthu
nivili
agglutinin
gna
tetram
contain
one
three
mannosebind
site
per
subunit
respect
select
investig
concept
base
reconstitut
fluoresc
signal
preliminari
complex
bbv
quencher
mannosylatedcomplex
disrupt
favor
tight
interact
take
place
glycodendrim
lectin
spontan
gain
fluoresec
observ
addit
nm
cona
initi
mixtur
hexaval
complex
bbv
contrast
modest
gain
fluoresc
obtain
dendrim
contain
mannosid
condit
steadi
linear
increment
continu
higher
concentr
cona
similar
experi
higher
valenc
lectin
gna
induc
tendenc
base
result
detect
limit
rucomplex
evalu
compar
indic
hexaval
glycoconjug
sensit
wherea
higher
detect
limit
determin
exhibit
broader
limit
rang
linear
respons
conclus
although
complex
repres
best
compromis
encapsul
effici
quench
properti
sensit
lectin
sens
glycodendrim
also
suitabl
sensit
biomark
studi
lectincarbohydr
interact
owe
high
quantum
yield
excel
lectinaffin
high
carbohydr
densiti
earli
thoma
et
al
present
altern
concept
polyval
present
ligand
base
supramolecular
chemistri
rather
small
molecul
fulfil
singlemolecul
entiti
criteria
describ
noncoval
dynam
selfassembl
origin
function
dendron
cap
carbohydr
ligand
aqueou
solut
gener
polyval
glyconanoparticl
dendrit
scaffold
prepar
converg
outsidein
approach
iter
methodolog
base
singl
build
block
obtain
coupl
methyl
tertbocaminomethyl
benzoic
acid
select
cleavag
methyl
ester
group
give
subsequ
remov
nboc
group
liber
compris
g
dendrim
gener
two
amin
end
group
coupl
follow
orthogon
methyl
ester
cleavag
furnish
g
dendrim
gener
contain
four
termin
anchorag
function
thirdgener
dendrim
eight
end
group
obtain
treatment
procedur
repetit
appli
yield
dendrim
end
group
correspond
sixth
gener
peripher
amin
glycodendron
gener
isol
tfa
salt
transform
introduct
chloroacetamid
group
use
larg
excess
chloroacet
anhydrid
dmf
lead
complet
convers
subsequ
introduct
thiolat
oligosaccharid
galili
antigen
lacsh
onto
dendrit
core
realiz
final
step
synthet
sequenc
presenc
dbu
afford
watersolubl
glycodendrim
shown
sixth
gener
present
control
number
peripher
oligosaccharid
residu
base
gener
scheme
aggreg
glycodendrim
water
observ
h
nmr
quantifi
use
multiangl
light
scatter
mal
measur
indic
format
small
aggreg
kda
first
gener
wherea
tetraval
analogu
form
larg
particl
kda
correspond
aggreg
individu
molecul
per
particl
surprisingli
particl
weight
obtain
higher
gener
dendrim
decreas
increas
mass
individu
molecul
furthermor
thirdgener
glycodendrim
contain
eight
rsor
r
residu
exhibit
similar
size
weight
indic
particl
structur
depend
primarili
dendrit
core
architectur
less
size
natur
carbohydr
group
synthesi
sever
dendrit
core
contain
branch
aliphat
compon
structur
cyclohexyl
ring
linear
alkyl
chain
methyl
amid
demonstr
highli
aromat
architectur
induc
aggreg
result
pstack
hydrophob
interact
rigid
author
assum
intramolecular
pstack
led
preorgan
allow
effici
corecor
contact
optim
corecor
interact
record
second
gener
wherea
lowest
gener
dendrim
small
largest
one
shield
dens
carbohydr
addit
shape
size
homogen
nanoparticl
within
factor
investig
afm
indic
disklik
morpholog
averag
diamet
decreas
increas
mass
individu
molecul
thu
resembl
tendenc
solut
biolog
activ
noncoval
multival
ligand
investig
via
inhibit
decaval
igm
direct
agal
galili
xenoantigen
assess
compound
polyval
igm
ligand
author
employ
two
vitro
assay
inhibit
antiag
igm
bind
xenoantigen
agalmedi
lysi
pig
erythrocyt
measur
agreement
previou
result
monomer
agal
inact
mm
assay
wherea
activ
observ
dival
conjug
secondand
thirdgener
dendrim
highli
potent
assay
mm
mm
respect
fourthgener
analogu
contain
peripher
agal
residu
also
show
high
potenc
bind
assay
mm
significantli
less
potent
hemolysi
assay
mm
gener
potenc
decreas
drastic
larger
dendrim
induc
aggreg
avid
thu
correl
size
aggreg
size
individu
particl
preliminari
vitro
result
highlight
involv
polyval
aggreg
antibodi
bind
without
nonspecif
interact
dendrim
backbon
potent
compound
bear
eight
trisaccharid
epitop
select
vivo
profil
cynomolgu
monkey
within
min
inject
antiag
igm
detect
elisa
diminish
initi
valu
determin
prior
administr
remain
low
level
h
importantli
antiag
antibodymedi
hemolyt
activ
complet
elimin
even
though
exampl
remain
rather
scarc
prepar
multival
structur
via
supramolecular
chemistri
involv
selforgan
ligand
around
coordin
core
afford
glycoconjug
valenc
size
structur
effici
tailor
natur
coordin
metal
chemic
composit
ligand
instanc
stabl
complex
gener
constitut
promis
organ
enhanc
biolog
properti
compar
correspond
monomer
ligand
moreov
noncoval
dynam
revers
selfassembl
process
ideal
allow
util
polyval
receptor
lectin
templat
optim
polyval
inhibitor
organ
carbohydr
moieti
fit
perfectli
recognit
site
adapt
also
emphas
signific
improv
biolog
activ
compar
individu
speci
observ
homogen
noncoval
glycoparticl
selfassembl
aqueou
media
via
similar
dynam
equilibrium
process
light
promis
applic
offer
supramolecular
glycoconjug
structur
notabl
intrins
optic
electrochem
properti
metal
complex
underexploit
research
area
undoubtedli
infanc
hold
promis
system
biomark
sensit
biosensor
introduct
definit
historya
dendrim
synthet
highli
branch
monodispers
polyfunct
macromolecul
constitut
repetit
unit
socal
gener
chemic
bound
arboresc
process
around
multifunct
central
core
thu
oppos
tradit
polym
often
poorli
defin
molecular
structur
clearli
import
drawback
medic
applic
term
product
characterist
dendrim
structur
well
defin
synthes
fulli
control
iter
approach
although
differ
exist
term
rigid
compact
dendrim
often
compar
artifici
protein
semiglobular
globular
structur
mostli
high
densiti
peripher
function
small
molecular
volum
accept
dendrit
polym
fourth
major
class
polymer
architectur
consist
three
subset
base
degre
structur
control
name
random
hyperbranch
polym
b
dendrigraft
polym
c
dendrim
concept
repetit
control
synthet
growth
branch
first
report
achiev
construct
low
molecular
weight
cascad
polyamin
howev
group
newkom
tomalia
independ
describ
diverg
macromolecular
synthesi
give
birth
first
wellcharacter
true
dendrim
name
arborol
pamam
poli
amidoamin
dendrim
respect
strategi
thu
effici
avoid
problem
low
yield
puriti
purif
encount
cascad
synthesi
chapter
tomalia
et
al
pave
way
dendrit
structur
definit
construct
introduc
first
time
term
dendrim
aris
greek
dendron
mean
tree
branch
mero
mean
part
origin
effici
methodolog
still
constitut
prefer
commerci
rout
trademark
starburst
dendrim
famili
molecular
weight
rang
sever
hundr
million
dalton
name
gener
synthet
challeng
aesthet
structur
stimul
numer
research
group
investig
intens
rang
synthet
strategi
effort
gave
rise
origin
dendrit
structur
emerg
two
main
synthet
strategi
use
construct
perfectli
branch
dendrim
diverg
converg
approach
time
acceler
version
converg
strategi
develop
order
increas
throughput
effici
use
clever
adapt
core
dendron
initi
effort
gave
rise
wellcharacter
dendrit
macromolecul
applic
remain
limit
lack
specif
function
exponenti
increas
public
volum
observ
year
testifi
grow
interest
dendrim
led
versatil
power
iter
methodolog
systemat
expediti
access
complex
dendrit
structur
perfect
control
tridimension
paramet
size
shape
geometri
coval
introduct
function
core
branch
high
number
extrem
physic
encapsul
microenviron
creat
caviti
confer
desir
properti
solubl
hydrophilichydrophob
balanc
thu
creativ
allow
structur
becom
integr
nearli
contemporari
scientif
disciplin
undoubtedli
biolog
nanomedecin
particularli
biomed
therapeut
applic
domain
gener
highest
infatu
architectur
howev
complex
mechan
involv
biolog
process
present
import
challeng
effici
structur
design
fact
histor
problem
concern
toxic
hydrosolubl
degrad
target
specif
pharmacokinet
biodistribut
profil
kind
applic
recurr
use
monomer
system
applic
polymer
system
exploit
advantag
enhanc
hydrosolubl
biocompat
lack
toxic
immunogen
order
improv
drug
stabil
select
toward
malign
tissu
enhanc
therapeut
properti
observ
use
prodrug
explain
physic
properti
polymer
structur
present
high
hydrodynam
volum
facilit
blood
persist
accumul
tumor
tissu
particularthi
phenomenon
call
epr
effect
ie
enhanc
permeat
retent
may
roughli
explain
physiolog
biochem
differ
observ
tumor
healthi
tissu
fact
tumor
tissu
present
specif
vascular
defect
lymphat
drainag
system
allow
macromolecul
molecular
weight
kda
permeabl
retent
accumul
howev
high
polydispers
index
low
drug
load
often
respons
critic
lack
reproduc
effici
dendrim
combin
sever
advantag
describ
polym
along
monodispers
high
densiti
function
small
molecular
volum
exploit
year
surpass
problem
usual
encount
thu
particularli
uniqu
structur
properti
motiv
use
numer
applic
drug
gene
deliveri
devic
anticanc
therapi
antibacteri
antivir
antitumor
agent
use
dendrim
biolog
system
also
systemat
studi
common
dendrit
scaffold
determin
biocompat
vitro
vivo
cytotox
biostabl
immunogen
extens
review
one
typic
exampl
concern
use
dendrim
glycocarri
control
multimer
present
biolog
relev
carbohydr
moieti
use
target
modifi
tissu
malign
diseas
diagnost
therapeut
purpos
molecul
term
glycodendrim
saccharid
portion
conjug
accord
principl
dendrit
growth
ligat
preexist
highli
function
repetit
dendrit
scaffold
vari
molecular
weight
structur
sinc
first
appear
literatur
glycodendrim
relat
glycodendron
spheroid
dendrit
wedg
structur
initi
design
bioisoster
cellsurfac
multiantennari
glycan
stimul
wide
interest
within
scientif
commun
convent
dendrit
structur
glycodendrim
obtain
dendron
spheric
globular
architectur
hybrid
dendron
polym
accord
diverg
converg
acceler
approach
origin
synthet
cluster
construct
way
valenc
shape
carbohydr
content
could
vari
control
integr
dendrit
build
block
henc
recent
progress
synthesi
dendrit
structur
allow
easier
optim
afford
tailor
glycoconjug
biolog
adapt
optim
properti
b
glycodendrim
syntheseshistor
diverg
strategi
use
prepar
first
dendrit
structur
dendrim
built
iter
central
core
layer
layer
requir
activationaddit
step
afford
desir
dendrit
structur
focal
multifunct
molecul
systemat
expand
outward
use
variou
chemic
linkag
firstgener
dendrim
simpli
form
attach
branch
unit
core
molecul
form
secondgener
dendrim
peripher
function
group
react
complementari
chemic
function
present
branch
build
block
avoid
hyperbranch
polymer
step
care
control
use
protect
inert
group
build
block
activ
deprotect
chemic
transform
newli
attach
surfac
group
lead
secondgener
dendrim
gener
growth
quickli
allow
exponenti
multipl
activ
termin
function
process
repeat
requir
degre
branch
obtain
glycodendrim
sugar
append
peripheri
molecul
although
approach
conceptu
straightforward
synthet
problem
sometim
encount
involv
use
larg
excess
reagent
monom
synthet
step
ensur
complet
function
necess
effici
coupl
regard
exponenti
increas
number
function
accentu
difficulti
although
monom
gener
easi
remov
separ
requir
dendrim
structur
flaw
byproduct
usual
remain
challeng
mass
size
gener
properti
close
perfect
dendrim
sake
simplic
diminish
cost
inner
scaffold
portion
glycodendrim
either
synthes
onepot
procedur
use
hyperbranch
polym
methodolog
purchas
directli
inde
sever
dendrim
variou
surfac
function
build
block
commerci
avail
polyamidoamin
dendrim
pamam
starburst
dendrit
nanotechnolog
polypropyleneimin
ppi
astramol
dsm
fine
chemic
polyglycerol
dendrim
hyperbranch
dendrit
polym
boltorn
commonli
use
multibranch
dendrit
core
glycodendron
precursor
known
nontox
nonimmunogen
altern
efficaci
converg
strategi
report
hawker
use
symmetr
natur
structur
order
overcom
synthet
purif
problem
associ
diverg
methodolog
involv
preliminari
synthesi
peripher
branch
dendrit
arm
name
dendron
glycodendron
outsidein
concept
describ
envisag
attach
x
termin
unit
contain
one
reactiv
group
one
polyfunct
monom
possess
orthogon
protect
function
result
firstgener
dendron
transform
uniqu
focal
site
follow
treatment
x
equival
protect
monom
polyfunct
central
core
afford
next
higher
gener
dendron
dendrim
advantag
converg
strategi
lie
diminish
number
reaction
carri
step
moreov
purif
desir
dendrim
becom
less
problemat
diverg
case
fewer
byproduct
gener
structur
differ
perfect
target
dendrim
howev
fact
focal
function
wedg
may
steric
inaccess
within
infrastructur
depend
gener
caus
difficulti
toward
subsequ
linkag
core
thu
result
slower
less
effici
reaction
gener
grow
nevertheless
well
establish
larg
number
surfac
glycan
moieti
imped
access
carbohydr
carbohydratebind
receptor
consid
synthet
advantag
methodolog
use
success
access
dissymmetr
dendrit
structur
cumbersom
purif
synthet
disadvantag
observ
iter
approach
motiv
investig
toward
acceler
synthet
methodolog
improv
synthesi
efficaci
limit
synthet
step
preserv
monodispers
function
versatil
new
strategi
success
address
includ
develop
larger
build
block
involv
multigener
coupl
larg
describ
et
al
way
high
molecular
weight
dendrim
dendron
synthes
use
highli
polyfunct
dendrit
core
hypercor
highgener
dendron
subsequ
coupl
reaction
hypermonom
also
obtain
orthogon
protect
function
approach
doubl
exponenti
growth
strategi
eleg
applic
describ
base
design
allow
rapid
dendrit
construct
start
small
glycoclust
attach
branch
unit
form
glycosyl
hypermonom
final
suitabl
central
part
recent
anoth
clever
strategi
base
orthogon
monom
system
design
judici
use
function
build
block
coupl
togeth
without
need
protectiondeprotect
step
allow
rapid
easi
access
homogen
heterogen
dendrim
converg
altern
synthesi
glycodendrim
attract
sinc
earli
synthes
glycoco
molecular
wedg
present
readili
avail
interest
multival
candid
biolog
investig
obvious
analog
classic
synthesi
globular
structur
growth
eman
control
success
suitabl
function
build
block
provid
standard
ab
ab
system
ab
systemsaromat
ab
dendrit
build
block
wide
use
construct
glycodendron
possess
interest
biolog
activ
one
first
applic
prevent
tissu
infect
pentamer
bacteri
toxin
v
cholera
approach
prevent
bind
ctgm
consist
consid
termin
galactos
residu
fig
anchor
fragment
variou
pharmacophor
could
attach
provid
optim
smallmolecul
antagonist
ct
strategi
base
fact
galactos
residu
bound
specif
buri
pocket
receptorbind
site
howev
rest
bind
site
shallow
lack
welldefin
hydrophob
pocket
exploit
use
tradit
structurebas
drug
design
arriv
potent
inhibitor
initi
studi
made
screen
commerci
avail
galactos
deriv
use
elisa
result
mnitrophenyl
adgalactopyranosid
mnpg
best
inhibitor
identifi
ic
mm
correspond
better
affin
ct
lead
galactosid
addit
small
librari
antagonist
show
improv
compar
best
mnpg
candid
design
librari
consist
phenyl
galactosid
ab
anomer
mixtur
hydrophob
ringsystem
link
via
short
flexibl
aliphat
linker
amid
linkag
remain
meta
posit
mnpg
core
improv
obtain
use
simplifi
strategi
base
use
rel
simpl
lactos
deriv
fig
fig
simpl
lactosid
analogu
surrog
complex
gm
oligosaccharid
ligand
pentamer
bacteri
toxin
vibrio
cholera
inhibitor
ct
develop
k
mm
direct
fluorescencebind
assay
rather
low
valu
attribut
presenc
thiourea
moieti
aryl
group
seem
contribut
bind
enhanc
compar
unsubstitut
lactos
k
mm
improv
bind
affin
observ
group
new
lactos
conjug
form
cycliz
thiourea
sulfur
atom
onto
tripl
bond
contain
rigid
spacer
sugar
aryl
group
fluoresc
studi
reveal
one
order
magnitud
enhanc
affin
k
mm
ctb
subunit
compar
thiourea
deriv
order
improv
respect
inhibitori
potenc
ct
optim
monoval
inhibitor
describ
link
variou
ab
build
block
thu
ad
concept
multival
therefor
improv
receptorbind
activ
expect
use
glycodendron
approach
take
advantag
symmetr
arrang
five
ident
bind
site
toxin
b
pentam
mention
earlier
section
context
allow
synthesi
gener
lactosyl
dendron
base
benzoic
acid
repeat
unit
contain
peripher
lactosid
residu
respect
bound
dendrit
scaffold
via
thiourea
linkag
fig
bind
affin
ct
subunit
determin
fluoresc
assay
fret
rang
mm
lactos
mm
octaval
glycodendron
valu
correspond
eightfold
enhanc
compar
correspond
monoval
lactosid
deriv
condit
howev
increas
branch
dendron
name
valenc
provid
modest
increas
potenc
ligand
correspond
rather
constant
rel
potenc
per
lactos
regardless
number
peripher
epitop
advanc
effect
glycodendrim
group
incorpor
two
modif
system
first
alter
implic
glycodendron
slightli
modifi
scaffold
outfit
elong
arm
peripher
attach
gm
mimic
propos
earlier
bernardi
et
al
use
modifi
gm
analogu
fig
unlik
gm
modifi
deriv
obtain
gram
scale
synthet
sequenc
adapt
achiev
differenti
carboxyl
group
cyclohexanediol
moieti
allow
function
use
spr
inhibit
assay
product
show
good
inhibit
ic
mm
dival
mm
tetraval
correspond
improv
monoval
counterpart
octaval
analog
potent
compound
determin
use
elisa
assay
ongo
effort
highli
effect
ct
inhibitor
obtain
use
similar
architectur
combin
sever
critic
factor
design
use
authent
modifi
gm
oligosaccharid
sequenc
optim
monoval
ligand
bound
multival
dendrit
scaffold
present
elong
spacer
arm
optim
length
fig
compound
galactomodifi
analogu
bear
azido
group
conjug
polyalkyn
dendrit
scaffold
click
chemistri
evalu
potenc
inhibitor
correspond
di
tetra
octaval
deriv
elisa
assay
use
indic
unpreced
affin
potenc
notabl
octaval
exhibit
low
ic
around
pm
mean
gm
os
moieti
bound
strongli
correspond
monoval
diand
tetraval
gm
os
system
ic
valu
roughli
order
magnitud
lower
octam
agalacto
dendrim
seri
relat
octaval
weaker
inhibitor
tetraval
counterpart
ic
mm
studi
concern
activ
glycodendron
contain
two
four
peripher
gm
os
e
coli
heatlabil
toxin
ltbh
bpentam
similarli
describ
fig
fig
octamer
glycodendron
bear
gm
analogu
analyt
ultracentrifug
dl
use
demonstr
multival
inhibitor
induc
protein
aggreg
format
spacefil
network
aggreg
process
appear
take
place
use
ligand
match
valenc
protein
receptor
interestingli
valenc
inhibitor
dramat
effect
mechan
aggreg
influenc
kinet
aggreg
stabil
intermedi
protein
complex
addit
structur
studi
employ
afm
reveal
dival
inhibitor
induc
headtohead
dimer
protein
toxin
either
prevent
ltbh
pentam
sit
flat
surfac
gave
rise
protein
bilay
consid
tetraval
structur
shown
potent
inhibitor
pentaval
analogu
similar
size
develop
strategi
base
use
mismatch
valenc
may
provid
relev
multival
therapeut
pentamer
bacteri
toxin
thu
ad
arsen
multival
strategi
avoid
tediou
prepar
gm
deriv
direct
effici
prepar
dendrit
inhibitor
base
simpl
galactosid
also
propos
group
henc
simpl
bdgalactopyranosid
bear
poli
ethylen
glycol
unit
crude
mimick
sugar
ring
gm
os
end
lipophil
part
termin
azido
function
attach
keep
factor
system
mention
compound
highest
valenc
correspond
tetraval
system
show
ic
rang
gm
os
deriv
multival
effect
express
rel
potenc
per
sugar
still
increas
dito
tetraval
vs
remain
basic
octaval
analogu
although
result
obtain
dendrim
coat
sole
galactosid
residu
less
spectacular
observ
agalactogm
os
deriv
constitut
import
step
toward
potent
ligand
ct
low
cost
readi
avail
parallel
investig
group
describ
construct
new
rigidifi
multival
structur
bear
four
unit
peripheri
synthesi
dendrit
scaffold
start
aromat
diiodid
treat
bocprotect
propargylamin
modifi
sonogashira
coupl
condit
yield
branch
unit
fulli
orthogon
protect
key
build
block
scheme
part
materi
expos
ch
cl
tfa
mixtur
afford
quantit
ndeprotect
compound
part
smoothli
hydrolyz
tesser
base
lead
carboxyl
acid
deriv
two
fragment
coupl
standard
peptid
condit
subsequ
treat
tfa
yield
tetraamino
compound
coupl
di
tetraamin
lactosyl
bisothiocyan
presenc
ipr
net
subsequ
acid
treatment
facilit
format
aminothiazol
afford
glycoclust
moder
yield
respect
fig
standard
deacetyl
condit
yield
di
tetraval
dendron
deprotect
lactosid
evalu
inhibitor
lectin
bind
solidphas
inhibit
assay
immobil
asf
surfac
microtit
plate
well
mimick
cellsurfac
present
mammalian
solut
strong
multival
effect
select
observ
tetraval
lactosid
inhibit
bind
even
better
asf
ic
nm
correspond
enhanc
compar
lactos
thu
factor
rel
potenc
lactos
unit
hand
although
rigidifi
glycodendron
gener
gener
interest
result
correspond
analogu
mark
multival
effect
inher
bind
affin
observ
fluoresc
spectroscopi
compon
solut
biotinyl
glycopeptid
dendron
base
dendrit
llysin
scaffold
bear
four
tantigen
tumor
marker
bgal
agalnac
tag
fig
first
propos
baek
roy
doubli
associ
bind
interact
heterobifunct
biosensor
coat
streptavidin
togeth
mous
tag
monoclon
antibodi
demonstr
use
convent
solidphas
doubl
sandwich
elisa
henc
virtu
tag
glycodendrim
use
coat
agent
effect
anchor
motif
high
avid
nanomolar
coat
constitut
effici
cellsurfac
model
use
analog
aromat
ab
build
block
modular
approach
lead
glycoconjug
multipl
copi
analogu
induc
differenti
structur
homolog
shiga
shiga
toxin
complex
sampl
develop
end
dival
system
bear
fig
analogu
neutral
polysaccharid
correspond
serogroup
lp
construct
fig
interestingli
lp
resembl
signific
structur
differ
sinc
termin
digalactosid
moieti
wherea
neutral
polysaccharid
modifi
termin
digalactos
moieti
possess
bulki
nacetyl
group
contrast
bind
lp
abl
bind
neutral
effect
vero
cell
suggest
nacetyl
group
suffici
modifi
bind
specif
toward
tailor
biantennari
glycoconjug
consist
three
structur
compon
includ
peripher
carbohydraterecognit
compon
flexibl
aliphat
spacer
biotinyl
dimer
synthes
vari
nacetyl
pattern
biotin
use
afford
readi
access
multival
one
streptavidin
tetram
bind
four
biotin
molecul
conjug
commerci
streptavidin
matric
toxin
captur
molecul
design
biotin
henc
streptavidin
attach
opposit
end
rigid
scaffold
minim
interfer
biotin
bind
event
bind
variant
found
human
clinic
sampl
assess
elisa
analysi
result
indic
bound
diand
mononacetylsubstitut
galactosamin
respect
wherea
fail
bind
either
compound
precis
appear
better
substrat
contrast
surprisingli
construct
analogu
bound
exclus
probabl
due
biantennari
architectur
short
spacer
constrain
bind
final
author
prove
abil
captur
clinic
applic
without
interfer
complex
sampl
indic
feasibl
highli
select
sensit
synthet
glycoconjugatebas
detect
reagent
stx
introduc
simpl
manipul
structur
known
saccharid
receptor
use
versatil
modular
synthet
strategi
group
develop
biotinyl
bi
tetraantennari
mannosyl
glycoconjug
captur
detect
e
coli
cell
compar
rel
captur
abil
molecul
commerci
polyclon
antibodi
fig
instead
aliphat
spacer
tetraethylen
glycol
linker
use
diminish
nonspecif
bind
impart
flexibl
better
fit
activ
site
biotinyl
glycoconjug
antibodi
graft
commerci
streptavidinco
magnet
bead
result
materi
use
captur
isol
quantifi
bacteri
recoveri
use
luminesc
assay
context
glycomagnet
bead
complet
cover
glycan
incub
two
isogen
strain
e
coli
e
coli
bear
numer
fimbrial
adhesin
fimh
possess
bind
prefer
amannosid
second
strain
mutant
lack
pilu
express
initi
experi
strain
mediat
aggreg
bead
coat
mannosebear
dival
compound
within
minut
addit
bead
wherea
strain
bacteri
aggreg
shown
depend
multival
result
suggest
singl
bacterium
could
bind
multipl
bead
moreov
higher
concentr
e
coli
tetraval
conjug
respons
increas
captur
effect
author
compar
compet
rel
standard
antibodyco
bead
captur
bacteria
result
indic
glycoconjugateco
magnet
bead
outperform
tradit
antibodyco
magnet
bead
sensiv
select
compar
ident
experiment
condit
addit
system
could
captur
e
coli
environment
sampl
stagnant
water
possibl
target
specif
pathogen
bacteria
modul
natur
carbohydr
recognit
compon
experi
thu
clearli
reveal
power
glycan
biosens
demonstr
stabl
inexpens
glycomagnet
bead
could
use
captur
isol
pathogen
complex
matric
saladapur
lindhorst
report
synthesi
glycopeptid
dendron
peptid
coupl
orthogon
protect
ab
type
carbohydr
unit
form
basi
iter
sequenc
lead
variou
gener
glycodendron
either
diverg
converg
manner
synthet
strategi
base
use
effici
peptid
chemistri
link
step
avoid
sophist
glycosyl
techniqu
coupl
step
allow
possibl
adapt
solidphas
chemistri
scheme
key
ab
type
glucosid
build
block
use
prepar
multigener
glycopeptid
dendron
orthogon
deprotect
yield
complementari
build
block
henc
mildli
alkalin
hydrolysi
methyl
ester
group
led
dicarboxyl
acid
wherea
remov
nboc
protect
group
tfadimethyl
sulfid
mixtur
afford
aminofunction
glucosid
hatumedi
peptid
coupl
togeth
dipea
gave
protect
firstgener
glycodendron
yield
use
nbocdeprotect
peptidecoupl
reaction
sequenc
synthesi
higher
gener
glycopeptid
dendron
carri
converg
henc
convert
amin
deriv
whose
coupl
led
protect
g
glycopeptid
dendron
yield
converg
strategi
appli
construct
thirdgener
glycodendron
contain
eight
peripher
glucosid
unit
via
peptid
coupl
dendron
although
biolog
investig
propos
author
stabil
odeacetyl
g
glycodendron
bglycosidas
almond
evalu
degrad
observ
sever
hour
four
year
later
nelson
stoddart
design
diand
tetraval
lactosyl
dendron
accord
converg
pathway
mild
chemoselect
condit
scheme
strategi
base
photochem
addit
odeacetyl
follow
cleavag
acet
protect
group
aqueou
tfa
afford
g
dendron
whose
reduc
end
reduct
amin
bismethylamino
trisaccharid
use
cyanoborohydrid
meohh
furnish
g
dendron
yield
heideck
lindhorst
detail
origin
approach
toward
glycodendron
synthesi
use
precursor
serv
ab
system
hydroborationoxid
sequenc
radic
addit
mercaptoethanol
activ
step
subsequ
glycosyl
branch
unbranch
sugar
trichloroacetimid
constitut
key
step
toward
dendrit
growth
fig
collect
six
new
hyperbranch
mannosyl
glycodendron
therebi
prepar
test
use
elisa
potenti
inhibitor
fimbriaemedi
bacteri
adhes
e
coli
yeast
mannan
polysaccharid
saccharomyc
cerevisia
branch
oligomannosid
differ
regard
carbohydr
content
spacer
characterist
bind
data
e
coli
indic
glycodendron
perform
better
monoval
meaman
exceed
inhibitori
potenc
one
two
order
magnitud
small
conjug
consist
three
admannosyl
moieti
present
weakest
inhibit
ic
mmol
extend
analogu
two
admannosid
unit
tether
thiahexyl
spacer
perform
unexpectedli
well
instanc
show
averag
inhibitori
potenc
mm
exceed
larger
glycodendron
ic
mmol
carbohydr
moieti
spacer
propyl
unit
thu
regard
influenc
spacer
characterist
conclud
conform
flexibl
glycodendron
contain
four
peripher
mannosyl
unit
longer
thiahexyl
spacer
ic
mmol
respect
show
increas
inhibitori
potenc
rel
counterpart
bear
propyl
spacer
shorter
analogu
furthermor
oxid
sulfid
group
provid
sulfon
pronounc
neg
effect
inhibitori
potenc
indic
lipophil
properti
spacer
might
also
promot
affin
given
glycoconjug
previous
conclud
final
polyeth
ab
system
initi
develop
jayaraman
et
al
use
synthesi
diand
tetraval
cluster
decor
bdgalactosid
moieti
scheme
addit
converg
construct
allow
prepar
complex
system
consist
mix
glycodendron
carri
galactosid
mannosid
moieti
biolog
import
ligand
strategi
involv
sequenc
repetit
simpl
doubl
williamson
etherif
methallyl
dichlorid
follow
gener
alcohol
via
toward
better
mimet
highli
complex
natur
oligosaccharid
author
also
embark
synthesi
mix
glycodendron
bear
carbohydr
moieti
differ
kind
employ
two
differ
rout
first
one
involv
bisgalactosesubstitut
alcohol
equimolar
amount
allow
synthesi
chlorid
yield
subsequ
etherif
bismannosemodifi
alcohol
furnish
acid
deprotect
provid
exampl
mixedtyp
polyeth
glycodendron
second
way
base
preliminari
desymmetr
one
saccharid
follow
attach
one
remain
reactiv
function
gener
alcohol
group
doubl
bond
subsequ
williamson
etherif
afford
tfawat
deprotect
second
mix
glycodendron
c
ab
systemsamong
wide
use
ab
dendrit
build
block
deriv
aliphat
tri
aromat
acid
gallic
acid
provid
system
choic
construct
dens
glycodendron
accord
iter
orthogon
synthet
strategi
sinc
pioneer
work
newkom
cowork
earli
describ
synthesi
arborol
widespread
use
tri
deriv
afford
highli
function
structur
tri
thu
offer
synthet
advantag
term
symmetri
ensur
acceler
dendrit
growth
amin
serv
anchor
function
hydroxyl
group
allow
effici
trisfunction
instanc
trisbas
glycodendron
recent
design
group
wong
base
effici
synthesi
structur
display
multival
oligomannosid
high
densiti
notabl
mimic
glycan
fig
interact
antibodi
dcsign
lectin
character
glycan
microarray
bind
assay
ab
type
dendrit
skeleton
function
tri
chosen
precursor
construct
dens
pack
glycodendron
achiev
gener
versatil
ligat
ensur
use
catalyz
alkyneazid
cycloaddit
reaction
cuaac
conjug
steric
demand
azido
oligomannosid
design
man
man
respect
polypropargyl
dendron
scheme
converg
approach
also
design
facilit
homogen
dendrit
scaffold
use
iter
sequenc
base
nboc
remov
subsequ
edchobtmedi
peptid
coupl
tricarboxyl
acid
deriv
afford
polypropargyl
compound
first
second
third
gener
respect
interest
result
biolog
studi
indic
g
man
appear
effect
mimic
surfac
glycan
suitabl
conjug
carrier
protein
vaccin
candid
furthermor
evalu
inhibit
dcsign
studi
via
elisa
test
excel
inhibit
activ
nanomolar
rang
demonstr
contrast
millimolar
rang
refer
mannosid
experi
inhibit
observ
correspond
nonglycosyl
alkynyl
dendron
mm
indic
multival
oligomannos
residu
respons
dcsign
bind
inhibit
glycodendron
interact
antibodi
dcsign
indic
dendrit
architectur
especi
g
man
glycodendron
potenti
use
develop
carbohydr
vaccin
candid
antivir
agent
oligomannosideend
azid
use
clickchemistri
toward
mimet
recogn
human
antibodi
dcsign
tri
commerci
avail
gallic
acid
constitut
ideal
candid
branch
unit
rapid
dendrit
growth
allow
dendron
dendrim
scaffold
reach
n
surfac
group
nth
gener
thu
gallic
acid
deriv
afford
highli
function
glycosyl
structur
take
advantag
geometri
orthogon
transform
initi
use
roy
et
al
construct
hyperbranch
dendrit
lactosid
present
nine
peripher
saccharid
residu
scheme
converg
strategi
describ
reli
synthesi
thiolat
lactosid
deriv
ad
preform
gallic
acid
deriv
contain
g
g
dendron
cap
function
tetra
ethylen
glycol
afford
glycodendron
hydrophil
spacer
chosen
ensur
advantag
water
solubl
result
dendrim
counteract
hydrophob
effect
aromat
gallic
acid
two
year
later
group
describ
synthesi
hyperbranch
glycodendrim
contain
sialic
acid
residu
accord
similar
strategi
involv
gallic
acid
deriv
oligo
ethylen
glycol
dendrit
backbon
forego
condit
use
conjug
athiosialosid
onto
nchloroacetyl
dendrit
precursor
instanc
nucleophil
substitut
afford
anticip
sialodendrim
high
yield
interestingli
turbidimetr
analysi
confirm
strong
potenti
g
sialodendrim
nine
readili
access
sialic
acid
residu
effici
bind
crosslink
precipit
two
differ
lectin
wheatgerm
agglutinin
wga
lectin
slug
limax
flavu
lfa
similar
structur
later
employ
creat
origin
dendron
polym
base
chitosan
backbon
use
sialodendron
fig
chitosan
nontox
biodegrad
widespread
biolog
activ
major
intrins
drawback
low
solubl
organ
solvent
water
hamper
develop
bioactiv
polym
thu
synthesi
watersolubl
dendron
chitosansial
acid
hybrid
success
achiev
use
gallic
acid
focal
point
tri
ethylen
glycol
hydrophil
spacer
arm
order
investig
potenti
inhibit
viral
pathogen
includ
flu
viru
sialodendron
bear
focal
aldehyd
endgroup
trival
dendron
synthes
reiter
amidebond
strategi
base
use
polyamineend
trival
nonaval
dendrit
scaffold
gallic
acid
branch
unit
cap
acet
precursor
aldehyd
function
sialic
acid
pphenylisothiocyan
pitc
deriv
conjug
via
thiourea
linkag
follow
hydrolysi
result
aldehyd
acet
tfa
provid
aldehyd
procedur
follow
effici
access
next
gener
dendrim
final
focal
aldehyd
sialodendron
graft
converg
onto
chitosan
polysaccharid
backbon
reduct
amin
good
yield
degre
substitut
indic
fig
water
solubl
origin
hybrid
enhanc
unmodifi
amino
group
chitosan
backbon
succinyl
excess
succin
anhydrid
improv
strategi
use
microwaveassist
synthesi
involv
gallic
acid
core
coppercatalyz
cycloaddit
cuaac
afford
seri
glycodendron
fig
polysial
acid
dendron
chitosan
achiev
high
yield
start
azido
sugar
deriv
subsequ
cu
catalyz
cycloaddit
acetylenebear
dendrim
fig
strategi
allow
rapid
prepar
triazol
glycodendrim
nonaval
level
successful
use
unprotect
carbohydr
direct
introduct
unprotect
carbohydr
provid
interest
approach
avoid
tediou
final
deprotect
step
allow
steric
reason
effici
coupl
addit
exampl
provid
fernandezmegia
et
al
describ
quick
effici
reliabl
multival
conjug
unprotect
alkynederiv
carbohydr
three
gener
azidotermin
gallic
acidtriethylen
glycol
dendron
fig
work
azidetermin
dendron
favor
incorpor
termin
alkyn
potenti
bia
latter
cu
ii
catalyz
intradendrit
oxid
coupl
aqueou
condit
employ
typic
click
chemistri
glycodendrim
contain
g
unprotect
fucos
mannos
lactos
residu
effici
isol
high
yield
practic
purif
reaction
mixtur
ultrafiltr
investig
group
led
synthesi
three
gener
new
famili
block
copolym
peg
r
saccharid
good
excel
yield
interestingli
nmr
relax
studi
azidotermin
pegdendrit
block
copolym
precursor
reveal
radial
decreas
densiti
core
peripheri
becom
intens
increas
gener
dendrit
block
furthermor
result
pegyl
mannosyl
glycodendrim
demonstr
increas
capac
aggreg
lectin
increas
gener
glycopeptid
dendrimersa
state
earlier
first
glycopeptid
dendrim
describ
literatur
built
use
diverg
solidphas
peptid
fmocchemistri
llysin
repeat
amino
acid
wang
resin
initi
sugar
attach
sialic
acid
introduc
confer
strong
inhibitori
properti
flu
viru
hemagglutinin
lectinlik
protein
recogn
asialosid
respiratori
mucin
earli
hyperbranch
llysin
scaffold
elong
nchloroacetylglycylglycin
effici
coupl
peracetyl
athiosialosid
use
dendron
bear
eight
surfac
athiosialosid
roy
et
al
demonstr
saccharid
moieti
better
per
saccharid
basi
correspond
monom
stabl
viral
neuraminidas
interest
architectur
howev
potent
sialopolym
sinc
could
properli
cover
entir
surfac
spheric
virion
properti
well
exploit
randomcoil
polym
later
argu
dendron
polym
improv
potenc
respect
see
follow
pamam
section
polyllysin
scaffold
util
mannosid
residu
bear
optim
aryl
aglycon
result
glycodendron
show
increas
inhibitori
potenc
fimbriat
e
coli
per
mannosid
basi
structur
mannosyl
dendrim
illustr
fig
octamer
aminophenyl
admannopyranosid
ic
nm
nmman
found
competit
bind
assay
measur
bind
ilabel
highli
mannosyl
neoglycoprotein
bsa
fimbriat
e
coli
strain
suspens
gave
much
lower
ic
valu
equival
valu
obtain
hemagglutin
assay
involv
micropl
immobil
two
key
featur
strongli
influenc
affin
e
coli
adhesin
presenc
aorient
aglycon
bear
hydrophob
group
presenc
multipl
mannosid
residu
span
distanc
nm
longer
two
best
inhibitor
highli
mannosyl
neoglycoprotein
longest
link
arm
mannos
protein
amino
group
mannosyl
dendrim
fourth
gener
ic
nm
nmman
first
describ
patent
denkewalt
et
al
late
dendron
lysin
one
wide
use
core
structur
dendrim
glycodendrim
synthesi
excel
seri
review
group
synthesi
biolog
applic
lysinebas
glycodendrim
publish
glycosyl
lysin
dendrim
prepar
solid
support
solut
reaction
peripher
amino
group
varieti
electrophil
carri
pendant
sugar
residu
isothiocyan
carboxyl
acid
reduc
sugar
lead
glycodendrim
thiourea
amid
amin
respect
sugar
bear
activ
ester
group
also
coupl
dendrit
lysin
provid
galactosideand
nacetylglucosaminecap
glycoclust
includ
import
thomsen
friedenreich
tf
disaccharid
antigen
bdgal
adgalnac
known
breast
cancer
marker
monoclon
antibodi
rais
see
instanc
fig
correspond
tfbear
glycodendrim
bound
antibodi
shown
adsorb
strongli
onto
surfac
microtit
plate
analog
bdglcnac
glycodendrim
also
elabor
lewi
x
tetrasaccharid
antigen
use
multipl
chemoenzymat
process
fig
analog
mannosyl
architectur
also
propos
mbp
act
receptor
mediat
uptak
intern
solubl
particul
glycoconjug
take
part
innat
immun
broad
patternrecognit
display
mannos
receptor
togeth
implic
adapt
immun
stimul
consider
effort
toward
select
deliveri
enzym
drug
oligonucleotid
gene
antigen
cell
express
therapeut
vaccin
strategi
anoth
import
mannos
receptor
membraneassoci
protein
restrict
sinusoid
liver
cell
peripher
bone
marrow
macrophag
dendrit
cell
also
recogn
intern
mannosyl
glycoconjug
patholog
microorgan
tumor
yeast
cell
glycoprotein
typei
procollagen
tissuetyp
plasminogen
activ
variou
lysosom
enzym
mannos
receptor
contribut
nonimmun
hostdefens
system
addit
macrophag
receptor
implic
major
histocompat
complexmedi
antigen
mhc
present
dendrit
cell
dcsign
dendrit
cellspecif
grab
nonintegrin
intercellular
adhes
molecul
dcsign
also
belong
famili
ctype
lectin
abl
bind
highmannos
glycoprotein
ebolagp
denguegp
e
dcsign
also
known
oligomer
therefor
particularli
import
understand
intrins
bind
multival
bind
requir
lectin
context
biessen
et
al
conceiv
oligomer
linear
llysin
mannosid
bear
aryl
aglycon
describ
associ
pisothiocyanatophenyl
admannopyranosid
coupl
polyllysin
backbon
isothiourea
linkag
structur
illustr
fig
affin
mannoclust
toward
mannos
receptor
increas
steadili
mm
dimer
nm
consequ
high
affin
promis
target
devic
cellspecif
gene
deliveri
drug
liver
endotheli
cell
macrophag
bone
marrow
lung
spleen
atherosclerot
plaqu
anoth
investig
target
mannos
receptor
express
human
dendrit
cell
dcsign
present
grandjean
et
al
ad
carbohydr
mimicri
multival
concept
strategi
describ
quinic
shikim
acid
deriv
use
mannos
bioisoster
link
dendrit
llysin
scaffold
afford
novel
hyperbranch
glycomimet
fig
fluoresceinlabel
pseudoglycodendrim
valenc
two
eight
test
competitiveinhibit
assay
mannan
evalu
confoc
microscopi
use
mannos
receptor
express
transfect
cell
express
mannos
receptormedi
uptak
assay
monocytederiv
human
dendrit
cell
cytofluorometr
analysi
synthet
cluster
shown
effect
ligand
dendrit
cell
optimum
affin
toward
cluster
valenc
four
howev
glycomimet
well
natur
mannosid
perform
although
result
indic
mannos
receptor
could
accommod
structur
diverg
significantli
previous
identifi
natur
ligand
could
optim
use
qsar
addit
monodispers
lysin
dendrim
cap
mono
di
triadmannopyranosyl
residu
induc
dendrit
cell
matur
state
dcsign
key
mannosid
receptor
exogen
pathogen
use
virus
entri
lymph
node
inhibit
process
thu
sought
interest
strategi
block
viral
adhes
consequ
seri
mannosyl
boltorn
dendrim
prepar
see
later
section
rather
effici
respect
interest
extens
strategi
propos
use
variou
fluoresc
probe
fluorescein
rhodamin
pyren
dansyl
group
fig
incorpor
onto
mannosyl
dendron
prepar
entir
spp
fmocchemistri
use
imag
studi
mannos
receptormedi
entri
dendrit
cell
confoc
fluoresc
microscopi
pathogen
captur
intern
digest
peptid
fragment
express
mhc
molecul
cellspecif
immun
respons
therebi
initi
sequenc
biolog
event
exploit
vaccin
design
see
next
heterobifunct
highaffin
multival
ligand
assembl
nontox
nonimmunogen
polyllysin
dendrim
requir
number
mannosyl
residu
attach
simultan
via
acid
linker
substanc
occur
natur
mammal
synthesi
model
polyllysin
dendron
initi
perform
commerci
tentagel
resin
preload
fmocsieb
amid
linker
low
load
level
commerci
resin
mmolg
ensur
suffici
space
allow
larg
fourth
fifthgener
dendron
assembl
without
problem
steric
hindranc
time
mild
cleavag
condit
requir
type
resin
caus
signific
acidpromot
glycosid
hydrolysi
mannopyranosyloxi
butano
acid
introduc
classic
peptidecoupl
reagent
establish
protocol
next
appli
toward
fluoresc
label
analogu
introduc
focal
point
lysin
residu
possess
acidlabil
mtt
protectinggroup
side
chain
focal
eamin
protect
mtt
group
use
label
conjunct
consider
less
acidlabil
commerci
rink
amid
linker
maximum
versatil
thu
rink
amid
tentagel
resin
load
fmocli
mtt
oh
ntermin
fmoc
group
remov
classic
treatment
piperidin
dmf
reiter
insert
bisfmoc
lysin
termin
mtt
group
remov
low
tfa
concentr
minim
loss
dendron
newli
freed
amin
directli
label
onto
resin
accordingli
treatment
polymersupport
g
dendron
tfa
ch
cl
led
complet
remov
mtt
group
within
short
time
lower
concentr
tfa
ineffici
free
amin
group
glycodendron
treat
appropri
fluoresc
probe
provid
desir
mannosyl
glycodendron
fig
spheric
hemispher
glycodendrim
contain
polylysin
scaffold
elabor
fig
thirdgener
polylysin
dendrim
prepar
tfa
salt
tri
amin
trival
core
stepwis
condens
diboclysin
accord
publish
strategi
nbocprotect
group
remov
use
standard
condit
tfa
provid
free
polyamin
polylysin
dendrim
termin
amino
group
surfac
treat
peracetyl
cellobiosid
use
bopmedi
peptid
coupl
deprotect
crude
peracetyl
glycodendrim
achiev
condit
naom
meoh
h
free
dendrit
glycopeptid
obtain
yield
fulli
character
cellobiosyl
glycopeptid
dendrim
would
show
key
biolog
activ
antihiv
blood
anticoagul
activ
solidphas
combinatori
synthesi
furnish
larg
neoglycopeptid
dendrim
librari
end
cfucosid
deriv
tetraval
dendrim
fig
show
strongest
bind
affin
ic
mm
p
aeruginosa
paiil
lectin
virul
factor
cystic
fibrosi
cf
patient
optim
ligand
combin
multival
presenc
posit
guanidin
charg
proxim
carbohydr
residu
happen
better
comparison
dival
analogu
lack
ntermin
lysin
residu
ic
mm
improv
peptid
dendrim
librari
prepar
analog
dendrim
afucch
colysproleu
lysphelysil
lyshisilenh
potent
ligand
model
plant
lectin
ulex
europaeu
ueai
ic
mm
bacteri
lectin
paiil
p
aeruginosa
ic
mm
glycopeptid
librari
also
synthes
dival
carbohydr
structur
optim
multival
carbohydratebind
protein
interact
subsit
vicin
carbohydraterecognit
domain
crd
state
earlier
dendrit
cell
macrophag
valuabl
antigenpres
cell
apc
cell
express
mbp
constitut
import
entri
mechan
vaccin
target
thu
instead
link
short
peptid
antigen
classic
immunogen
protein
carrier
keyhol
limpet
hemocyanin
klh
tetanu
toxoid
like
studi
evalu
toward
possibl
use
mannosidecap
polylysin
glycodendrim
construct
ntermin
sever
immunogen
peptid
fig
peptid
sequenc
protein
bear
llsgiv
motif
capabl
inhibit
viral
fusion
sarscov
influenza
hemagglutinin
built
rink
amid
resin
lysin
moieti
introduc
g
lysin
dendron
follow
mannosyl
use
mannopyranosyloxi
butano
acid
termin
e
amino
group
lysylpeptid
dendrim
preliminari
data
result
vaccin
candid
contain
llsgiv
motif
demonstr
could
elicit
polyclon
antibodi
respons
rabbit
much
stronger
klh
construct
conclud
mannosyl
dendron
stabil
peptid
proteolysi
ntermin
mannosyl
peptid
carri
one
six
mannos
residu
also
shown
kone
cowork
elicit
immun
respons
effici
greater
peptid
antigen
alon
captur
antigen
determin
apc
ultim
appear
mhc
helper
cell
stimul
depend
sever
factor
apc
repres
b
cell
multival
becom
issu
recognit
bind
event
trigger
cellsurfac
immunoglobulin
classic
exampl
success
applic
regard
present
high
immunogen
bacteri
capsular
polysaccharid
cp
elicit
protect
antibodi
howev
result
antibodi
usual
limit
lowaffin
igm
immun
respons
lack
memori
effect
absenc
fig
entir
synthet
antihiv
vaccin
candid
capabl
apc
uptak
celldepend
antigen
normal
associ
peptid
cp
thu
said
independ
antigen
altern
b
cell
antigen
multival
found
small
peptid
oligosaccharid
greatli
benefit
mount
dendrit
scaffold
moreov
key
cell
epitop
need
context
mhc
complex
typic
short
peptid
yet
small
effici
uptak
apc
consequ
design
dendrit
glycoconjug
bear
multipl
copi
oligosaccharid
b
cell
epitop
short
peptid
cell
epitop
propos
entir
synthet
vaccin
candid
fig
eleg
applic
principl
recent
propos
trigger
neutral
antibodi
loop
glycoprotein
isol
recogn
bind
high
mannos
oligosaccharid
epitop
man
glcnac
fig
present
numer
copi
propos
base
observ
swap
human
antibodi
name
identifi
patient
success
mount
protect
antihiv
immun
respons
fig
besid
glycoclust
base
central
peptid
earlier
present
section
group
kunz
first
fulli
demonstr
feasibl
efficaci
elicit
complet
immun
respons
memori
effect
use
carbohydr
cancer
antigen
built
multipl
antigen
glycopeptid
scaffold
thu
immunogen
synthet
multipl
antigen
glycopeptid
mag
display
four
cluster
n
epitop
anchor
oligomer
branch
lysin
core
examin
fig
convent
sp
peptid
structur
perform
fmocmethodolog
wang
resin
dendrit
immunogen
contain
cluster
three
consecut
n
epitop
link
polioviru
cell
epitop
klfavwkitykdt
test
mice
prophylact
therapeut
cancer
vaccin
analog
mag
harbor
four
monomer
n
antigen
shown
increas
surviv
tumorbear
mice
ad
result
indic
show
high
immunogen
good
protect
develop
n
express
tumor
cell
polioviru
cell
epitop
cap
monomer
trimer
n
antigen
confer
high
murin
immunogen
nlink
pentasaccharid
core
man
glcnac
glycopeptid
bear
extracellular
mmp
induc
sequenc
emmprin
success
link
g
pamam
aminodendrim
thioester
activ
fig
result
octamer
kda
construct
obtain
low
yield
purifi
prepar
electrophoresi
fulli
character
malditof
mass
spectrometri
multival
architectur
built
evalu
requir
emmprin
multimer
induc
mmp
express
numer
success
achiev
solidphas
synthes
sp
glycopeptid
dendrim
coupl
eas
prepar
purif
also
trigger
chemist
appli
sp
nucleotid
chemistri
toward
synthesi
phosphodiesterlink
glycodendrim
mention
earlier
glycoclust
section
chemistri
geometri
phosphodiest
triester
obvious
appeal
factor
use
glycodendrim
scaffold
follow
strategi
base
synthesi
key
phosphoramidit
build
block
bear
either
nchloroacetyl
alcohol
end
group
branch
deg
spacer
initi
transform
mono
tertbutyldiphenylsilyl
deriv
upon
treatment
n
ndiisopropylphosphoramid
dichlorid
cl
pn
ipr
dipea
ch
cl
provid
essenti
build
block
n
ndiisopropyldiphosphoramidit
yield
fig
altern
mono
nchloroacetyl
deg
deriv
prepar
commerci
avail
ethanol
clch
co
h
eedq
c
h
similarli
treat
provid
phosphoramidit
coupl
alcohol
presenc
gave
correspond
phosphotriest
oxid
tbutyl
peroxid
coupl
tri
nchloroacetyl
deriv
meoh
et
n
thiolat
nacetylgalactosaminid
afford
firstgener
phosphoglycodendrim
three
adgalnac
moieti
shown
thiol
prepar
allyl
nacetyladgalactosaminid
reaction
thioacet
acid
hsac
meoh
aibn
reflux
h
follow
sdeacetyl
tertbutyldiphenylsilylprotect
phosphotriest
deprotect
fluorid
anion
bu
nf
thf
give
triol
branch
build
block
provid
secondgener
phosphotriest
six
nchloroacetyl
residu
oxid
phosphit
nucleophil
displac
hexaval
nchloroacetyl
precursor
provid
hexaval
dendrim
process
synthet
sequenc
coupl
tether
strategi
variou
spacer
gave
access
famili
dendrim
mani
differ
valenc
galnacbear
phosphodendrim
thu
produc
test
inhibitor
plant
lectin
v
villosa
bind
asialoglycophorin
natur
ligand
hepatocyt
receptor
result
indic
hexam
enhanc
affin
monoval
ligand
thu
support
glycosid
cluster
effect
interestingli
sugar
part
key
determin
known
tfantigen
overlay
express
breast
cancer
tissu
melanoma
cancer
structur
higher
oligosaccharid
homologu
form
basi
dendrit
glycopeptid
vaccin
alreadi
describ
addit
exampl
dendrit
phosphodiest
highlight
dubber
mannosid
galactosid
oligonucleotid
conjug
use
dna
synthes
fig
sp
multival
glycoconjug
enabl
custom
tailor
within
hour
valenc
structur
requir
toward
biolog
target
oppos
cumbersom
tradit
approach
tetramer
mannosid
thu
prepar
simpl
precursor
use
phosphoramidit
chemistri
glycodendron
built
fluorescein
probe
anoth
one
thiolat
oligonucleotid
code
antisens
inhibit
induc
nitric
oxid
synthas
construct
prepar
mmol
scale
satisfactorili
character
standard
h
nmr
malditof
ms
b
commerci
dendrit
scaffold
pamam
dendrim
sever
dendrim
scaffold
variou
surfac
function
valenc
construct
divers
build
block
accord
gener
synthet
strategi
fig
see
also
section
v
one
illustr
fig
among
readili
avail
wide
use
dendrit
scaffold
poli
amidoamin
dendrim
pamam
dendrit
nanotechnolog
constitut
candid
choic
extens
exploit
mani
group
glycochemist
notabl
rapid
synthesi
highli
branch
glycodendrim
sinc
pioneer
synthesi
poli
amidoamin
dendrim
propos
tomalia
et
al
use
diverg
growth
procedur
attract
molecul
constitut
excit
new
class
macromolecular
highli
branch
architectur
welldefin
size
shape
geometri
drawn
much
interest
sever
research
area
accordingli
pamambas
dendrim
builtin
surfac
amin
function
first
frequent
use
scaffold
attach
sugar
first
exampl
saccharidesubstitut
pamam
dendrim
propos
okada
cowork
describ
synthesi
sugar
ball
via
amid
bond
format
start
sugar
lacton
although
process
straightforward
manipul
suffer
disadvantag
sacrif
reduc
sugar
altern
serv
extend
linker
scheme
sever
strategi
use
adequ
function
pamam
dendrim
carbohydr
involv
introduct
thiourea
linkag
form
treat
amino
dendrim
isothiocyan
saccharid
deriv
b
direct
amid
linkag
sugarbear
carboxyl
activ
ester
deriv
c
reduct
amin
incorpor
chloroor
bromoacetamido
group
onto
pamam
dendrim
saccaharid
afford
highli
electrophil
speci
instanc
react
thio
amino
deriv
synthet
approach
illustr
follow
section
thiourea
linkag
attach
saccharid
unit
surfac
pamam
thiourea
linkag
offer
one
effici
way
develop
multival
ligand
quickli
effici
studi
proteincarbohydr
interact
histor
lindhorst
kieburg
first
publish
simpl
effici
coupl
differ
lowgener
polyamin
scaffold
includ
pamam
bdgluco
aand
bdmanno
bdgalacto
bcellobio
blactoconfigur
glycosyl
isothiocyan
improv
version
use
hydrophob
aryl
aglycon
later
permit
synthes
first
four
gener
monodispers
neoglycoconjug
mannosid
unit
pisothiocyanatophenyl
admannopyranosid
use
key
precursor
scheme
result
glycodendrim
evalu
ligand
phytohemagglutinin
con
pisum
sativum
pea
lectin
use
ella
turbidimetr
analys
rel
bind
data
indic
incorpor
termin
asubstitut
mannosid
residu
furnish
glycodendrim
show
increas
bind
capac
moreov
abil
bind
form
insolubl
carbohydratelectin
complex
also
demonstr
radial
doubl
immunodiffus
turbidimetr
assay
capac
precipit
select
homolog
protein
receptor
crude
lectin
mixtur
made
conveni
tool
rapid
simpl
isol
protein
procedur
success
adapt
group
year
later
allow
introduct
pisothiocyanatophenyl
bdlactosid
onto
pamam
scaffold
studi
rel
bind
behavior
toward
famili
galectin
influenc
gener
bindingsit
orient
receptor
similar
simplifi
procedur
involv
aqueou
solut
avoid
protect
group
synthesi
methylthiourylen
admannopyranosid
aromat
deriv
g
pamam
dendrim
contain
six
peripher
mannosyl
residu
propos
parallel
investig
thompson
schengrund
involv
synthesi
glycodendrim
poli
propylen
imin
starburst
pamam
dendrit
scaffold
provid
potent
inhibitor
ct
use
pitc
deriv
ic
valu
determin
oligogm
pitc
dendrim
nativ
gm
oligosaccharid
moieti
gm
oligogm
studi
reveal
glycodendrim
inhibit
bind
ct
gm
coat
well
molar
concentr
lower
nativ
gm
lower
free
oligosaccharid
g
g
sialic
acidcontain
pamam
glycoconjug
pisothiocyanatophenyl
asialosid
fig
precursor
also
describ
zanini
roy
lectinbind
properti
evalu
preliminari
turbidimetr
studi
g
g
athiosialodendrim
present
peripher
sugar
unit
respect
demonstr
abil
bind
slug
lectin
lfa
show
wellorgan
precipit
pattern
furthermor
rel
effici
inhibit
bind
hrpolabel
lfa
human
agp
orosomucoid
determin
competit
ella
interestingli
increas
multival
result
steadi
increas
inhibitori
potenti
ic
valu
nanomolar
rang
g
g
respect
correspond
jump
inhibitori
potenti
monomer
analogu
subsequ
baker
cowork
evalu
similar
sialic
acidconjug
g
pamam
structur
mean
prevent
adhes
three
influenza
viru
subtyp
furnish
one
first
document
function
dendrim
conjug
antiinfect
agent
vivo
hai
vitro
show
glycodendrim
inhibit
specif
influenza
subtyp
strain
concentr
time
lower
sialic
acid
monom
vivo
studi
also
demonstr
abil
glycodendrim
protect
experiment
infect
influenza
viru
mice
woller
cloning
describ
largest
glycodendrim
built
prepar
gener
g
pamam
dendrim
contain
mannosid
residu
compar
methyl
admannosid
taken
monomer
control
dendrim
g
g
show
increas
activ
toward
phytohemagglutinin
con
g
dendrim
bound
roughli
one
order
magnitud
better
g
g
methyl
mannosid
suggest
glycosid
clustereffect
enhanc
local
concentr
g
g
glycodendrim
g
small
multival
bind
occur
chelat
effect
dendrim
g
g
show
two
order
magnitud
increas
activ
tetramer
con
indic
multival
bind
occur
also
possibl
chang
shape
circular
g
g
pamam
spheric
g
g
caus
observ
bind
enhanc
studi
led
group
effici
incorpor
complex
saccharid
unit
aman
man
disaccharid
manifest
fact
dimannos
function
g
g
pamam
dendrim
averag
peripher
group
compet
recruit
cyanovirinn
cvn
hivinactiv
protein
block
virustocel
fusion
high
mannosemedi
interact
scheme
final
subsequ
investig
provid
first
exampl
use
glycodendrim
model
system
studi
carbohydratecarbohydr
interact
cci
particularli
lactosyl
pamam
dendrim
variou
peripher
carbohydr
number
depend
gener
synthes
examin
cci
lactos
mix
langmuir
monolay
contain
gm
dipalmitoyl
phosphatidylcholin
dppc
thiourea
ligat
glycosyl
isothiocyan
deriv
amin
dendrit
core
follow
standard
protocol
afford
glycodendrim
contain
appropri
amount
lactos
cap
poli
ethylen
glycol
chain
carbohydr
result
corrobor
concept
lactosyl
dendrim
engag
cci
gm
langmuir
monolay
cci
depend
carbohydr
densiti
densiti
glycolipid
within
monolay
moreov
specif
cci
observ
presenc
calcium
ion
least
onefifth
monolay
compos
gm
amid
linkag
strategi
base
direct
format
amid
bond
via
carboxyl
acid
activ
estercontain
saccharid
pamam
dendrim
afford
sophist
dendrit
architectur
promis
biolog
properti
instanc
use
similar
approach
one
describ
aoi
et
al
describ
synthesi
dendrimerbas
star
polym
oligoglycopeptid
sugar
ball
origin
macromolecular
design
live
polymer
actual
dendrit
oligoglycopeptid
thu
synthes
live
oligomer
glyconcarboxi
anhydrid
glyconca
poli
amidoamin
pamam
dendrim
multifunct
macro
initi
polymer
system
term
radialgrowth
polymer
rgp
sinc
dendrimerbas
live
polymer
offer
highli
order
starshap
macromolecul
number
arm
differ
convent
star
polym
result
sugar
ball
studi
dendrit
nanocapsul
surround
radial
oligoglycopeptid
chain
roy
et
al
describ
systemat
prepar
biolog
evalu
glycopamam
contain
tfantigen
unit
bgal
agalnac
known
cancerrel
epitop
import
antigen
detect
immunotherapi
carcinoma
particularli
relev
breast
cancer
patient
synthet
sequenc
base
effici
acid
function
allyl
tfantigen
deriv
accomplish
use
acid
provid
acid
yield
glycopamam
present
peripher
tfantigen
prepar
direct
amid
bond
format
unprotect
pamam
use
effici
tbtu
coupl
reagent
tetrafluorobor
dipea
base
scheme
proteinbind
properti
glycodendrim
evalu
use
peanut
lectin
arachi
hypogaea
mous
monoclon
igg
antibodi
base
bulk
conjug
glycopamam
highest
carbohydr
densiti
exhibit
strongest
inhibit
clearli
indic
cluster
effect
conjug
antigenet
activ
ic
valu
nmol
respect
g
g
correspond
inhibitor
abil
time
higher
monom
toward
antibodyco
antigen
interact
base
ident
approach
mannosyl
pamam
dendrim
construct
order
evalu
rel
inhibitori
properti
fimbriat
uropathogen
e
coli
altern
synthet
strategi
describ
author
chose
admannopyranosid
pretreat
diglycol
anhydrid
result
extend
acid
deriv
coupl
peripher
pamam
amino
group
typic
peptid
coupl
reagent
bop
dimethylamino
phosphonium
hexafluorophosph
tbtu
scheme
deprotect
glycodendrim
test
use
newli
develop
elisabas
inhibit
assay
abil
inhibit
bind
recombin
fimbriat
e
coli
fimh
monolay
cell
line
deriv
human
urinari
bladder
epithelium
pamam
mannodendrim
display
potent
affin
toward
target
fimh
ic
mm
g
g
respect
although
rel
potenc
per
mannos
rather
low
synthesi
mannos
pamam
dendrim
also
investig
studi
abil
bind
goatliv
receptor
mpr
prepar
glycodendrim
achiev
initi
prepar
amineteth
deriv
sinc
amino
function
present
saccharid
residu
author
use
preform
halfgener
g
g
pamam
dendrim
exhibit
carboxyl
acid
group
respect
result
dendrit
conjug
obtain
direct
amid
bond
format
use
dichobt
edc
carbodiimid
nh
nhydroxysuccinimid
coupl
reagent
scheme
preliminari
biolog
studi
suggest
newli
synthes
dendrim
could
act
adsorb
relat
affin
chromatographi
interest
potenti
bind
purifi
goatliv
receptor
mpr
protein
addit
conjug
variou
nonprotect
glycosid
similarli
describ
use
pnitrophenyl
activ
saccharid
ester
conjug
disaccharid
sialic
acid
compon
onto
pamam
scaffold
reduct
amin
sashiwa
et
al
use
reduct
amin
provid
dendron
chitosansial
acid
hybrid
contain
differ
spacer
scheme
sialic
acid
residu
success
attach
pamam
dendrim
reduct
nalkyl
pformylphenyl
asialosid
use
nabh
cn
meoh
furnish
hybrid
chitosan
howev
sinc
excess
aldehyd
must
use
high
incorpor
sialic
acid
procedur
also
gave
rise
doubl
nalkyl
reaction
thu
gave
complex
sialic
acid
constitu
afford
undesir
mix
structur
circumv
drawback
nmethylamino
deriv
see
scheme
subsequ
use
reduct
amin
sialodendrim
prepar
target
immunoglobulin
expos
siglec
nucleophil
substitut
via
incorpor
haloacetamido
group
zanini
roy
describ
design
synthesi
novel
famili
symmetr
dendrim
present
even
valenc
residu
base
propylamin
synthet
approach
base
converg
assembl
suitabl
multibranch
dendrim
contain
nchloroacetyl
end
group
provid
electrophil
speci
could
readili
react
thiolat
carbohydr
deriv
mani
synthet
benefit
eman
strategi
first
method
gener
highyield
readili
amen
exist
commerci
avail
aminetermin
dendrim
pamam
could
similarli
treat
chloroacet
anhydrid
second
synthesi
dendrit
famili
present
viabl
altern
pamam
dendrim
avoid
need
larg
excess
reagent
commonli
use
ensur
complet
convers
importantli
scheme
synthesi
dendron
chitosansial
acid
hybrid
structur
suscept
basecatalyz
retromichael
degrad
contrast
classic
pamam
sinc
substitu
bcarbonyl
posit
author
thu
accomplish
effici
prepar
dendrit
athiosialosid
start
ab
type
core
iminobi
propylamin
subsequ
transform
afford
variou
symmetr
nchloroacetyl
dendron
tetram
scheme
slight
excess
thiosialosid
allow
synthesi
glycodendrim
mild
condit
deprotect
afford
dendrit
architectur
contain
four
scheme
sialosid
residu
fig
respect
group
conduct
systemat
studi
similar
tether
sialodendrim
even
valenc
base
ab
core
accord
synthet
strategi
potenti
sialodendrim
crosslink
precipit
lfa
confirm
preliminari
turbidimetr
analysi
test
enzymelink
lectin
inhibit
assay
use
human
agp
orosomucoid
coat
antigen
hrpolabel
lfa
detect
tetraval
dendron
show
ic
valu
nm
present
higher
valu
nm
hand
assay
indic
correspond
tether
dendrim
inhibitori
potenc
increas
correspond
increas
valenc
highest
ic
valu
obtain
nm
constitut
increas
inhibitori
potenti
monoval
azid
use
standard
ic
nm
group
extend
approach
use
solidphas
chemistri
despit
demonstr
pamam
dendrim
exhibit
function
scaffold
alway
one
highest
proteinbind
activ
fact
lessfunction
ligand
may
often
present
optim
potenc
plausibl
explan
phenomenon
suggest
highlight
fact
high
load
peripher
saccharid
portion
might
becom
less
access
protein
increas
steric
hindranc
anoth
hypothesi
base
drawback
use
larg
dendrim
bear
aromat
aglycon
intramolecularli
undergo
pstack
thu
tighten
saccharid
unit
dendrim
surfac
furthermor
solubl
problem
often
encount
pamam
dendrim
bear
aryl
mannosid
moieti
straightforward
solut
problem
address
follow
public
describ
synthesi
sialosid
dendrim
glycan
interspac
tri
residu
use
dummi
function
fig
aim
valid
concept
wolfenden
cloning
conduct
control
prepar
seri
heterobifunction
mannosid
hydroxylg
g
pamam
dendrim
fig
systemat
studi
address
effect
carbohydr
load
activ
dendrim
lectin
influenc
conjug
size
degre
function
mannosehydroxyl
group
via
thiourea
linkag
control
stoichiometr
amount
isothiocyan
deriv
compar
reactiv
ms
data
allow
determin
averag
number
mannos
surfac
residu
dendrim
gener
hemagglutin
assay
perform
ad
rabbit
erythrocyt
preincub
solut
con
vari
concentr
deprotect
dendrim
comparison
fourth
sixth
pamam
gener
differ
load
surfac
mannos
residu
suggest
bind
effici
highest
gener
load
interest
observ
highest
activ
correl
maximum
sugar
load
rather
occur
slightli
closer
pack
sugar
gener
increas
suggest
unfavor
steric
interact
preclud
optim
bind
high
carbohydr
densiti
followup
investig
describ
simultan
anchor
variou
sugar
mannos
galactos
glucos
residu
via
thiourea
linkag
order
quantifi
effect
function
dendrim
monom
vari
affin
would
multival
activ
lectin
mention
earlier
work
malditof
ms
use
determin
exact
number
carbohydr
residu
type
result
glycodendrim
chang
mw
sequenti
addit
chang
molecular
weight
deacetyl
use
accur
measur
extent
function
associ
correspond
deprotect
dendrim
con
studi
precipit
hemagglutin
assay
expect
increas
number
mannos
residu
decreas
number
glucos
residu
caus
increas
rel
affin
toward
con
dendrim
bear
mannos
glucos
load
linear
relationship
man
glc
load
assay
activ
observ
compound
gener
howev
rel
bind
differ
mannosyl
dendrim
glucosyl
dendrim
vari
one
gener
anoth
altern
g
mannosyl
pamam
fivefold
higher
rel
affin
toward
con
compar
glucosefunction
analogu
summari
report
result
suggest
multival
influenc
fig
modifi
pamam
scaffold
bear
interspac
tri
residu
promot
better
access
surfac
saccharid
predict
therefor
tunabl
way
monoval
differ
amplifi
multival
associ
mixtur
lowand
highaffin
ligand
use
attenu
multival
bind
activ
given
commerci
access
pamam
scaffold
wide
use
modern
investig
modifi
larg
varieti
sugar
deriv
vari
sugar
densiti
fig
use
sever
import
bind
phenomena
repres
deepli
studi
scaffold
toxic
evalu
addit
scaffold
glycodendrim
shown
nonimmunogen
key
properti
use
bacteri
viral
antiadhesin
b
ppi
dendrimersa
conveni
reaction
sequenc
largescal
synthesi
ppi
dendrim
poli
propyleneimin
dabdendr
nh
x
fig
describ
meijer
group
nice
adapt
origin
strategi
propos
earlier
group
suffer
cumbersom
purif
repetit
doubl
michael
addit
acrylonitril
primari
amin
follow
metalcatalyz
hydrogen
prepar
welldefin
dabdendr
nh
x
contain
primari
amin
surfac
group
effici
achiev
pamam
dendrim
famili
commerci
dendrit
scaffold
wide
function
obvious
saccharidebas
ppi
dendrim
also
synthes
first
exampl
glycodendrim
use
ppi
scaffold
propos
ashton
et
al
describ
use
rapid
facil
construct
high
molecular
weight
g
g
carbohydrateco
dendrim
diverg
approach
follow
glycodendrim
contain
respect
dgalactos
lactos
peripher
group
effici
synthes
saccharid
residu
attach
amin
dendrit
scaffold
amid
continu
effort
author
construct
tri
galactosid
modifi
dab
dendrim
acceler
converg
strategi
particular
approach
saccharid
connect
first
small
tri
branch
deriv
form
cluster
serv
build
block
suitabl
function
nsuccinimidylactiv
ester
coupl
onto
g
g
group
modifi
linker
use
differ
number
carbon
atom
afford
variat
local
saccharid
concentr
dendrim
surfac
studi
aim
determin
influenc
linker
paramet
glycodendrimerprotein
interact
relationship
structur
water
solubl
investig
amphiphil
properti
addit
poli
sulfogalactosyl
dendrim
base
dab
scaffold
investig
studi
antagonist
properti
infect
first
assess
interact
report
altern
glycolipid
receptor
seri
glycodendrim
built
mimic
galactosyl
ceramid
galcer
sulfat
deriv
synthes
analyz
spr
ligand
iiib
evalu
abil
inhibit
infect
indic
cell
synthesi
base
direct
amin
bond
format
carboxyl
galactosid
residu
g
g
dabdendrim
scheme
afford
compound
polysulf
dendrim
obtain
random
sulfat
averag
number
sulfat
determin
malditof
ms
analysi
vitro
studi
effect
inhibit
infect
cell
bal
indic
sulfat
glycodendrim
better
inhibitor
nonsulf
compound
effect
sulfat
dextran
control
investig
led
group
increas
degre
sulfat
galactosyl
dendrim
base
hypothesi
glycosphingolipid
sgalcer
best
ligand
recombin
virusassoci
therefor
synthesi
g
dabdendrim
contain
peripher
galactosid
group
averag
two
sulfat
group
per
galactos
residu
versu
first
exampl
perform
abil
inhibit
infect
cultur
indic
cell
compar
dextran
result
show
inhibit
iiib
well
dextran
sulfat
known
potent
inhibitor
infect
ec
valu
nanomolar
rang
compar
abil
inhibit
hiv
infect
indic
cell
furthermor
cytotox
studi
reveal
neither
glycodendrim
toxic
cell
highest
concentr
mgml
test
critic
paramet
number
posit
sulfat
group
especi
may
constitut
key
structur
compon
effici
inhibitor
clarifi
studi
interest
applic
hiv
develop
use
g
mannosyl
ppi
dendrim
mppi
carrier
control
target
deliveri
antiretrovir
nonnucleosid
reversetranscriptas
inhibitor
lamivudin
efavirenz
efv
numer
benefit
standard
treatment
base
free
drug
ppiencapsul
version
demonstr
vitro
nanocontain
ensur
effici
entrap
bioactiv
drug
allow
prolong
releas
profil
h
vs
h
ppi
toxic
system
gener
found
negligbl
cellularuptak
experi
mppi
interact
lectin
receptor
present
surfac
cell
monocytesmacrophag
lead
cellular
uptak
drug
time
higher
free
drug
furthermor
phenomenon
may
respons
signific
preliminari
antihiv
activ
display
mppi
despit
promis
result
studi
need
consid
encapsul
system
potent
carrier
effici
control
target
deliveri
antihiv
drug
c
hyperbranch
boltorn
dendrimershyperbranch
dendrit
boltorn
polym
perstorp
special
chemic
also
use
scaffold
use
multival
present
variou
function
group
select
base
fact
second
third
fourth
gener
polym
respect
commerci
avail
low
cost
sinc
prepar
bulk
quantiti
polymer
howev
polydispers
nevertheless
also
synthes
simpl
iter
approach
use
pentaerythritol
central
core
hydroxymethyl
propano
anhydrid
bismpa
anhydrid
scheme
deprotect
acid
media
furnish
g
boltorn
polym
mimic
natur
organ
highmannos
structur
notabl
present
pathogen
mannosyl
glycodendrim
obtain
multival
scaffold
synthes
commerci
hyperbranch
polym
second
third
fourth
gener
first
function
succin
anhydrid
furnish
poli
acid
cap
admannopyranosid
give
mannosyl
dendrim
variou
gener
g
fig
preliminari
studi
glycodendrim
perfectli
solubl
physiolog
condit
nontox
sever
cell
line
evalu
interact
len
culinari
lectin
lca
group
demonstr
mannodendrim
block
interact
dcsign
ebola
viru
envelop
glycoprotein
interestingli
dendrim
contain
averag
peripher
mannosid
abl
inhibit
select
dcsignmedi
ebola
infect
effici
dosedepend
manner
ic
nm
show
inhibitori
effect
infect
experi
use
dcsignneg
cell
line
result
show
potent
inhibitor
ebola
infect
mediat
dcsign
ci
tran
intraand
intercellular
presum
via
inhibit
mechan
involv
interact
lectin
viral
envelop
addit
carbohydratedepend
inhibitori
effect
confirm
multival
effect
two
order
magnitud
demonstr
sinc
monoval
manosid
abl
inhibit
interact
millimolar
concentr
relat
applic
use
click
chemistri
synthesi
azidofunction
boltorn
dendrim
touaibia
roy
unpublish
data
dendrim
obtain
treatment
hexadecahydroxyl
averag
azidoacet
anhydrid
ir
analysi
demonstr
complet
hydroxylgroup
transform
introduct
azid
function
click
hyperbranch
dendrim
obtain
typic
reaction
condit
cuso
sodium
ascorb
use
nonprotect
propargyl
admannosid
scheme
rel
inhibitori
potenc
mannosyl
dendrim
inhibit
agglutin
e
coli
yeast
mannan
approxim
time
higher
respect
methyl
mannosid
benhamioud
roy
unpublish
data
practic
biolog
applic
glycodendrim
three
function
unit
usual
requir
target
moieti
biolog
activ
agent
probe
gener
facil
strategi
functionalgroup
introduct
defin
posit
dendrim
best
achiev
dendrim
synthes
stepwis
perspect
sharpless
hawker
group
provid
exampl
sophist
multifunct
materi
construct
stepwis
yet
facil
manner
use
effici
click
methodolog
fashioncontrol
strategi
toward
unsymmetr
glycodendrim
two
distinct
moieti
target
detect
probe
place
chain
end
dendrit
block
copolym
fourth
gener
coupl
via
key
step
cu
catalyz
azidealkyn
cycloaddit
prepar
rapidli
dualpurpos
multifunct
materi
without
use
protect
group
orthogon
synthet
approach
base
hydroxymethyl
propano
acid
bismpa
constitut
main
build
block
synthesi
commerci
boltorn
dendrim
correspond
bismpa
anhydrid
provid
access
alkyn
ester
azid
ester
condens
appropri
alcohol
scheme
remov
protect
group
subsequ
condens
click
chemistri
allow
gener
growth
core
afford
asymmetr
structur
diol
focal
point
two
molecul
function
coumarintyp
fluoresc
dye
introduc
esterif
two
free
hydroxyl
group
anhydrid
follow
cycloaddit
acet
hydrolysi
subsequ
introduct
alkyn
via
esterif
follow
cycloaddit
unprotect
admannopyranosid
thfh
furnish
asymmetr
heterobifunct
dendrim
perform
result
mannosyl
dendrim
investig
standard
hemagglutin
assay
use
mbp
con
rabbit
redblood
cell
compar
activ
singl
mannos
exhibit
greater
potenc
correspond
rel
activ
per
sugar
moieti
thu
demonstr
synergist
benefit
provid
multival
dendrit
array
sugar
group
ab
ab
subunitcontain
glycodendrim
aromat
ab
system
mention
earlier
aromat
ab
build
block
constitut
privileg
compon
rapid
design
highli
branch
glycodendrim
possess
biolog
potenti
well
exampl
present
earlier
approach
involv
design
synthesi
g
g
glycodendrim
contain
build
block
acid
homoand
heterobifunct
glycodendrim
end
fucosid
andor
galactosid
residu
instal
via
click
cycloaddit
synthes
via
outsid
strategi
scheme
synthesi
bifunct
glycodendron
two
distinct
moieti
contain
target
detect
probe
diazid
deriv
methyl
fig
alkynefunction
carbohydr
saccharid
select
base
fact
bacterium
p
aeruginosa
respons
chronic
lung
colon
major
caus
morbid
mortal
cf
patient
express
two
lectin
pail
leca
paiil
lecb
specif
dgalactos
lfucos
residu
respect
polyazido
dendrit
scaffold
contain
peripher
azido
function
synthes
success
format
amid
linkag
dendrit
subunit
polyazid
total
function
lfucosid
unit
give
fig
heterobifunction
dendrim
bear
dgalactosid
lfucosid
residu
also
prepar
provid
bind
access
either
pail
paiil
simultan
sugar
heterogen
incorpor
order
increas
biolog
activ
dendrit
architectur
afford
potent
new
antiadhesin
agent
p
aeruginosa
turbidimetr
assay
indic
glycodendrim
possess
minimum
four
fucosid
residu
side
show
rapid
crosslink
abil
tetramer
p
aeruginosa
paiil
lectin
form
insolubl
complex
expect
heterodendrim
contain
fucosid
galactosid
abil
recogn
bindingsit
domain
pail
paiil
ii
ab
system
one
first
exampl
glycodendrim
base
ab
build
block
propos
stoddart
et
al
design
dens
multival
neoglycoconjug
carbohydr
locat
peripheri
short
peptid
chain
eman
aromat
central
core
triscontain
branch
system
converg
approach
adopt
preliminari
construct
dendron
base
initi
glycosyl
three
hydroxylmethyl
group
tri
glucos
scheme
avail
singl
free
amino
group
follow
deprotect
enabl
elabor
format
amid
bond
could
accomplish
directli
triacid
prefer
avoid
steric
problem
intermediaci
iminodipropano
acidderiv
dendron
glycinederiv
glucosyl
dendron
thu
connect
trifunct
scaffold
afford
glycodendrim
decor
peripher
glucosid
singl
step
scheme
converg
strategi
construct
glucosyl
dendrim
use
tri
branch
compon
author
prepar
even
larger
dendrit
deriv
employ
two
differ
yet
close
relat
converg
acceler
strategi
result
dglycopyranosidecontain
glycodendrim
bear
saccharid
residu
obtain
good
yield
socal
reaction
sequenc
involv
three
equival
dendrit
wedg
one
equival
trifunct
core
scheme
advanc
strategi
circumv
problem
incomplet
dendrim
format
aris
limit
reactiv
core
access
imped
decreas
interstiti
space
around
highgener
glycodendrim
thu
obtain
precis
molecular
size
shape
completli
monodispers
despit
dens
pack
surfac
group
furthermor
avoid
anticip
limit
upon
growth
type
dendrim
common
saccharid
contain
protect
group
jayaraman
stoddart
focus
synthesi
glycodendrim
wherein
saccharid
total
unprotect
construct
e
carbosilan
glycodendrim
dendrim
well
effici
methodolog
construct
multival
carbosilan
scaffold
author
simultan
develop
gener
synthet
strategi
attach
carbohydr
moieti
employ
effici
substitut
alkyl
halid
highli
reactiv
thiolat
anion
addit
typic
advantag
encount
dendrim
multival
carbosilan
architectur
offer
synthet
simplic
extend
gener
thu
provid
access
deriv
definit
molecular
weight
number
termin
function
ii
neutral
natur
dendrit
scaffold
chemic
biochem
stabilti
iii
biolog
inert
dendrim
display
uniqu
shape
fanshap
ballshap
dumbbellshap
respect
call
super
twig
present
fig
group
studi
super
twig
therapeut
agent
treatment
infect
stxproduc
e
coli
demonstr
inhibit
potenti
spr
studi
show
dendrim
present
low
k
valu
mm
respect
stli
valu
time
higher
indic
super
twig
bound
directli
high
affin
stli
bsubunit
addit
six
trisaccharid
situat
appropri
distanc
span
central
silicon
core
one
molecul
allow
full
embrac
predict
gb
bind
site
cbp
notabl
suffici
highaffin
bind
furthermor
vivo
inhibitori
effect
super
twig
lethal
intraven
administr
sltii
mice
indic
better
candid
specif
applic
sltii
use
studi
toxic
slti
vitro
vivo
clinic
signific
assay
indic
complet
supress
lethal
effect
stlii
administr
along
toxin
mice
surviv
month
without
patholog
symptom
wherea
nontreat
mice
die
within
day
biolog
result
suggest
suppress
lethal
sltii
diminish
deposit
sltii
brain
consequ
fatal
damag
also
protect
mice
challeng
fatal
dose
e
coli
even
administr
establish
infect
light
result
uniqu
dual
mechan
action
propos
explain
spectacular
effici
bound
slt
high
affin
inhibit
gb
depend
incorpor
target
cell
ii
induc
activ
uptak
subsequ
degrad
slt
macrophag
present
reticuloendothelium
year
later
group
identifi
optim
dendrit
structur
name
optim
valenc
shape
requir
slt
neutral
identifi
anoth
potent
slt
neutral
function
vivo
examin
addit
structur
featur
allow
identif
crucial
structur
paramet
dumbbellshap
structur
two
cluster
trisaccharid
symmetr
locat
hydrophob
core
optim
length
least
first
requir
indic
group
trisaccharid
import
number
trisaccharid
dumbbel
shape
least
six
trisaccharid
need
involv
vivo
activ
termin
trisaccharid
spacer
branch
termin
silicon
atom
cluster
high
densiti
structur
requir
essenti
appropri
induct
macrophagedepend
incorpor
degrad
sltii
support
pivot
role
mechan
vivo
sltsneutral
activ
super
twig
optim
structur
interestingli
data
demonstr
crucial
implic
cbp
present
sltii
bsubunit
show
essenti
suffici
site
highaffin
bind
addit
core
length
major
structur
paramet
perfectli
embrac
three
site
multipl
way
consequ
provid
adequ
hydrophob
volum
recognit
macrophag
consid
fact
galabios
also
known
bind
slt
high
affin
matsuoka
et
al
consid
enhanc
bind
abil
cluster
galabios
would
advantag
compar
cluster
globotriaos
term
synthet
access
viewpoint
practic
use
slt
neutral
accord
synthet
strategi
describ
seri
watersolubl
carbosilan
dendrim
made
bear
peripher
galabios
trimer
interspac
adjust
bindingsit
distanc
fig
bind
affin
slti
sltii
b
subunit
determin
scatchard
plot
analysi
hexaval
compound
show
k
valu
mm
slti
sltii
respect
constitut
onetenth
potenc
homolog
triand
tetraval
analogu
respect
also
present
weaker
affin
mm
respect
slt
hand
evalu
ilabel
slt
bind
cytotox
assay
show
multival
inhibit
bind
ilabel
slt
vero
cell
present
weak
inhibitori
effect
cytotox
assay
compar
best
dumbbel
summari
result
vivo
experi
show
effect
carbosilan
dendrim
cluster
p
k
carbohydr
moieti
complet
neutral
potenc
stlii
discov
dumbbellshap
dendrim
identifi
potent
candid
inibitor
although
precis
mechan
action
remain
elucid
type
inhibitor
provid
new
strategi
detoxif
slt
present
circul
research
group
report
synthesi
asialyl
lactosyl
moieti
bgal
bglc
use
seri
carbosilan
dendrim
scaffold
product
interest
biolog
activ
variou
human
influenza
viru
strain
dendrim
thu
uniformli
function
asialyl
lactos
residu
differ
degre
freedom
sugar
moiti
depend
spacer
length
core
shape
thu
respons
varieti
structur
fig
inhibitori
activ
hemagglutin
influenza
virus
erythrocyt
suggest
dumbbel
amid
longest
spacerarm
carbohydr
epitop
possess
highest
activ
glycolibrari
ic
mm
virus
follow
initi
complex
glycosylyl
architectur
design
finish
seri
larg
multigener
glycodendrim
fig
character
hand
c
nmr
element
analysi
ir
spectroscopi
confirm
low
polydispers
growth
size
dendrim
g
g
also
upon
function
within
gener
shown
diffus
light
scatter
dsl
dosi
nmr
size
exclus
chromatographi
sec
satisfactorilli
agre
expect
size
nanostructur
f
glycodendrimerssever
type
glycodendrim
synthes
wide
varieti
multival
scaffold
three
relev
examp
describ
follow
section
anoth
interest
exampl
illustr
use
scylloinositol
allequatori
stereoisom
myoinositol
also
ad
grow
select
suitabl
scaffold
synthesi
multival
neoglycoconjug
nbocprotect
amino
scylloinositol
scaffold
constitut
key
intermedi
subsequ
glycosyl
well
chain
elong
multipl
direct
toward
next
dendrimer
gener
scheme
henc
conjug
triamin
excess
methyl
acryl
follow
amid
result
ester
ethylenediamin
afford
amidoamin
dendrim
condit
previous
seen
synthesi
pamam
dendrim
reiter
twostep
sequenc
success
doubl
peripher
amino
function
toward
g
dendrim
glycoconjug
dendrim
achiev
thiourea
linkag
discuss
previous
base
mannosyl
isothiocyan
anoth
architectur
yet
exot
propos
sakamoto
design
origin
glycodendrim
base
shapepersist
polyphenylen
build
fig
converg
diverg
rout
use
allow
sugar
instal
dendrim
surfac
also
within
hydrophob
intern
scaffold
employ
success
schmidt
glycosyl
dielsald
reaction
describ
glycodendrim
exhibit
good
solubl
weakli
acid
aqueou
solut
possess
interior
sugar
moieti
reminesc
activ
center
situat
insid
hydrophob
pocket
natur
enzym
identifi
interest
candid
hostguest
molecular
recognit
final
group
major
prepar
addit
phosphorusbas
glycodendrim
involv
hydrazon
group
deriv
dxylos
contain
peripher
epitop
excel
yield
simpl
precipitationbas
purif
process
fig
multival
deriv
obtain
via
substitut
chlorid
atom
termin
p
cl
group
triacetyl
phenol
deriv
dxylos
basic
condit
cs
co
eqcl
atom
consequ
g
g
glycodendrim
contain
xylosid
residu
respect
readili
purifi
filtrat
extract
step
uniform
confirm
notabl
p
nmr
spectroscopi
control
odeacetyl
allow
full
deprotect
furnish
valuabl
amphiphil
glycodendrim
without
decomposit
chapter
highlight
differ
strategi
lead
vast
rang
neoglycoconjug
architectur
glycodendrim
matur
expand
unpredict
level
synthet
strategi
lead
nanostructur
also
wit
consider
progress
includ
organometal
chemistri
chemoenzymat
buildup
silicon
chemistri
selfassembl
initi
challeng
complet
substitut
carbohydr
structur
determin
resolv
undoubtedli
fundament
contribut
toward
goal
util
classic
dipolar
cycloaddit
use
soft
effici
coppercatalyz
coupl
reaction
azid
alkyn
method
extens
use
field
proven
extrem
versatil
addit
enhanc
acceler
converg
strategi
offer
clear
synthet
advantag
eas
purif
import
addit
arsen
sophist
glycodendrim
methodolog
recognit
complex
carbohydr
epitop
advantag
replac
simpler
saccharid
importantli
glycomimet
way
combin
multival
scaffold
carbohydr
ligand
togeth
replac
simpler
higher
affin
mimet
research
commun
deliv
potent
antiadhesin
candid
viral
bacteri
infect
includ
hiv
ebola
virus
key
discoveri
applic
glycodendrim
permit
better
understand
appreci
complex
natur
multival
carbohydrateprotein
interact
upcom
challeng
must
address
issu
finetun
specif
face
numer
famili
carbohydratebind
protein
common
conserv
crd
identifi
instanc
galectin
mbp
anoth
challeng
determin
toxic
glycodendrim
allow
develop
safe
therapeut
agent
